Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647497 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "bone marrow: 44.6" "Group enriched" "Detected in some" 5 "Basal respiratory cells: 33.8;Club cells: 25.8;Respiratory ciliated cells: 101.5" "Cancer enhanced" "Detected in some" "lung cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.8;LHCN-M2: 2.4;U-2 OS: 6.4;U-266/84: 2.9" "Not detected" "Not detected" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.0 0.0 0.1 0.1 0.3 44.6 0.6 0.1 0.2 0.3 0.3 0.2 0.2 0.1 1.1 1.2 1.2 0.3 0.0 0.3 0.1 0.9 0.3 1.3 0.1 0.1 0.3 0.0 0.7 0.0 1.2 0.0 0.1 0.0 0.3 0.4 0.9 0.2 0.0 0.9 0.1 0.0 0.0 0.5 0.0 1.6 0.1 0.6 3.0 0.0 1.7 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.0 1.3 0.0 1.2 0.3 0.7 1.4 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.2 0.0 0.1 2.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 6.4 0.3 1.0 1.9 2.9 0.0 0.8 0.3 0.2 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.1 33.8 0.0 0.0 1.2 0.3 10.5 0.0 25.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.8 0.5 0.2 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.9 0.2 0.0 0.5 0.2 6.1 0.0 0.0 6.1 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 101.5 0.0 0.0 0.1 1.8 3.6 3.7 1.7 0.0 0.0 0.1 0.1 0.5 0.2 ABCB10 "EST20237, M-ABC2, MTABC2" ENSG00000135776 "ATP binding cassette subfamily B member 10" Q9NRK6 1 229516582-229558707 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HL-60: 101.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB044063, CAB044065, HPA055175" Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727" "unprognostic (1.00e-1)" "unprognostic (1.29e-2)" "unprognostic (5.56e-3)" "unprognostic (5.64e-2)" "unprognostic (2.04e-1)" "unprognostic (8.06e-3)" "unprognostic (9.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.15e-2)" "unprognostic (5.61e-2)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (8.32e-2)" "unprognostic (2.58e-1)" "unprognostic (3.83e-1)" "unprognostic (5.29e-2)" "unprognostic (3.37e-2)" 8.9 6.0 4.7 8.9 4.8 60.1 7.9 6.6 6.4 6.8 5.0 11.1 17.2 6.9 4.6 8.3 7.9 6.7 7.9 4.4 4.5 9.8 19.0 8.8 11.0 4.8 4.7 5.5 7.3 9.4 3.4 11.3 4.6 8.4 11.3 6.4 6.7 7.3 12.9 8.1 13.9 9.2 4.3 8.6 10.1 3.8 5.2 8.2 7.5 10.9 9.6 8.5 6.3 5.7 25.1 14.6 11.9 9.8 19.9 17.1 51.6 22.5 16.8 20.0 18.1 15.1 18.7 27.3 20.1 20.7 8.2 21.1 25.8 18.6 20.1 18.7 32.5 30.0 12.2 19.3 14.2 101.9 16.1 11.8 15.7 12.2 14.1 12.1 21.9 47.9 65.2 61.0 20.8 7.9 26.1 57.9 15.9 28.8 12.3 23.4 23.5 29.0 16.2 15.9 8.8 13.3 17.6 19.4 28.6 7.3 15.0 35.0 17.0 21.5 13.5 13.5 31.2 14.9 11.9 23.7 11.3 17.5 13.8 0.5 0.6 0.8 0.7 0.8 1.0 0.5 0.9 1.1 0.8 0.6 0.8 1.0 0.1 0.4 0.6 0.9 0.8 0.3 4.7 4.8 6.6 6.4 4.4 4.5 4.8 4.7 4.6 4.3 5.2 5.7 6.9 9.6 2.0 16.0 3.8 3.2 2.7 4.3 3.4 6.8 6.4 4.2 11.5 5.7 5.5 0.0 12.5 6.5 7.9 13.5 1.9 4.6 0.2 6.3 8.7 6.5 10.2 170.0 21.9 5.3 10.4 5.0 6.1 6.0 5.7 3.5 8.6 19.2 9.1 10.1 27.3 10.6 2.0 13.3 6.6 0.5 5.0 8.3 8.8 10.3 16.8 3.6 4.1 31.2 30.3 4.7 8.8 4.5 5.5 8.4 13.5 4.9 12.1 4.8 6.6 5.4 6.8 4.2 4.5 8.3 5.1 3.6 5.9 2.8 11.5 3.7 AC018755.2 ENSG00000268500 "Novel transcript, sense intronic to AC018755.18" 19 51612091-51646889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 26.1;lymphoid tissue: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 5.0" "Immune cell enhanced" "Detected in many" "neutrophil: 180.3" "Group enriched" "Detected in many" 5 "granulocytes: 180.3;monocytes: 70.1" "Group enriched" "Detected in some" 10 "HMC-1: 78.0;U-937: 33.2" HPA009085 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA009085: AB_1079965" 1.4 0.4 0.1 7.2 0.2 26.1 0.1 0.3 5.0 0.3 0.3 0.3 0.8 0.1 0.0 1.0 0.2 1.0 0.3 0.1 0.4 0.1 0.2 1.3 2.9 0.7 0.4 0.0 0.2 0.1 0.0 0.5 1.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.5 0.4 4.0 0.4 0.1 0.7 0.6 0.0 0.1 0.5 1.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.6 78.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 33.2 0.1 11.2 32.4 1.0 0.1 32.3 0.0 2.0 0.0 0.0 22.8 2.7 0.0 0.0 180.3 0.8 70.1 4.9 0.0 17.3 0.1 0.2 0.3 5.0 0.1 0.4 0.7 0.4 1.6 0.4 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRG3 "GPR97, Pb99, PGR26" ENSG00000182885 "Adhesion G protein-coupled receptor G3" Q86Y34 16 57668277-57689378 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 147.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.4;dendritic cells: 2.9;Endothelial cells: 2.8;Erythroid cells: 5.3;T-cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebral cortex: 10.6" "Immune cell enhanced" "Detected in some" "eosinophil: 142.3;neutrophil: 169.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 169.8" "Group enriched" "Detected in some" 6 "NB-4: 5.0;SK-MEL-30: 2.1;U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA040469 Uncertain NA NA 1200000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA040469: AB_10794032" "unprognostic (4.41e-3)" "unprognostic (3.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" "unprognostic (8.84e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-4)" "unprognostic (5.25e-3)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.67e-3)" "unprognostic (4.75e-2)" "unprognostic (3.77e-1)" "unprognostic (1.00e-1)" "unprognostic (2.90e-1)" 8.5 0.3 0.1 14.6 0.2 147.0 1.7 0.1 10.6 1.1 0.3 1.6 2.2 1.0 0.0 1.0 4.3 2.3 1.2 0.1 0.1 0.8 2.3 12.0 0.3 0.2 0.2 0.4 0.7 0.0 0.2 1.7 2.0 0.6 1.4 0.0 0.4 0.1 0.3 0.7 3.4 2.6 0.1 29.4 1.3 0.3 0.4 0.6 3.2 2.8 0.4 3.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 75.5 0.0 142.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 36.4 0.1 0.0 0.0 0.9 0.1 0.2 0.1 10.6 0.1 0.1 0.2 0.2 2.0 0.1 0.4 0.1 1.0 9.6 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 1.8 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.6 0.5 0.2 2.8 0.0 5.3 0.1 0.0 0.1 0.9 0.0 0.4 2.5 0.2 2.2 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.2 1.5 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.1 4.2 0.0 0.0 0.1 AHSP "EDRF, ERAF" ENSG00000169877 "Alpha hemoglobin stabilizing protein" Q9NZD4 16 31527900-31528803 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 62 "bone marrow: 1669.9" "Cell type enriched" "Detected in some" 296 "Erythroid cells: 8721.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 3.0;K-562: 1.5" "Low region specificity" "Detected in some" HPA040940 Enhanced NA NA 5300000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 6: Erythroid cells - Oxygen transport" "HPA040940: AB_10796231" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (8.44e-2)" "unprognostic (3.76e-1)" "unprognostic (1.53e-1)" "unprognostic (3.10e-1)" "unprognostic (2.16e-1)" "unprognostic (3.70e-3)" "unprognostic (2.04e-2)" "unprognostic (9.02e-2)" "unprognostic (3.25e-2)" 1.3 0.1 0.6 0.2 0.6 1669.9 0.4 0.6 2.6 0.4 0.6 0.1 0.0 0.1 0.0 0.2 0.2 0.0 1.5 0.6 0.5 1.9 4.7 4.5 0.2 0.7 0.7 0.2 0.3 0.1 1.4 27.1 0.7 0.1 0.3 0.0 0.5 0.0 0.2 1.4 0.1 0.0 0.6 23.7 0.2 4.1 0.6 2.9 0.7 8.9 0.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 4.7 0.6 0.6 0.6 2.6 0.6 0.5 0.7 0.7 0.7 0.6 0.6 0.8 0.1 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.6 0.0 8721.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 2.9 4.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 29.4 0.3 2.8 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.0 0.0 2.1 0.0 0.0 0.1 ALAS2 ASB ENSG00000158578 "5'-aminolevulinate synthase 2" P22557 X 55009055-55030977 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "bone marrow: 606.2" "Cell type enriched" "Detected in some" 166 "Erythroid cells: 2366.7" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.6" "Group enriched" "Detected in some" 93 "HEL: 71.7;K-562: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "unprognostic (7.82e-2)" "unprognostic (2.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-3)" "unprognostic (5.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (8.68e-2)" "unprognostic (4.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.45e-1)" "unprognostic (2.32e-2)" "unprognostic (6.63e-3)" "unprognostic (4.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" 1.9 0.5 0.9 0.4 0.9 606.2 0.6 0.8 2.5 0.2 1.6 0.5 0.6 0.1 0.0 0.8 1.1 0.8 3.4 0.7 0.8 2.5 3.2 5.2 0.3 1.8 1.2 0.4 0.3 0.0 1.2 44.9 1.6 0.2 0.0 0.2 1.0 0.2 0.5 0.6 0.3 0.1 1.6 25.2 0.2 0.2 1.0 1.0 1.2 18.2 0.0 0.6 0.7 1.3 0.1 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.6 71.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 85.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.6 0.0 5.9 0.9 0.9 0.8 2.5 0.7 0.8 1.8 1.2 1.6 1.6 1.0 1.3 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.3 1.8 2366.7 0.0 0.2 1.8 0.3 0.0 0.1 0.0 0.0 1.4 1.3 2.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 7.3 14.2 1.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.1 APOBEC3B "FLJ21201, PHRBNL" ENSG00000179750 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3B" Q9UH17 22 38982347-38992804 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.4;intestine: 12.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 11.8;Ductal cells: 14.7;Erythroid cells: 14.1;Plasma cells: 26.2;Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 256.0;Karpas-707: 283.6" "HPA056980, HPA066719" Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (2.92e-2)" "prognostic favorable (2.58e-5)" "unprognostic (4.29e-2)" "unprognostic (1.19e-1)" "unprognostic (2.50e-1)" "unprognostic (1.35e-1)" "unprognostic (1.69e-2)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (6.36e-2)" "unprognostic (1.08e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.47e-2)" "unprognostic (2.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.04e-1)" 0.9 1.2 0.1 5.7 0.1 28.4 2.0 0.1 0.2 1.2 0.1 12.1 7.3 1.0 0.4 3.0 0.7 1.1 0.8 0.1 0.1 2.7 1.1 1.9 5.9 0.1 0.1 0.7 3.3 1.2 0.2 1.6 0.1 0.4 12.0 0.3 2.8 0.2 0.4 2.1 4.3 1.4 0.1 6.4 4.1 0.3 0.2 2.5 1.3 0.2 8.6 7.6 1.5 0.2 256.0 28.0 10.5 68.1 1.5 6.0 18.6 23.0 19.7 43.0 56.5 54.7 46.6 3.0 20.4 22.9 63.0 108.2 1.3 4.5 43.1 92.1 2.5 72.5 5.6 14.0 0.7 61.7 43.0 2.3 0.5 45.1 2.2 8.9 17.0 0.0 41.6 283.6 68.1 6.9 0.2 35.3 0.3 24.6 25.2 1.8 105.0 95.6 9.1 42.2 1.8 0.0 0.0 0.3 16.0 1.8 33.0 18.1 10.2 48.0 81.9 7.5 0.7 62.8 18.0 0.3 34.4 68.2 100.7 0.4 1.0 0.0 0.2 4.9 0.0 7.2 0.5 0.3 0.6 3.1 0.0 0.3 1.4 1.7 1.7 0.0 2.8 3.5 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 1.7 0.0 2.2 5.4 3.2 11.8 0.6 0.0 1.5 0.5 0.3 0.0 8.1 0.0 0.0 1.0 0.4 4.6 0.0 14.7 0.0 5.9 0.6 0.2 0.0 14.1 0.0 1.8 1.8 0.8 3.1 5.3 0.0 0.8 0.4 0.0 2.1 0.0 0.0 0.4 10.2 1.2 6.3 0.0 0.0 2.3 7.2 0.0 1.4 0.0 0.0 0.0 0.0 6.0 9.9 0.0 26.2 1.4 0.4 0.3 9.3 0.0 0.0 0.0 0.9 0.0 0.0 4.2 3.3 0.8 0.5 0.1 1.6 11.4 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "bone marrow: 78.1" "Cell type enriched" "Detected in many" 6 "Microglial cells: 248.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.2;NK-cell: 11.0" "Group enriched" "Detected in many" 5 "granulocytes: 15.2;NK-cells: 11.0" "Cell line enhanced" "Detected in some" "HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 1.4 1.1 2.3 2.5 2.4 78.1 0.7 3.5 6.5 1.5 3.0 1.1 0.7 6.4 4.2 0.5 3.1 2.2 0.4 4.5 2.9 1.2 1.6 1.1 1.0 2.5 2.6 0.4 0.5 0.2 0.3 3.5 2.8 0.6 1.7 0.1 0.5 0.8 0.1 0.3 1.3 3.1 3.1 2.6 0.6 0.4 2.4 0.5 0.1 0.1 1.0 1.4 0.4 4.9 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.5 0.5 0.2 0.0 0.2 12.2 0.0 7.3 1.7 0.1 0.0 13.6 40.2 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 19.2 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.1 1.2 0.0 0.0 0.1 0.0 26.7 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 1.3 103.7 0.0 15.2 2.0 3.8 0.4 1.2 0.1 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.8 11.0 0.4 0.0 0.0 0.9 2.3 2.4 3.5 6.5 4.5 2.9 2.5 2.6 2.8 3.1 2.4 4.9 1.7 0.0 1.9 1.6 0.8 1.5 0.1 0.2 0.6 0.6 0.2 0.6 1.3 0.0 0.1 0.0 0.0 5.4 12.5 0.3 0.0 0.0 27.6 0.3 1.7 1.0 0.0 12.2 20.3 0.0 1.8 8.1 3.1 0.2 19.7 0.0 1.1 3.7 16.4 0.0 17.5 0.3 2.0 37.0 17.7 25.3 1.8 27.0 1.8 248.3 6.3 0.5 15.5 1.0 2.1 0.0 0.1 0.7 4.8 2.3 0.7 1.2 0.7 0.2 0.0 1.0 7.0 0.5 0.6 0.6 0.3 2.9 13.4 1.1 0.2 0.3 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "bone marrow: 1578.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in some" 15 "THP-1: 659.5" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 320000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA055851: AB_2682943, HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.8 0.2 0.4 0.0 0.4 1578.1 1.5 0.2 0.9 0.2 0.2 0.2 0.0 0.5 0.0 0.1 1.4 0.0 2.0 0.4 0.3 0.4 2.8 15.9 0.6 0.3 0.3 0.2 0.2 0.0 0.9 0.9 0.4 0.4 0.0 0.0 2.6 0.0 0.5 0.6 0.2 0.0 0.2 33.1 0.2 2.4 0.4 3.1 0.5 0.0 0.0 0.3 0.2 0.3 1.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 44.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.6 659.5 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.6 0.0 34.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.2 0.9 0.4 0.3 0.3 0.3 0.4 0.2 0.4 0.3 3.5 0.0 0.0 0.0 0.6 0.0 0.1 1.2 0.0 0.0 4.5 4.6 0.7 0.0 0.5 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 8.9 1.2 1.0 0.0 8.8 0.8 0.0 0.3 0.8 0.0 2.3 0.0 0.1 0.0 0.4 3.2 0.0 1.4 0.4 0.0 3.7 0.4 0.7 0.0 3.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.0 4.5 0.0 0.0 5.7 1.2 0.1 6.4 0.9 0.1 0.0 1.0 0.0 0.6 0.0 BAZ1A "ACF1, hACF1, WALp1, WCRF180" ENSG00000198604 "Bromodomain adjacent to zinc finger domain 1A" Q9NRL2 14 34752731-34875647 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 74.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 428.6;Early spermatids: 555.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 29.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002730 Supported NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "HPA002730: AB_1078269" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (2.76e-2)" "unprognostic (1.84e-2)" "unprognostic (4.24e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (4.11e-2)" "unprognostic (3.99e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-3)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.31e-7)" "unprognostic (2.44e-1)" "unprognostic (7.83e-2)" "unprognostic (2.90e-2)" "unprognostic (4.37e-2)" 14.4 6.0 4.7 22.5 5.8 74.6 11.7 4.5 6.4 8.5 5.0 12.5 10.4 7.6 7.3 16.6 8.9 13.5 5.7 4.8 5.6 6.8 11.9 19.3 25.2 6.3 5.6 7.8 7.1 6.2 3.6 12.7 5.9 8.8 12.9 1.7 11.5 5.8 9.7 21.6 12.4 9.0 5.1 20.2 13.1 30.8 6.6 21.7 7.7 6.4 20.7 27.9 11.2 7.0 46.4 24.1 39.7 30.5 16.9 19.6 49.2 36.7 20.0 33.6 33.6 23.9 32.8 92.1 28.0 26.3 18.7 47.0 68.4 23.8 58.2 33.4 29.5 60.0 22.6 66.9 19.9 99.6 69.8 18.2 24.2 36.3 48.1 13.5 49.3 41.2 56.4 23.0 28.5 52.9 95.3 31.3 19.1 36.4 34.1 72.4 40.9 25.7 21.0 44.2 50.4 41.2 49.6 67.4 20.2 13.5 34.5 68.7 44.6 31.0 22.7 33.6 37.2 12.7 13.5 77.1 10.0 45.9 36.0 7.6 5.7 7.7 3.5 6.2 2.5 5.3 3.6 3.9 3.4 4.7 3.6 2.9 29.3 2.7 7.1 4.2 4.2 1.5 4.7 5.8 4.5 6.4 4.8 5.6 6.3 5.6 5.9 5.1 6.6 7.0 68.5 60.9 77.9 24.5 103.5 428.6 237.6 96.9 174.2 2.6 79.7 54.0 14.7 28.6 82.8 16.5 2.1 68.6 135.4 89.2 0.0 86.8 555.2 87.5 72.3 103.8 30.5 85.2 12.2 74.7 118.0 76.1 66.3 112.1 101.6 33.1 27.8 28.6 87.9 0.0 9.4 69.9 77.3 96.7 263.7 373.0 40.4 158.7 72.9 47.8 165.8 2.4 129.8 26.7 35.8 121.7 133.6 13.5 90.5 213.2 51.6 15.3 89.2 2.0 6.6 106.8 76.1 199.9 38.7 141.8 389.6 196.9 152.1 23.8 62.1 372.5 BCL2A1 "ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1" ENSG00000140379 "BCL2 related protein A1" Q16548 15 79960892-79971196 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 617.3" "Group enriched" "Detected in many" 5 "B-cells: 177.4;granulocytes: 220.7;Hofbauer cells: 214.9;Langerhans cells: 508.2;Macrophages: 604.2;monocytes: 386.0" "Cancer enhanced" "Detected in all" "melanoma: 39.4" "Group enriched" "Detected in all" 4 "cerebral cortex: 39.7;pons: 12.5" "Group enriched" "Detected in all" 5 "eosinophil: 284.0;intermediate monocyte: 195.8;neutrophil: 534.0;non-classical monocyte: 378.9" "Group enriched" "Detected in all" 7 "granulocytes: 534.0;monocytes: 378.9" "Cell line enriched" "Detected in many" 5 "SK-MEL-30: 525.0" "Low region specificity" "Detected in single" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 41: Macrophages - Immune response" "unprognostic (3.19e-3)" "unprognostic (2.61e-1)" "unprognostic (3.99e-2)" "unprognostic (3.54e-3)" "unprognostic (9.65e-3)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-2)" "unprognostic (4.01e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.61e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" 28.6 1.7 2.5 105.1 2.7 617.3 4.3 2.8 39.7 4.3 4.3 5.9 4.6 2.8 1.5 2.4 8.4 17.4 4.6 2.4 2.7 3.4 14.7 59.0 72.0 4.9 3.9 0.9 4.7 0.9 1.3 20.4 12.5 2.3 5.9 0.6 4.4 0.9 0.9 1.7 8.0 13.5 3.4 57.9 5.6 0.4 6.3 17.2 2.4 10.8 56.7 52.1 1.7 5.8 0.4 1.4 0.0 0.1 0.6 0.9 0.0 0.0 6.9 0.0 0.6 0.0 0.1 3.0 0.2 0.0 0.2 0.0 0.0 14.3 4.1 1.5 0.0 0.6 0.0 1.4 2.2 3.7 111.4 2.0 0.1 8.2 0.0 0.2 0.7 0.6 0.0 0.4 0.2 0.0 0.1 19.3 0.1 0.0 3.5 0.2 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.0 525.0 0.0 0.0 5.0 0.0 51.8 4.9 0.2 1.1 0.5 0.3 4.3 2.3 40.3 27.4 24.2 42.3 284.0 24.5 195.8 13.9 64.4 31.3 32.4 25.2 44.2 38.1 35.1 534.0 21.5 378.9 5.0 8.0 49.1 2.5 2.7 2.8 39.7 2.4 2.7 4.9 3.9 12.5 3.4 6.3 5.8 7.6 22.4 57.3 0.0 177.4 11.0 0.8 50.9 0.6 0.1 2.9 3.7 4.3 0.0 38.0 1.8 0.0 1.9 33.9 0.3 1.9 2.2 1.3 12.0 4.2 6.2 0.0 1.3 0.1 1.6 2.3 8.4 2.0 41.1 220.7 0.2 1.4 1.6 214.9 0.0 0.1 0.1 2.0 60.5 508.2 1.5 0.0 604.2 33.8 0.0 386.0 0.3 13.4 0.0 0.0 6.5 0.1 0.0 14.6 1.4 0.1 0.8 13.8 0.2 0.0 1.3 4.8 0.3 0.2 0.5 10.2 4.5 53.3 0.1 0.2 1.8 BCLAF1 "BTF, KIAA0164" ENSG00000029363 "BCL2 associated transcription factor 1" Q9NYF8 6 136256627-136289851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 135.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006484, HPA006669, HPA027770" Enhanced Enhanced "Nuclear speckles" NA NA 21000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484" "prognostic unfavorable (1.64e-4)" "unprognostic (1.60e-1)" "prognostic favorable (3.44e-4)" "unprognostic (1.45e-1)" "unprognostic (9.46e-3)" "unprognostic (2.29e-1)" "unprognostic (2.13e-3)" "unprognostic (1.63e-1)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (4.19e-3)" 24.4 22.3 14.3 26.9 17.3 135.0 32.9 23.6 18.6 21.4 19.7 29.5 18.8 23.2 24.0 24.3 21.3 14.8 16.7 15.9 19.2 21.5 27.4 24.6 28.2 11.1 12.9 24.4 25.5 33.4 18.0 21.3 12.0 21.2 28.4 34.8 21.2 20.5 27.5 21.8 21.1 28.3 14.7 24.8 27.9 21.3 16.7 35.2 30.4 24.3 32.9 23.0 19.3 19.3 82.4 70.0 162.5 136.2 50.4 42.6 82.3 153.0 94.4 100.6 106.5 100.4 54.4 172.7 92.8 117.9 112.8 78.0 183.5 101.1 125.5 95.1 114.2 213.7 96.0 110.3 58.6 362.6 131.0 58.3 49.2 142.8 88.6 37.2 90.9 77.6 193.6 82.3 107.0 97.4 145.3 40.2 120.2 55.2 72.0 130.3 203.2 76.4 76.3 155.0 137.2 94.5 150.0 71.3 60.4 60.6 66.9 71.5 125.7 79.2 116.7 95.9 151.2 69.5 134.8 227.9 47.2 113.3 94.2 32.6 27.1 42.1 32.4 33.2 32.7 36.6 29.9 28.1 42.3 32.9 37.7 34.5 57.9 49.5 35.3 24.7 25.5 24.5 14.3 17.3 23.6 18.6 15.9 19.2 11.1 12.9 12.0 14.7 16.7 19.3 165.3 205.1 178.7 68.9 174.3 68.2 118.9 99.5 104.2 129.7 86.9 71.5 88.4 65.8 131.6 57.0 210.6 111.9 173.3 86.3 33.2 96.8 12.6 157.2 173.5 117.5 118.9 134.6 80.5 65.2 99.4 138.0 128.0 169.8 156.4 130.5 74.3 60.0 74.0 102.6 82.6 106.0 93.6 92.5 88.9 13.8 122.1 121.8 69.4 56.2 136.9 91.6 118.4 63.3 93.4 77.5 81.4 109.4 197.8 128.6 83.3 42.9 147.1 139.9 111.7 259.8 130.7 102.2 129.7 121.4 71.2 128.3 174.8 154.8 101.6 123.8 BID ENSG00000015475 "BH3 interacting domain death agonist" P55957 22 17734138-17774770 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 103.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 273.2;Langerhans cells: 658.8;monocytes: 491.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 6 "dendritic cells: 345.8;granulocytes: 925.5;monocytes: 985.3" "Cell line enhanced" "Detected in all" "MCF7: 241.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000722, CAB003771" Enhanced Supported Cytosol NA NA 800000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" Cytosol "CAB003771: AB_365478, HPA000722: AB_1078283" "unprognostic (1.59e-1)" "unprognostic (5.51e-2)" "unprognostic (5.02e-2)" "unprognostic (3.04e-2)" "unprognostic (4.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.84e-2)" "unprognostic (5.21e-3)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-13)" "unprognostic (4.66e-3)" "unprognostic (1.59e-1)" "unprognostic (3.55e-3)" "unprognostic (2.18e-2)" 13.6 6.9 19.4 30.5 20.9 103.5 10.7 19.2 22.4 6.0 12.8 14.7 15.1 5.7 7.2 7.5 6.2 14.7 17.4 20.0 19.5 10.0 28.2 12.0 35.6 19.9 19.8 5.7 9.5 3.5 6.4 7.9 20.8 8.1 11.0 36.9 8.1 4.1 23.3 7.6 17.5 6.8 20.1 30.0 12.2 3.6 22.0 26.4 5.8 7.8 16.7 34.4 7.5 20.2 117.5 90.6 14.4 43.7 15.2 27.7 20.4 59.1 45.4 44.8 38.4 55.4 67.2 22.8 41.5 25.7 52.3 97.8 14.5 14.7 24.7 37.0 73.4 101.3 39.7 81.3 19.1 110.4 107.0 26.7 31.4 49.8 11.3 35.6 46.8 64.8 84.0 27.2 23.0 241.6 161.0 148.2 47.2 130.2 62.8 76.6 37.3 32.8 12.0 141.2 91.3 65.9 12.5 38.2 37.1 6.2 80.3 132.9 80.4 26.0 36.0 43.9 46.7 39.8 57.2 75.7 74.6 113.0 33.8 156.9 417.0 691.4 82.1 748.3 81.7 53.0 75.8 92.5 345.8 33.0 61.2 72.2 925.5 124.1 985.3 245.8 108.0 428.1 19.4 20.9 19.2 22.4 20.0 19.5 19.9 19.8 20.8 20.1 22.0 20.2 49.0 16.0 14.5 16.0 34.5 71.9 53.1 273.2 21.1 3.0 30.0 30.5 17.5 17.2 142.6 9.2 2.1 9.3 70.3 25.1 7.9 67.9 0.6 10.5 14.5 47.4 34.1 23.3 17.6 51.4 5.6 24.9 13.7 11.4 25.3 34.3 23.2 44.0 134.1 0.0 15.6 38.7 63.1 69.1 658.8 1.6 5.3 164.2 58.7 13.1 491.3 3.0 65.9 4.5 2.1 78.5 85.1 4.1 45.2 186.4 16.5 28.6 59.7 1.7 0.0 12.0 24.3 1.3 11.9 13.2 64.5 5.1 38.3 13.6 49.8 213.0 BIN3 ENSG00000147439 "Bridging integrator 3" Q9NQY0 8 22620418-22669148 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Septation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 94.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023769 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 5: Muller glia cells - Visual perception" "HPA023769: AB_1845361" "unprognostic (4.93e-3)" "unprognostic (4.42e-2)" "unprognostic (6.44e-3)" "unprognostic (1.44e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (7.36e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-2)" "unprognostic (1.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.53e-2)" "unprognostic (2.20e-3)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" 18.6 28.4 13.4 8.5 14.1 40.3 17.6 13.2 16.3 12.4 14.4 11.4 6.8 9.6 9.4 15.8 15.1 9.5 11.5 14.0 13.6 21.0 14.0 11.6 10.4 14.1 13.2 10.4 9.7 12.5 12.6 8.4 13.8 15.5 9.9 7.7 11.6 9.4 9.2 13.9 11.1 8.0 12.8 13.3 12.6 10.4 13.5 13.3 13.2 4.4 10.9 13.5 12.9 13.7 20.6 17.5 7.7 16.6 19.9 18.4 8.6 18.2 31.0 28.4 23.2 7.2 7.9 16.6 8.0 20.0 19.9 22.7 14.9 19.0 19.4 12.6 10.1 13.8 9.0 13.6 16.7 14.3 14.8 19.0 22.2 20.9 11.1 18.0 18.4 9.7 27.5 10.2 14.8 10.0 22.8 31.7 14.6 26.9 7.6 11.4 8.2 8.1 28.4 16.2 4.0 8.8 8.7 6.4 94.2 10.3 6.2 12.7 17.7 8.8 10.8 18.1 13.7 6.8 6.1 15.1 25.1 10.3 58.5 56.3 34.2 78.3 29.0 33.9 30.0 25.8 29.5 21.9 27.5 29.1 28.9 23.5 94.9 36.4 26.1 24.9 41.0 36.9 13.4 14.1 13.2 16.3 14.0 13.6 14.1 13.2 13.8 12.8 13.5 13.7 31.7 9.6 13.0 9.1 16.5 9.8 30.9 32.9 5.2 14.0 11.5 10.0 1.1 18.6 17.2 14.7 41.7 42.8 14.7 24.0 15.6 25.1 28.5 26.7 15.3 21.0 19.8 14.3 13.3 27.6 22.5 14.0 21.4 28.4 31.7 13.6 17.2 6.1 20.2 25.2 9.8 22.1 34.6 9.6 8.7 4.9 18.3 13.0 19.6 8.4 18.6 69.3 32.0 4.0 7.2 41.7 26.1 12.0 8.5 23.4 16.7 13.9 34.1 33.8 13.1 25.4 14.6 18.0 14.0 5.4 11.5 79.4 15.0 24.4 18.2 41.2 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646811-134679816 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 87.3" "Group enriched" "Detected in all" 4 "Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 118.2;RT4: 186.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 81000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 15: RT4 - Unknown function" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 11.4 12.6 16.3 9.1 17.1 87.3 12.4 17.9 20.5 12.5 15.8 12.9 8.4 9.6 18.5 26.9 8.5 12.9 13.5 16.5 19.0 35.1 13.1 14.0 11.1 17.9 17.8 7.1 8.4 35.3 18.1 47.0 18.2 13.5 10.0 19.9 17.8 17.9 37.8 10.7 8.0 12.1 19.6 12.5 11.9 14.7 17.7 16.3 11.9 27.0 26.2 39.0 17.2 18.5 14.0 16.3 21.7 29.6 24.3 14.4 21.9 41.3 49.9 15.7 23.2 6.5 18.5 17.1 12.0 23.2 30.9 11.2 23.3 22.7 27.6 118.2 19.9 9.8 15.4 7.8 16.7 18.8 12.4 14.2 20.0 29.7 16.0 24.0 58.0 20.8 28.8 20.9 37.8 6.6 30.7 26.0 22.7 27.7 15.3 23.2 15.5 12.4 36.1 186.8 18.7 31.1 19.3 23.1 21.7 23.1 15.1 11.8 44.7 25.1 6.0 33.7 33.9 33.9 41.2 21.5 43.3 17.7 43.7 61.1 16.4 48.9 23.3 22.2 16.7 19.3 15.0 20.7 17.5 18.9 20.7 21.1 30.2 18.5 23.0 11.4 21.1 23.6 16.3 17.1 17.9 20.5 16.5 19.0 17.9 17.8 18.2 19.6 17.7 18.5 17.6 9.6 25.5 6.5 15.7 39.0 18.5 60.6 10.8 19.2 15.9 18.7 25.0 18.6 52.3 27.6 2.1 44.5 43.0 5.0 129.1 45.9 3.4 10.0 7.0 18.8 13.1 456.6 8.0 18.2 32.7 17.0 4.1 8.5 24.7 6.6 10.0 4.7 15.1 20.2 9.3 4.6 36.7 11.7 10.5 7.2 10.2 11.8 23.2 5.6 15.7 25.6 47.4 7.5 11.6 49.0 4.6 12.0 14.2 26.0 5.5 68.8 50.5 13.5 6.6 12.0 22.1 33.9 21.8 13.5 13.2 368.9 25.0 7.8 4.8 19.2 BPI BPIFD1 ENSG00000101425 "Bactericidal permeability increasing protein" P17213 20 38304150-38337505 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "bone marrow: 1503.7" "Group enriched" "Detected in some" 8 "Early spermatids: 201.8;Late spermatids: 220.6;Proximal tubular cells: 99.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "classical monocyte: 14.5;neutrophil: 7.1" "Group enriched" "Detected in many" 17 "granulocytes: 7.1;monocytes: 14.5" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA061284 Enhanced "Secreted to blood" NA NA 7290000 78000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA061284: AB_2684465" "unprognostic (9.30e-4)" "unprognostic (5.49e-2)" "unprognostic (1.97e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.56e-1)" "unprognostic (4.50e-2)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-1)" "unprognostic (8.83e-6)" "unprognostic (2.66e-4)" "unprognostic (9.29e-2)" "unprognostic (2.32e-2)" "unprognostic (9.47e-3)" 0.5 0.2 0.1 0.1 0.2 1503.7 0.6 0.1 0.4 2.6 0.2 0.2 0.0 0.7 1.0 0.1 0.4 0.5 0.5 0.1 0.2 3.4 0.8 3.7 0.3 0.2 0.2 1.7 0.0 0.0 0.6 0.5 0.2 0.4 0.0 0.0 1.4 1.2 0.1 1.8 0.1 0.2 0.2 13.0 0.1 17.1 0.2 3.7 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.1 0.0 0.6 0.0 0.0 9.8 0.1 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 1.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.0 0.4 3.7 0.0 0.0 0.0 0.0 9.8 0.0 201.8 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 20.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 220.6 17.7 1.3 1.8 0.0 7.1 0.0 1.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 99.7 0.3 0.0 0.0 0.2 0.4 2.1 1.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091644-9121635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.1" "Cell type enhanced" "Detected in all" "Late spermatids: 643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 42: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: AB_2685850" "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.0 17.4 15.7 18.2 17.8 106.1 17.2 14.9 20.3 15.9 14.0 14.9 14.8 15.2 17.3 19.6 12.8 19.0 15.8 18.8 16.7 18.6 26.8 17.5 20.1 14.1 15.8 14.2 18.6 22.3 9.8 17.1 14.9 15.9 15.0 20.8 14.2 14.7 32.4 17.0 13.6 16.8 13.8 20.9 15.8 17.3 16.8 19.4 18.8 27.8 22.0 17.8 15.2 16.8 17.3 18.9 29.6 27.1 34.4 26.7 15.5 33.2 27.6 18.8 19.3 15.9 22.0 30.8 18.6 38.6 14.8 19.8 27.5 29.4 39.2 20.3 15.4 20.7 27.2 33.6 44.4 26.3 23.2 40.7 45.3 31.5 44.7 30.1 33.1 31.7 31.6 45.7 33.6 24.9 23.5 23.3 36.1 17.7 16.5 39.6 36.1 33.1 24.6 31.3 19.1 21.4 39.9 27.8 35.1 27.4 32.1 26.6 38.3 36.6 24.0 47.6 21.7 51.7 48.0 42.5 32.6 23.2 30.3 5.5 2.8 3.2 3.7 3.1 4.2 2.5 3.1 2.6 2.2 3.0 3.5 3.2 10.9 2.3 3.4 2.8 2.7 1.7 15.7 17.8 14.9 20.3 18.8 16.7 14.1 15.8 14.9 13.8 16.8 16.8 65.3 48.1 37.2 17.6 47.5 76.9 45.4 13.0 78.6 43.6 81.6 53.8 39.3 35.8 19.1 22.0 87.6 29.6 76.0 45.8 19.6 28.1 210.0 75.7 75.1 52.5 48.2 21.7 27.6 29.4 35.7 42.9 35.2 115.7 18.3 51.9 38.6 59.5 32.5 43.7 28.2 35.1 8.2 83.8 65.6 643.5 24.5 83.5 32.0 28.1 49.0 41.8 33.0 24.6 33.3 38.9 37.7 27.1 59.2 52.0 44.5 36.8 15.9 51.2 32.9 78.0 56.3 41.5 22.3 84.5 64.4 57.1 58.8 35.3 34.9 70.1 C17orf99 "GLPG464, UNQ464" ENSG00000187997 "Chromosome 17 open reading frame 99" Q6UX52 17 78146353-78166177 "Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 9.0" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "HaCaT: 3.5;HMC-1: 7.1;K-562: 4.2" "Not detected" "Not detected" HPA029655 Uncertain "Secreted to blood" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA029655: AB_10601691" "unprognostic (3.55e-5)" "unprognostic (1.87e-2)" "unprognostic (2.06e-1)" "unprognostic (1.22e-1)" "unprognostic (1.88e-1)" "unprognostic (1.45e-3)" "unprognostic (1.47e-3)" "unprognostic (2.39e-1)" "unprognostic (3.86e-1)" "unprognostic (9.77e-2)" "unprognostic (2.05e-2)" "unprognostic (5.13e-2)" "unprognostic (1.38e-4)" "unprognostic (6.58e-2)" "unprognostic (4.72e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 1.8 0.4 0.6 1.1 0.1 0.3 0.5 0.0 0.7 1.8 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 52.6 0.3 0.4 0.4 0.4 0.0 0.3 0.0 0.1 0.4 0.2 0.5 0.0 0.3 0.7 0.0 0.0 0.7 0.1 0.6 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.7 0.2 0.1 0.2 0.1 0.0 1.1 0.6 0.1 0.1 0.6 0.9 0.3 0.2 0.9 0.4 0.8 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 98.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8" "Group enriched" "Detected in all" 20 "dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8" "Cell line enriched" "Detected in some" 4 "U-937: 50.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 3.6 1.0 3.5 11.2 3.9 98.0 1.2 4.2 4.5 2.1 3.5 1.8 1.7 1.0 2.7 1.0 2.3 2.9 0.9 3.4 4.1 1.2 3.2 6.1 5.2 5.2 4.3 2.0 1.7 0.4 0.8 1.8 5.2 1.3 1.2 0.7 0.9 0.9 2.7 0.5 2.3 3.4 4.6 21.7 1.6 11.1 4.0 3.2 0.5 1.5 3.0 4.6 1.6 6.0 2.4 0.1 0.2 0.4 2.2 1.2 0.2 0.4 0.1 0.4 0.9 0.2 0.4 5.9 0.5 0.0 0.2 0.2 0.3 0.3 0.3 2.7 0.6 0.3 0.0 0.0 1.6 3.9 0.6 6.0 0.7 1.0 0.3 0.1 0.1 0.6 0.3 12.2 0.2 2.2 0.2 9.3 0.5 0.4 0.4 4.5 0.0 3.1 0.0 0.2 0.3 0.1 1.2 0.0 0.9 0.1 0.2 8.7 0.0 0.1 0.0 1.1 0.1 7.3 3.7 1.7 0.0 50.9 0.0 7.8 282.3 169.4 0.6 312.5 1.6 13.0 0.8 0.8 162.2 8.5 4.9 1.5 230.1 8.0 392.8 3.6 2.3 157.7 3.5 3.9 4.2 4.5 3.4 4.1 5.2 4.3 5.2 4.6 4.0 6.0 0.3 0.0 1.8 1.6 10.6 0.8 0.4 2.1 1.2 0.1 0.6 0.5 1.1 0.0 1.7 1.8 2.1 1.0 0.7 0.3 0.0 0.1 3.7 0.9 0.3 1.1 0.0 4.8 0.9 1.3 0.9 1.6 4.1 1.0 2.5 0.3 0.4 1.1 22.3 0.0 0.9 0.6 2.0 90.1 33.4 6.1 0.9 59.2 1.8 0.0 86.7 3.1 4.1 0.0 3.1 0.1 3.5 0.7 24.7 0.3 0.2 0.7 5.1 1.1 6.6 0.5 0.6 28.5 19.2 0.3 0.9 0.7 2.1 0.1 0.6 0.6 CA1 Car1 ENSG00000133742 "Carbonic anhydrase 1" P00915 8 85327608-85379014 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 55 "bone marrow: 1798.9;intestine: 2109.9" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 11487.3" "Group enriched" "Detected in some" 10 "colorectal cancer: 3.4;stomach cancer: 0.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 987 "HEL: 1022.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006558, CAB025790" Enhanced NA NA 4600000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB025790: , HPA006558: AB_1845989" "unprognostic (1.44e-1)" "unprognostic (7.56e-2)" "unprognostic (1.70e-1)" "unprognostic (3.57e-3)" "unprognostic (2.08e-2)" "unprognostic (1.66e-1)" "unprognostic (2.84e-2)" "unprognostic (2.03e-2)" "unprognostic (1.73e-2)" "unprognostic (6.12e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (5.61e-2)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" 2.0 0.4 0.4 0.5 0.3 1798.9 2.1 1.0 1.5 0.3 0.0 1023.3 0.2 1.6 0.1 0.7 2.2 0.3 1.6 0.2 0.2 2.0 6.7 5.9 0.2 0.3 0.3 0.4 0.3 0.1 1.9 20.7 0.3 0.4 2109.9 0.4 1.1 1.8 1.0 1.4 1.8 30.7 0.1 35.4 2.3 0.2 0.5 0.5 0.9 3.4 0.1 0.4 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1022.7 0.0 0.5 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.4 0.3 1.0 1.5 0.2 0.2 0.3 0.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 4.2 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 2565.3 0.0 0.0 0.5 0.1 0.0 0.5 45.8 11487.3 11.8 0.0 0.0 0.1 0.0 0.1 22.3 0.0 4.2 4.4 0.0 0.0 12.1 159.4 0.0 11.4 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 13.0 2.2 0.0 754.9 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.4 0.1 298.4 0.0 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" P49913 3 48223347-48225491 "Plasma proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 2914.5" "Cell type enhanced" "Detected in some" "Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 84.4;neutrophil: 335.4" "Lineage enriched" "Detected in many" 12 "granulocytes: 335.4" "Cell line enhanced" "Detected in some" "Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5" "Not detected" "Not detected" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 28000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.8 0.1 0.1 1.6 0.1 2914.5 0.5 0.1 0.5 0.6 0.1 0.3 0.0 0.6 339.9 0.4 0.1 0.3 1.4 0.1 0.1 0.4 3.9 7.4 6.8 0.2 0.1 0.2 0.1 0.1 0.5 2.4 0.2 0.5 0.1 0.0 15.2 0.6 0.2 3.7 1.7 0.1 0.1 23.2 0.4 1.9 0.1 10.7 5.7 0.2 2.9 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 27.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 19.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 1.0 1.4 0.1 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 77.5 0.0 3.4 0.1 37.9 5.5 84.4 0.0 9.8 0.0 2.3 0.0 0.0 7.7 2.4 0.0 0.0 335.4 2.6 28.1 4.7 0.0 86.9 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.9 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.3 0.9 0.3 0.2 0.0 2.1 0.0 0.2 0.0 6.9 0.5 1.4 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 0.0 1.3 1.1 17.4 0.9 3.6 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.8 9.4 0.0 0.1 0.7 0.0 0.0 0.0 0.1 5.0 7.2 0.0 0.0 0.0 1.0 0.0 0.4 0.6 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839440 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 130.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.8;SK-MEL-30: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 9.3 14.2 9.6 11.1 10.8 130.3 9.0 8.8 12.5 9.1 0.0 7.9 7.1 6.3 4.6 20.7 8.1 6.3 16.0 12.4 9.7 10.6 21.6 12.3 14.6 11.5 9.5 9.6 19.0 17.0 19.1 15.2 10.7 9.3 3.2 12.3 13.2 4.6 3.4 31.6 11.9 3.8 8.2 20.9 12.9 6.9 12.2 23.1 8.6 1.4 7.2 6.7 10.3 16.6 32.1 28.3 8.4 36.3 5.2 4.7 23.5 14.3 8.5 5.1 5.4 20.5 17.5 12.3 19.7 5.6 11.4 16.3 9.3 9.5 3.8 13.3 17.7 7.0 28.0 38.4 25.4 37.0 52.5 6.5 54.4 4.7 8.4 8.5 4.3 35.5 21.7 67.5 5.5 23.0 50.9 37.7 4.6 33.2 28.2 51.9 8.6 56.3 7.2 15.3 8.7 16.6 21.4 110.8 130.9 3.5 26.3 58.3 11.2 29.8 26.3 18.4 18.6 58.0 32.4 35.0 18.7 31.6 40.4 1.6 0.5 1.8 0.9 0.6 0.6 1.5 1.2 1.3 0.3 1.5 1.4 1.3 2.1 0.4 0.7 1.7 0.2 0.6 9.6 10.8 8.8 12.5 12.4 9.7 11.5 9.5 10.7 8.2 12.2 16.6 40.4 3.2 15.7 4.6 31.8 23.3 5.4 13.4 36.5 31.7 65.2 79.8 51.6 30.0 12.1 1.8 22.9 34.2 77.6 26.6 0.0 7.5 0.2 63.9 19.3 21.6 52.7 7.8 5.5 7.3 5.0 15.8 20.9 62.8 7.0 22.3 15.7 16.3 13.8 20.2 5.5 49.5 2.0 19.8 17.0 1.0 4.4 35.4 17.8 12.2 15.4 39.2 15.5 6.0 11.6 10.0 18.4 5.7 26.1 6.3 9.6 2.8 14.6 44.3 6.6 15.3 24.4 0.5 2.4 65.7 30.7 8.6 42.5 13.7 29.7 5.2 CCL7 "FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7" ENSG00000108688 "C-C motif chemokine ligand 7" P80098 17 34270221-34272242 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "bone marrow: 25.9" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 56.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "thalamus: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.5;BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 2.8;HSkMC: 3.3" "Not detected" "Not detected" "Secreted to blood" NA NA 29700 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 4: Macrophages - Innate immune response" "unprognostic (7.66e-2)" "unprognostic (1.05e-2)" "unprognostic (8.53e-2)" "unprognostic (4.65e-2)" "unprognostic (2.54e-2)" "unprognostic (9.54e-2)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (2.63e-2)" "unprognostic (2.27e-3)" "unprognostic (7.04e-2)" "unprognostic (1.99e-8)" "unprognostic (2.83e-1)" "unprognostic (8.74e-2)" "unprognostic (3.74e-1)" "unprognostic (1.79e-2)" 0.8 0.2 0.0 2.5 0.0 25.9 0.1 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.0 0.0 0.5 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 2.3 0.3 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.3 11.5 2.3 2.8 0.0 0.0 0.0 0.4 0.8 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 3.3 0.0 0.9 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197177 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 20.0" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEL: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 3.2 1.4 2.3 1.3 2.1 20.0 2.1 3.8 2.6 1.4 1.9 1.7 1.5 1.4 2.1 1.2 2.0 1.0 1.3 2.0 2.4 1.5 1.7 2.7 2.2 2.4 2.3 0.7 1.3 1.1 1.2 1.4 2.5 1.3 1.9 1.8 1.5 1.1 1.7 2.8 2.6 1.2 1.8 2.6 2.1 0.9 2.6 1.5 1.7 1.2 1.9 1.7 1.1 2.4 0.2 0.2 0.4 0.2 1.3 0.8 0.4 0.3 1.6 0.3 0.3 0.4 0.3 0.5 0.4 1.1 0.1 0.5 1.1 0.5 0.2 0.7 1.1 13.5 0.6 0.5 0.9 0.7 0.7 1.5 1.2 0.1 0.2 1.3 1.0 0.2 0.8 0.4 0.4 0.0 0.4 1.4 0.9 0.5 0.3 0.4 0.5 1.2 1.7 0.6 0.6 0.9 0.5 0.4 0.3 0.5 0.0 1.1 1.2 0.2 0.1 1.0 0.2 1.4 0.6 0.1 1.3 1.4 0.4 21.8 1.9 5.6 5.1 3.7 5.4 4.7 5.5 5.2 1.8 5.3 5.6 5.9 6.2 4.8 9.5 3.0 8.4 1.8 2.3 2.1 3.8 2.6 2.0 2.4 2.4 2.3 2.5 1.8 2.6 2.4 59.8 48.1 54.9 11.1 81.8 34.7 55.7 83.3 25.0 28.9 38.0 40.9 52.6 40.0 78.6 29.5 20.9 362.7 92.0 63.6 90.1 64.0 24.2 61.6 33.8 45.2 46.2 361.2 20.7 59.3 82.1 55.9 45.3 37.0 57.0 40.2 53.6 31.0 85.4 45.4 17.8 47.7 154.6 83.5 36.2 12.6 47.2 57.1 64.0 11.2 137.8 55.9 74.2 9.5 23.4 68.6 55.8 29.3 54.2 42.1 85.8 47.5 128.0 66.0 46.0 35.2 49.4 124.3 61.6 27.8 40.3 1055.9 85.9 37.8 42.2 88.5 CCNT1 "CCNT, CYCT1, HIVE1" ENSG00000129315 "Cyclin T1" O60563 12 48688458-48716998 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004892, CAB009016, HPA072012" Supported Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: " "unprognostic (1.76e-3)" "unprognostic (3.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.76e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (5.78e-3)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.22e-1)" "unprognostic (3.43e-2)" "unprognostic (4.50e-2)" "unprognostic (1.92e-1)" 9.4 9.6 5.3 9.6 5.5 29.4 9.9 7.3 6.4 7.1 7.8 7.7 6.7 9.2 8.2 7.8 8.2 7.1 6.8 4.7 8.6 8.9 8.4 8.3 11.7 5.7 5.8 10.8 8.8 11.5 6.7 7.9 5.7 7.6 8.3 12.2 6.3 7.0 10.2 9.6 7.8 7.9 6.1 10.5 7.3 11.5 6.3 13.0 11.7 9.9 11.3 7.5 6.9 7.5 15.1 21.8 20.6 19.8 14.9 18.2 23.8 20.0 16.6 15.3 11.8 26.0 17.3 40.4 25.6 13.4 10.4 19.3 35.6 13.7 22.6 24.0 20.5 43.9 34.2 11.2 18.4 45.1 20.0 14.1 19.6 21.4 25.3 21.0 11.9 23.5 44.7 18.1 18.9 9.9 24.6 20.9 20.7 8.7 16.1 21.8 33.4 17.0 14.0 26.2 23.0 24.0 32.0 15.5 23.5 14.9 21.3 25.8 12.5 16.1 17.0 11.7 17.1 25.8 37.0 35.3 19.1 64.9 9.4 9.0 2.6 7.7 3.3 1.7 4.5 4.3 2.7 3.2 1.6 5.3 3.9 3.6 13.6 3.5 2.0 4.4 1.8 0.9 5.3 5.5 7.3 6.4 4.7 8.6 5.7 5.8 5.7 6.1 6.3 7.5 41.4 16.0 18.9 16.0 38.0 38.5 19.4 11.8 48.9 23.5 21.9 19.0 14.4 12.8 16.1 12.9 22.9 13.8 58.7 13.1 3.9 8.2 131.4 18.9 23.7 26.4 12.0 24.0 18.9 6.9 16.7 23.9 29.0 26.1 29.8 27.3 27.8 15.2 10.2 38.7 18.5 15.8 14.2 17.5 33.0 27.9 16.8 29.9 21.4 19.7 12.1 16.2 18.6 18.6 22.6 8.1 9.2 14.7 37.8 26.2 13.3 9.8 25.1 16.3 6.6 23.3 28.5 18.3 14.4 32.1 44.9 17.4 45.0 27.3 13.7 33.3 CD177 "HNA2A, NB1, PRV1" ENSG00000204936 "CD177 molecule" 19 43353686-43363172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 285.9;intestine: 164.6" "Group enriched" "Detected in some" 5 "Distal enterocytes: 632.4;Paneth cells: 314.8" "Cancer enhanced" "Detected in many" "prostate cancer: 27.6" "Group enriched" "Detected in many" 4 "cerebellum: 3.6;cerebral cortex: 7.7;pons: 2.3" "Immune cell enriched" "Detected in some" 7 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.7" "Cell line enriched" "Detected in some" 26 "RPMI-8226: 98.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041820, HPA046601, HPA077640" Enhanced "Intracellular and membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA041820: AB_2677691, HPA046601: AB_2679716, HPA077640: " "unprognostic (4.32e-2)" "prognostic favorable (3.66e-4)" "unprognostic (1.04e-2)" "unprognostic (2.04e-3)" "unprognostic (1.61e-1)" "unprognostic (3.89e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (2.05e-1)" "unprognostic (1.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.90e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (1.24e-1)" 4.8 0.4 0.1 7.2 0.3 285.9 1.3 3.6 7.7 6.0 3.7 155.2 0.3 0.4 0.2 2.2 2.3 0.2 2.2 0.3 0.1 1.9 2.6 20.6 0.2 0.3 1.0 0.3 1.1 0.0 2.9 1.6 2.3 64.8 164.6 0.1 1.8 0.2 0.7 0.4 0.7 3.0 0.3 64.4 1.4 0.2 0.4 1.4 0.7 0.8 10.4 2.1 5.4 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 1.3 0.6 0.6 0.0 0.0 0.1 2.4 0.6 1.7 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.2 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 1.2 0.0 0.2 0.0 0.0 98.0 1.4 0.3 0.7 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.3 2.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 1.2 0.0 0.7 0.0 0.1 0.3 3.6 7.7 0.3 0.1 0.3 1.0 2.3 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.0 632.4 0.0 0.5 0.4 0.2 0.1 0.0 8.4 3.6 0.0 0.2 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 87.2 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 314.8 0.0 0.1 29.2 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 28.0 0.2 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 209.6" "Cell type enhanced" "Detected in many" "B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454, HPA073595" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Vesicles "Golgi apparatus" "CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: " "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 10.2 19.9 14.7 34.9 13.9 209.6 7.0 16.1 17.9 26.2 23.0 5.2 4.6 7.3 4.0 4.5 5.1 17.0 4.8 15.6 19.2 18.7 14.9 39.9 51.3 20.2 16.6 16.5 4.2 6.6 7.2 9.2 21.0 8.3 9.2 5.0 19.5 13.8 1.3 5.0 11.5 6.9 16.7 20.1 5.7 5.2 21.0 38.0 5.3 2.9 70.2 15.5 15.4 21.6 18.1 0.8 12.7 17.7 18.2 4.2 0.4 5.1 17.6 8.3 14.4 1.3 11.6 79.1 14.6 1.3 16.8 2.0 4.8 5.5 27.0 71.9 7.6 10.6 21.4 2.1 0.6 15.8 16.5 4.8 2.3 8.0 2.6 2.5 0.2 26.4 2.4 0.0 0.8 6.5 12.6 29.7 5.3 3.2 3.7 12.1 28.1 10.9 6.0 17.2 2.8 5.2 1.0 0.6 13.5 7.3 3.0 12.3 0.4 12.8 8.1 1.9 12.0 0.7 0.2 121.5 2.8 21.6 19.7 0.0 3.1 2.0 4.4 19.0 4.8 19.7 4.0 3.7 9.0 31.0 2.8 3.3 2.2 5.0 29.3 3.2 6.2 4.4 14.7 13.9 16.1 17.9 15.6 19.2 20.2 16.6 21.0 16.7 21.0 21.6 41.3 19.2 77.9 5.2 668.5 49.5 16.0 10.0 41.5 4.2 26.5 46.4 30.9 2.8 8.2 11.0 6.2 1.5 100.4 5.4 3.9 0.9 0.9 29.0 24.1 39.1 24.0 3.0 5.6 1.6 2.4 31.1 11.2 74.8 238.8 8.1 2.9 1.1 145.6 1.7 6.1 7.3 4.1 83.0 1390.2 1.9 0.3 539.4 44.4 13.1 513.6 3.5 1.0 2.5 1.3 2.1 0.4 0.0 20.4 26.2 1.7 17.7 4.9 2.7 0.0 17.2 17.0 2.1 10.2 17.2 38.5 2.7 69.2 21.0 11.6 3.5 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20589086-20618903 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 193.5;esophagus: 87.1;liver: 86.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 1234.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 1234.7" "Cell line enhanced" "Detected in many" "A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064202 Enhanced Approved Nucleoplasm NA NA 3700000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA064202: AB_2685211" "unprognostic (2.38e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 7.1 3.0 8.0 9.6 8.1 193.5 3.7 8.3 10.6 19.7 7.4 23.7 6.4 5.3 5.5 87.1 6.4 4.3 6.7 7.9 8.3 14.0 86.7 7.1 1.5 9.0 8.2 1.5 0.8 3.2 1.2 10.8 9.5 4.3 27.8 0.5 15.0 3.1 1.7 17.1 16.3 11.3 8.3 23.4 2.1 1.0 8.9 2.0 4.5 6.4 4.4 5.5 38.5 8.7 200.3 21.4 0.0 0.0 0.2 5.5 0.0 16.7 4.3 4.1 16.2 1.0 141.9 0.0 8.1 30.8 8.7 63.9 4.5 46.8 10.7 0.1 3.9 0.0 207.1 34.4 1.4 0.0 0.0 8.8 8.9 31.4 0.0 0.5 2.7 0.0 0.0 0.0 1.6 0.2 0.0 1.0 0.1 24.7 107.0 0.0 0.1 3.4 1.5 0.0 0.1 0.0 249.9 0.0 0.3 2.2 0.0 4.3 3.4 0.2 8.3 18.5 1.2 0.0 0.1 0.0 2.4 96.9 0.0 216.2 207.2 471.1 0.5 124.7 0.8 0.1 0.4 0.9 12.7 0.2 0.3 0.4 1234.7 0.4 110.8 3.1 0.7 86.8 8.0 8.1 8.3 10.6 7.9 8.3 9.0 8.2 9.5 8.3 8.9 8.7 9.9 3.2 1.1 0.3 1.2 1.5 0.1 2.4 0.0 0.2 0.2 0.3 2.6 1.5 2.7 5.5 0.0 1.1 0.0 364.9 43.0 7.5 0.8 2.1 2.6 42.7 0.0 6.1 0.2 1.5 6.4 9.1 0.0 20.3 0.0 0.0 47.2 107.8 5.9 0.0 0.3 23.1 85.5 60.7 0.9 1.0 0.3 36.6 0.0 5.6 61.5 0.1 0.0 0.5 0.0 120.2 400.5 0.0 3.0 2.1 137.6 0.6 0.4 0.1 0.0 1.3 1.3 0.0 1.2 6.3 1.1 2.5 1.7 0.0 19.8 0.8 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803789-88809258 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 38.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 149.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.7 0.8 0.8 3.8 1.2 38.5 0.7 2.5 1.3 1.7 0.0 3.3 4.1 0.5 0.2 6.7 0.5 0.2 0.5 0.8 2.3 0.7 1.0 1.3 4.8 2.2 1.1 0.4 0.6 1.3 2.1 2.8 1.9 0.7 1.6 0.4 1.1 0.2 0.1 3.6 3.9 0.6 0.7 3.1 2.4 3.5 1.1 8.7 0.6 0.0 3.3 0.5 2.3 1.0 33.6 34.5 16.5 25.3 0.7 3.4 64.2 24.1 6.6 19.4 12.0 79.3 33.8 51.4 24.2 5.5 12.7 46.0 21.6 17.7 6.2 18.2 92.1 51.8 28.8 59.9 0.3 28.8 21.5 1.8 1.4 19.8 4.4 1.6 5.9 60.9 80.8 18.4 7.6 90.6 109.3 149.4 41.8 12.2 31.6 120.3 22.9 42.4 4.3 23.8 36.6 26.2 44.4 13.1 16.9 7.4 39.0 55.9 5.9 24.6 42.6 37.2 35.4 61.4 55.7 73.6 19.3 71.9 31.6 0.2 0.1 0.9 0.3 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.7 0.4 0.1 0.1 0.7 0.2 0.8 1.2 2.5 1.3 0.8 2.3 2.2 1.1 1.9 0.7 1.1 1.0 0.4 0.0 1.1 0.7 4.9 11.2 4.3 1.4 7.4 0.7 5.4 7.5 2.2 1.5 1.7 1.8 0.0 51.4 2.2 12.7 1.9 1.1 0.4 1.4 1.4 2.2 2.4 71.3 0.2 0.0 92.0 5.2 9.2 2.2 0.0 29.0 0.4 1.0 19.5 0.0 0.8 16.1 4.1 5.6 5.5 1.2 0.3 2.8 1.8 0.0 1.9 1.5 4.1 0.0 0.6 0.6 2.3 0.4 23.1 2.2 2.0 1.6 2.1 1.9 0.0 2.1 3.4 6.6 37.1 10.8 7.1 24.8 5.4 5.7 30.1 4.4 CEACAM3 "CD66d, CGM1" ENSG00000170956 "CEA cell adhesion molecule 3" P40198 19 41796587-41811554 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 44.3" "Cell type enriched" "Detected in some" 13 "Paneth cells: 56.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 6 "neutrophil: 289.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 289.3" "Not detected" "Not detected" HPA011041 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA011041: AB_1078481" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (8.09e-3)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "unprognostic (1.62e-1)" "unprognostic (8.07e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (4.68e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-1)" 0.9 0.1 0.0 5.1 0.0 44.3 0.1 0.0 0.9 0.3 0.3 0.3 0.0 0.2 0.0 0.4 0.3 0.3 0.3 0.0 0.0 0.1 0.6 1.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.0 5.1 0.1 0.0 0.0 0.6 0.1 1.2 0.4 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.2 0.0 0.0 19.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 289.3 0.0 45.8 0.0 0.0 3.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.0 3.3 0.0 1.4 0.0 4.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 56.4 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.4 CEACAM8 "CD66b, CGM6" ENSG00000124469 "CEA cell adhesion molecule 8" P31997 19 42580243-42595055 "CD markers, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "bone marrow: 217.6" "Cell type enhanced" "Detected in single" "Paneth cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 1.6;non-classical monocyte: 1.2" "Group enriched" "Detected in many" 6 "granulocytes: 1.6;monocytes: 1.2" "Not detected" "Not detected" CAB033676 Approved "Intracellular and membrane" NA NA 9200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "CAB033676: AB_1125678" "unprognostic (2.01e-1)" "unprognostic (4.52e-2)" "unprognostic (3.31e-1)" "unprognostic (6.30e-2)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (1.71e-2)" "unprognostic (7.77e-2)" "unprognostic (9.62e-2)" 0.2 0.0 0.3 0.2 0.2 217.6 0.0 0.3 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.4 0.0 0.1 0.5 0.1 0.0 0.0 6.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 1.6 0.2 1.2 0.0 0.0 2.7 0.3 0.2 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 CEBPE CRP1 ENSG00000092067 "CCAAT enhancer binding protein epsilon" Q15744 14 23117306-23119255 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 51.8" "Cell type enhanced" "Detected in some" "Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "eosinophil: 750.4" "Lineage enriched" "Detected in many" 250 "granulocytes: 750.4" "Group enriched" "Detected in some" 4 "HL-60: 233.8;NB-4: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Plasma membrane, Cytosol" "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.1 0.0 0.1 1.6 0.1 51.8 0.0 0.0 0.2 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 3.2 0.3 0.1 3.4 0.8 0.0 0.3 0.5 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 233.8 39.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.9 122.5 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 26.3 0.0 0.5 3.0 750.4 0.0 0.6 0.1 0.5 1.0 0.4 1.5 0.5 1.8 1.5 3.4 0.0 0.3 1.5 0.0 1.8 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.0 1.4 0.6 0.1 0.0 2.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.0 CIB3 KIP3 ENSG00000141977 "Calcium and integrin binding family member 3" Q96Q77 19 16161368-16173525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "bone marrow: 1.2" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 30.2;Late spermatids: 9.5" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043553, HPA043995" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane, Cytosol" "HPA043553: AB_10964566, HPA043995: " "unprognostic (8.43e-2)" "unprognostic (7.26e-5)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.25e-1)" "unprognostic (3.14e-1)" "unprognostic (2.93e-2)" "unprognostic (3.05e-1)" "unprognostic (5.68e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 1.4 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.3 30.2 0.0 0.1 0.0 0.0 0.2 0.1 1.8 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLC "Gal-10, LGALS10, MGC149659" ENSG00000105205 "Charcot-Leyden crystal galectin" Q05315 19 39731255-39738029 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "bone marrow: 451.9" "Cell type enriched" "Detected in some" 15 "Erythroid cells: 127.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.0" "Not detected" "Not detected" "Group enriched" "Detected in all" 312 "basophil: 28756.2;eosinophil: 21481.0" "Lineage enriched" "Detected in all" 2254 "granulocytes: 28756.2" "Cell line enriched" "Detected in some" 12 "HMC-1: 7553.4" "Not detected" "Not detected" HPA041751 Enhanced NA NA 400000 "Cluster 2: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" "HPA041751: AB_10793973" "unprognostic (4.53e-2)" "unprognostic (3.04e-2)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-1)" "unprognostic (1.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.21e-1)" "unprognostic (4.28e-2)" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" 2.0 0.1 0.0 30.0 0.0 451.9 0.3 0.2 0.4 0.3 0.0 10.2 25.4 0.3 0.1 0.9 1.7 16.6 0.5 0.0 0.5 0.3 4.8 6.2 1.8 0.1 0.1 0.0 0.4 0.2 0.4 1.4 0.1 0.1 8.1 0.0 0.9 0.2 0.1 1.5 41.6 24.5 0.1 11.3 15.6 0.6 0.8 7.3 0.3 0.2 0.2 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 619.0 7553.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 3.5 0.7 0.9 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 2.3 0.0 0.0 3.8 0.0 2.4 28756.2 5.0 21481.0 2.5 11.1 6.0 4.8 6.9 1.7 5.3 6.2 3.1 9.2 80.3 2.5 12.7 7.8 4.0 100.3 0.0 0.0 0.2 0.4 0.0 0.5 0.1 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 127.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CLEC4D "CD368, CLECSF8, Dectin-3, MCL, Mpcl" ENSG00000166527 "C-type lectin domain family 4 member D" Q8WXI8 12 8509475-8522366 "CD markers, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 64.7" "Group enriched" "Detected in some" 5 "Kupffer cells: 10.6;Macrophages: 11.9;monocytes: 15.1" "Cancer enriched" "Detected in single" 50 "testis cancer: 11.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "classical monocyte: 57.1;neutrophil: 98.7" "Group enriched" "Detected in many" 32 "granulocytes: 98.7;monocytes: 57.1" "Group enriched" "Detected in some" 5 "NB-4: 2.4;NTERA-2: 9.0;SuSa: 9.1;U-937: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004906 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 5: NTERA-2 - Transcription" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA004906: AB_1078535" "unprognostic (1.10e-1)" "unprognostic (4.94e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (4.39e-1)" "unprognostic (3.84e-2)" "unprognostic (7.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-1)" "unprognostic (3.81e-1)" "unprognostic (7.91e-5)" "unprognostic (1.12e-2)" "unprognostic (8.57e-2)" "unprognostic (7.89e-2)" "unprognostic (2.18e-1)" 2.3 0.2 0.0 7.3 0.1 64.7 0.2 0.0 0.2 3.1 0.3 0.1 0.1 0.1 0.5 0.4 0.7 0.4 0.3 0.0 0.0 0.2 0.5 3.1 0.6 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.1 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.2 0.8 0.0 7.0 0.2 0.2 0.4 0.3 0.1 0.7 0.3 2.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 9.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.9 57.1 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.4 0.0 0.0 0.1 98.7 0.0 1.2 0.7 0.0 12.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.6 0.8 0.0 0.0 11.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 41.3" "Group enriched" "Detected in some" 6 "Hofbauer cells: 18.0;Langerhans cells: 67.5;Macrophages: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "classical monocyte: 9.1" "Lineage enriched" "Detected in many" 8 "monocytes: 9.1" "Group enriched" "Detected in some" 23 "HL-60: 40.9;U-937: 157.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" "HPA054137: AB_2732582" "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.1 1.8 1.1 7.3 1.2 41.3 0.6 1.3 2.6 0.7 2.1 0.2 0.1 0.3 0.0 1.2 0.5 1.8 0.5 1.0 3.3 0.5 1.8 4.0 0.1 2.2 3.3 0.3 1.3 1.2 0.5 0.9 2.2 0.4 0.3 1.0 1.2 0.5 0.0 2.6 0.0 1.3 1.6 1.1 0.2 0.5 4.9 0.6 0.7 0.0 0.1 2.3 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.3 0.0 0.0 9.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 1.8 1.1 1.2 1.3 2.6 1.0 3.3 2.2 3.3 2.2 1.6 4.9 2.4 0.1 0.0 4.8 0.7 0.6 1.9 0.0 0.0 0.0 0.2 0.1 0.1 0.3 1.5 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.5 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.0 2.5 0.0 0.0 0.0 18.0 0.0 0.2 0.0 0.0 4.7 67.5 0.7 0.0 58.1 1.8 7.5 6.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.9 0.4 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.3 0.4 0.0 0.0 0.0 CR1L ENSG00000197721 "Complement C3b/C4b receptor 1 like" Q2VPA4 1 207645113-207738416 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "bone marrow: 1.5" "Cell type enriched" "Detected in some" 18 "Erythroid cells: 128.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 1.3;HMC-1: 2.9;K-562: 1.6" HPA049348 Approved "Secreted in other tissues" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA049348: AB_2680723" "unprognostic (2.35e-2)" "unprognostic (8.27e-2)" "unprognostic (1.99e-1)" "unprognostic (8.89e-2)" "unprognostic (1.31e-2)" "unprognostic (5.50e-2)" "unprognostic (2.01e-1)" "unprognostic (7.45e-2)" "unprognostic (5.27e-2)" "unprognostic (8.21e-3)" "unprognostic (7.94e-2)" "unprognostic (3.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (9.68e-2)" 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.5 0.0 0.3 1.8 0.0 0.1 0.0 0.0 5.9 0.4 0.2 6.9 0.2 1.8 0.0 128.6 0.4 0.0 0.1 0.2 0.0 1.0 0.0 0.0 3.6 0.2 1.2 0.0 0.4 0.0 2.0 0.3 0.3 0.4 0.0 0.5 0.0 1.0 1.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.2 3.3 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.2 CREBRF "C5orf41, LRF" ENSG00000164463 "CREB3 regulatory factor" Q8IUR6 5 173056352-173139284 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 21.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015329 Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA015329: AB_2669192" "unprognostic (8.00e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (3.14e-2)" "unprognostic (5.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.35e-1)" "unprognostic (6.03e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.17e-2)" "unprognostic (4.69e-2)" "prognostic favorable (3.20e-7)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.52e-1)" "prognostic favorable (9.30e-4)" 12.9 10.8 9.6 10.4 12.6 68.1 11.1 14.6 11.6 12.2 11.6 9.9 8.4 11.6 11.3 8.7 8.7 9.8 11.2 8.1 12.3 14.5 10.8 11.8 13.2 12.0 11.6 19.0 7.9 15.9 5.8 12.7 12.2 10.0 8.5 11.2 8.8 11.6 8.4 12.1 9.5 10.4 11.0 15.2 8.3 13.4 10.7 12.4 23.2 11.9 10.4 10.3 9.3 14.6 1.2 2.8 2.6 4.1 11.7 15.6 6.1 3.7 18.0 3.4 6.5 3.8 6.3 2.3 8.7 3.8 6.3 1.5 1.2 2.9 4.8 8.4 2.5 1.8 1.9 1.2 9.0 1.4 10.0 9.5 7.3 3.7 9.2 8.3 4.2 2.9 1.6 11.7 4.0 2.3 2.2 2.0 0.8 1.9 1.4 2.1 1.8 3.6 4.8 2.5 2.0 3.0 3.7 1.6 13.6 5.5 1.7 2.6 6.9 5.2 1.7 3.5 1.0 13.0 11.7 4.0 3.8 2.5 1.8 5.6 2.7 6.1 3.6 2.4 3.3 2.9 3.6 3.1 1.4 5.6 4.4 3.6 21.8 1.5 3.3 3.1 3.6 1.8 9.6 12.6 14.6 11.6 8.1 12.3 12.0 11.6 12.2 11.0 10.7 14.6 103.6 51.3 48.4 33.6 95.9 79.2 26.0 19.7 105.3 50.1 68.3 48.1 61.4 44.3 25.9 38.6 68.8 11.6 104.1 50.8 15.6 17.4 5.3 68.9 51.1 66.3 76.7 70.7 57.3 15.7 11.1 67.5 21.4 154.0 48.1 75.2 64.6 39.5 20.4 112.7 64.2 30.3 32.6 96.2 57.7 8.4 51.9 76.7 65.8 70.3 81.7 33.1 55.6 40.2 65.3 17.4 31.8 54.9 78.9 67.6 42.4 23.2 34.8 65.0 59.2 89.8 65.6 74.8 48.0 42.7 92.9 37.4 83.5 26.2 20.5 40.9 CST7 ENSG00000077984 "Cystatin F" O76096 20 24949269-24959928 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 1095.6" "Group enriched" "Detected in many" 9 "dendritic cells: 1094.4;Langerhans cells: 541.7;monocytes: 659.7;NK-cells: 1385.2;T-cells: 544.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 1287.0" "Group enriched" "Detected in all" 27 "granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0" "Cell line enhanced" "Detected in some" "HL-60: 77.8;HMC-1: 204.6;NB-4: 212.1;U-937: 380.4" "Region enhanced" "Detected in single" "olfactory bulb: 1.9" "Low region specificity" "Detected in all" HPA040442 Enhanced "Secreted to blood" NA NA 26000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA040442: AB_2676988" "prognostic favorable (6.55e-4)" "prognostic favorable (7.90e-4)" "unprognostic (9.37e-2)" "prognostic favorable (9.17e-6)" "unprognostic (2.38e-2)" "prognostic favorable (5.85e-5)" "unprognostic (1.00e-2)" "unprognostic (8.66e-2)" "unprognostic (2.84e-3)" "unprognostic (7.93e-2)" "unprognostic (5.05e-2)" "unprognostic (7.42e-2)" "prognostic unfavorable (4.37e-6)" "unprognostic (7.64e-2)" "unprognostic (3.38e-1)" "unprognostic (4.45e-1)" "unprognostic (7.62e-2)" 18.0 3.6 1.3 24.2 1.6 1095.6 5.7 2.8 5.1 4.5 1.7 5.7 5.9 4.6 4.8 5.4 10.4 17.7 5.6 1.5 1.4 5.4 12.7 49.3 73.4 2.4 1.4 2.5 3.9 1.0 2.2 4.4 2.0 4.3 5.1 0.2 6.6 2.0 1.9 4.5 13.9 5.0 1.6 148.1 8.7 1.7 1.6 17.3 5.6 4.4 16.4 19.2 5.2 1.4 0.3 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.3 1.7 0.0 0.4 0.0 77.8 204.6 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 2.8 0.0 0.2 2.0 212.1 0.1 0.0 0.2 0.5 7.7 0.1 0.0 0.1 0.3 0.2 0.0 0.1 1.0 0.1 0.0 13.3 0.2 0.1 0.8 0.2 0.5 0.1 0.1 0.2 0.1 380.4 0.1 74.3 3.0 10.4 1287.0 3.4 720.2 3.7 186.8 904.7 28.4 3.9 38.8 531.2 342.2 655.3 3.5 7.2 123.0 600.8 1.3 1.6 2.8 5.1 1.5 1.4 2.4 1.4 2.0 1.6 1.6 1.4 8.1 9.6 14.1 0.0 14.5 22.8 0.3 0.0 0.0 0.0 2.5 2.4 1.4 4.3 0.6 0.0 0.0 0.2 1094.4 0.3 0.0 1.3 0.0 1.3 0.7 3.2 0.0 46.7 0.0 3.7 0.1 5.2 11.2 1.2 60.0 0.0 11.0 3.8 1.4 0.0 0.0 0.1 0.0 16.2 541.7 0.0 0.0 61.9 24.9 1.9 659.7 0.0 1385.2 0.0 0.1 0.2 0.1 0.0 90.9 0.1 0.4 2.3 2.2 0.0 0.0 2.2 3.6 0.0 0.2 0.5 23.9 1.1 544.5 0.0 0.6 0.6 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573518-24576250 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 154 "bone marrow: 5352.9" "Cell type enriched" "Detected in some" 16 "granulocytes: 534.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "THP-1: 8681.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" NA NA 330000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "CAB000110: , HPA047737: AB_2680140" "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.91e-4)" 23.4 0.1 0.0 13.5 0.0 5352.9 25.4 0.0 0.0 16.6 0.0 25.5 5.8 9.6 10.2 22.1 2.7 25.9 3.7 0.0 0.0 2.3 3.6 11.6 6.5 0.0 0.0 0.5 3.5 1.5 1.0 2.9 0.0 3.7 25.5 0.0 11.5 4.8 1.8 28.0 18.1 7.7 0.0 16.9 4.9 3.2 0.0 26.0 0.8 7.6 6.0 34.8 4.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 303.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 3.6 41.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.2 0.0 3.6 0.0 0.0 8681.4 0.0 0.0 0.3 0.0 5.3 0.0 0.8 2.8 0.0 1287.5 0.1 0.0 6.0 0.0 1.1 1.0 0.0 0.0 0.9 3.4 5.4 0.0 0.0 1.7 7.3 5.0 0.0 6.5 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.8 33.3 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 534.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 11.1 9.1 0.0 1.5 5.4 0.0 1.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.3 0.3 1.7 0.0 4.0 0.0 5.1 0.0 0.4 0.0 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800441-38825355 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 28.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 13.3 12.6 7.9 9.9 8.9 62.2 12.3 8.5 9.7 11.6 8.8 11.1 10.3 10.3 5.4 12.5 11.9 7.6 9.0 8.2 8.5 11.6 16.2 13.0 12.6 8.7 8.5 11.2 12.6 7.2 11.0 6.7 8.5 11.7 6.1 8.6 10.9 4.5 12.7 17.4 13.1 6.8 8.0 16.8 11.6 18.4 8.5 14.2 11.3 7.1 9.0 10.9 11.5 9.4 11.2 13.1 8.2 14.1 10.9 7.1 8.3 11.5 7.9 12.0 11.0 8.4 11.7 12.7 7.8 9.2 9.2 25.3 8.2 7.7 14.5 12.0 8.7 9.9 14.9 10.4 10.8 25.2 15.6 8.4 12.3 11.8 9.7 12.7 9.8 13.5 15.5 15.0 10.2 6.2 26.4 25.6 8.5 8.2 6.4 20.0 12.1 11.4 12.0 10.7 9.3 8.2 10.7 7.6 13.8 12.2 12.0 19.8 10.2 10.8 9.9 14.3 17.9 11.9 9.3 18.8 11.4 12.1 10.9 18.0 4.1 10.6 4.6 3.9 4.0 4.5 4.3 4.8 3.5 6.0 4.9 3.7 28.7 5.9 8.1 1.7 2.9 3.0 7.9 8.9 8.5 9.7 8.2 8.5 8.7 8.5 8.5 8.0 8.5 9.4 50.7 57.7 69.5 10.4 54.2 63.9 61.2 45.9 39.9 37.2 40.8 31.2 18.3 21.5 46.3 23.9 83.4 35.1 60.6 56.6 29.4 27.5 118.4 63.8 51.7 45.3 41.8 34.5 10.0 23.6 35.2 43.8 52.0 100.2 58.9 23.8 37.9 27.2 28.6 26.9 7.9 51.9 26.4 27.0 37.9 31.9 37.3 38.2 26.6 5.6 38.7 30.1 41.2 5.5 8.1 29.3 70.9 34.6 43.2 51.4 61.5 27.2 41.9 43.4 39.5 57.0 45.7 93.9 33.6 30.5 76.7 79.1 54.6 28.8 32.6 72.4 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740541-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3301.3" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 9 "cerebral cortex: 136.1" "Immune cell enriched" "Detected in some" 451 "neutrophil: 483.0" "Lineage enriched" "Detected in single" 788 "granulocytes: 483.0" "Group enriched" "Detected in many" 5 "BJ hTERT+: 4072.6;GAMG: 1080.2" "Not detected" "Not detected" HPA057179 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 7260 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 67.9 13.5 1.8 209.9 2.8 3301.3 3.6 1.7 136.1 54.5 7.6 10.6 3.6 41.0 0.2 3.7 8.9 177.2 33.8 1.7 1.6 10.8 77.7 91.2 1.2 2.1 1.6 6.0 16.1 1.8 3.2 41.1 15.1 9.6 7.3 0.9 25.4 1.5 1.3 3.2 4.9 12.7 1.9 10.3 8.8 0.7 4.9 15.2 3.4 8.1 8.7 456.7 4.0 1.9 2.7 1.4 0.0 0.1 3.9 19.4 0.2 25.7 4072.6 35.9 117.0 0.2 13.0 0.2 547.6 1.3 1080.2 48.2 0.0 1.0 562.3 1.8 0.2 0.9 0.4 6.5 6.8 41.0 2.5 12.4 1.7 119.0 2.9 12.9 124.9 0.0 1.4 0.8 0.7 0.0 0.0 55.7 0.0 14.7 20.3 0.3 0.5 0.9 317.3 17.2 0.1 0.0 1.9 0.1 61.1 0.8 0.1 5.6 308.3 56.8 5.1 15.1 55.0 0.4 0.7 1.7 252.5 30.9 88.2 1.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 483.0 0.0 0.0 0.0 0.0 0.1 1.8 2.8 1.7 136.1 1.7 1.6 2.1 1.6 15.1 1.9 4.9 1.9 28.6 51.3 254.1 0.0 26.4 0.0 13262.1 0.0 164.4 0.5 40.2 15.4 23.8 127.2 426.5 0.0 0.0 4.3 17.7 14.4 0.0 1695.0 3.2 717.6 257.1 712.2 19.1 8.0 0.0 260.7 5.2 1475.1 54.0 1708.7 51.2 0.5 15.7 3.6 367.1 0.0 0.0 26.4 0.0 543.0 0.0 1.9 0.6 3685.4 0.0 0.0 1178.5 0.5 0.0 0.0 0.0 584.9 0.3 0.4 27.3 8869.1 0.9 1.0 178.6 1.1 39.5 44.3 263.0 0.3 2.5 124.9 0.0 21.3 138.8 0.0 18.5 13149.4 DEFA1 "DEF1, DEFA2, HNP-1, MRS" ENSG00000206047 "Defensin alpha 1" P59665 8 6977649-6980080 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "bone marrow: 18020.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "NB-4: 2.1" "CAB032548, HPA052517" Enhanced "Secreted to blood" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "CAB032548: AB_2277258, HPA052517: AB_2681860" 31.6 4.3 0.7 0.6 0.8 18020.9 16.8 0.5 3.0 4.0 0.6 4.1 0.0 11.3 0.0 3.2 2.2 1.3 62.5 0.5 0.6 15.0 91.6 560.5 3.5 0.7 0.7 4.1 5.5 0.1 20.6 11.4 0.7 2.7 0.0 0.3 14.5 0.0 16.8 40.3 2.3 0.0 0.8 1803.8 6.4 3.1 0.8 37.0 15.8 0.0 0.8 3.4 5.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 3.0 0.5 0.6 0.7 0.7 0.7 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DEFA1B ENSG00000240247 "Defensin alpha 1B" P59665 8 6996766-6999195 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 872.0" "Cell type enriched" "Detected in single" 37 "T-cells: 3.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebral cortex: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052517 Supported "Secreted to blood" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA052517: AB_2681860" 2.3 0.3 0.1 0.8 0.1 872.0 1.1 0.1 2.0 0.0 0.1 0.2 0.0 0.9 0.0 0.1 0.1 0.0 3.8 0.2 0.1 0.9 9.1 52.1 0.0 0.2 0.1 0.3 0.1 0.0 1.4 7.2 0.4 0.1 0.0 0.1 9.4 0.0 0.8 0.2 0.2 0.0 0.1 150.4 0.6 0.1 0.4 27.8 1.2 5.8 1.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.2 0.1 0.2 0.1 0.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 DEFA3 "DEF3, HNP-3" ENSG00000239839 "Defensin alpha 3" P59666 8 7015869-7018297 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "bone marrow: 37615.2" "Cell type enhanced" "Detected in some" "B-cells: 17.9;Erythroid cells: 10.1;Hepatocytes: 17.0;Macrophages: 5.7;Plasma cells: 4.0;T-cells: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 19 "neutrophil: 854.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 854.3" "Cell line enriched" "Detected in single" 8 "NB-4: 1.5" HPA052517 Supported "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "HPA052517: AB_2681860" "unprognostic (8.21e-2)" 8.8 1.2 0.5 1.0 0.3 37615.2 5.0 0.2 1.2 2.0 0.3 1.3 0.0 5.6 0.0 1.0 0.7 0.2 16.1 0.2 0.3 4.4 26.1 180.2 5.3 0.4 0.6 1.3 1.6 0.0 7.6 18.8 0.5 0.8 0.0 0.2 24.2 0.0 5.0 42.1 0.7 0.0 0.5 589.4 1.8 0.6 0.6 147.9 4.5 1.1 1.3 1.1 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 24.4 3.6 44.3 1.2 1.6 2.3 1.0 0.8 1.0 1.1 6.9 0.3 854.3 0.4 2.6 1.4 0.3 6033.6 0.5 0.3 0.2 1.2 0.2 0.3 0.4 0.6 0.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.8 17.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 DEFA4 "DEF4, HP-4" ENSG00000164821 "Defensin alpha 4" P12838 8 6935820-6938306 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "bone marrow: 2702.9" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Hepatocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 13 "neutrophil: 13.1" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.1" "Cell line enriched" "Detected in single" 8 "THP-1: 6.8" HPA051266 Enhanced "Secreted to blood" NA NA 98000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "HPA051266: AB_2681414" 0.7 0.1 0.0 0.2 0.0 2702.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 2.7 14.2 0.6 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.4 2.0 0.1 0.0 0.0 46.4 0.1 0.1 0.0 8.9 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73247255 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 91.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" NA NA 39000 "Cluster 44: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 9.2 10.6 17.1 17.6 17.5 91.9 15.4 19.2 21.5 11.2 15.4 16.0 14.6 12.8 12.4 16.9 9.7 6.9 8.6 16.9 17.0 10.0 13.4 9.6 28.2 16.4 16.5 15.3 8.7 10.2 10.6 17.6 16.9 11.4 18.0 25.1 11.3 11.2 11.5 17.7 13.9 11.8 15.7 14.8 12.2 12.4 17.0 35.8 8.4 13.1 32.3 11.5 11.9 17.6 135.0 77.3 93.8 68.4 16.1 19.3 45.7 101.5 59.4 101.1 106.1 130.8 89.4 86.9 33.5 43.6 43.7 83.1 92.9 67.5 118.1 98.5 63.8 188.3 79.4 93.4 14.8 173.1 71.0 14.8 33.2 107.1 93.4 36.4 66.2 112.1 168.3 103.0 81.4 118.4 155.0 124.7 36.3 64.4 215.1 114.2 85.1 47.6 52.9 61.5 44.3 73.4 73.5 114.5 52.9 43.7 62.1 76.8 48.0 65.2 118.3 71.3 168.0 45.0 70.6 141.8 64.8 162.9 45.9 23.9 3.7 29.1 25.5 10.7 29.2 32.8 31.3 28.2 6.5 28.3 30.3 26.9 4.5 24.8 10.9 20.3 36.8 18.0 17.1 17.5 19.2 21.5 16.9 17.0 16.4 16.5 16.9 15.7 17.0 17.6 17.3 9.6 12.3 11.1 39.5 47.7 34.1 31.9 33.0 26.1 21.5 24.8 2.7 17.2 24.8 9.2 8.4 107.8 44.6 18.3 21.5 31.5 80.4 15.9 14.0 20.6 12.0 173.8 11.8 31.4 111.4 17.6 12.2 19.0 42.3 26.0 13.9 9.8 61.9 15.2 12.8 25.6 54.9 10.9 19.6 43.3 14.0 17.4 32.0 6.5 23.0 29.5 32.0 7.5 6.5 44.1 16.7 20.3 49.7 27.6 18.2 16.3 21.9 43.2 26.3 17.7 28.3 28.7 65.4 38.2 43.5 58.0 45.2 19.7 38.0 37.5 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427598-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.1" "Group enriched" "Detected in all" 6 "Early spermatids: 268.7;Late spermatids: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 12.9 9.0 9.2 10.5 8.9 57.1 9.1 7.2 9.4 7.2 7.7 9.0 10.6 7.9 7.6 9.8 7.0 10.4 5.1 10.3 11.1 11.2 19.0 8.3 10.7 9.6 10.3 5.6 9.8 11.8 8.6 10.2 12.3 10.0 9.9 7.7 6.9 6.8 5.3 10.7 10.0 8.3 7.8 9.8 11.4 7.3 10.6 10.6 10.5 5.8 11.1 11.5 5.8 7.9 10.3 16.6 17.1 17.6 9.8 8.3 137.4 14.7 10.5 16.7 16.3 22.7 11.4 28.7 9.3 10.9 10.9 8.6 22.5 13.2 19.2 23.6 16.2 24.8 14.5 20.8 22.1 23.6 19.2 11.0 22.8 24.3 16.2 12.8 16.8 23.1 26.9 20.6 14.1 21.2 23.6 13.2 30.7 19.3 16.9 21.3 14.2 16.0 14.5 17.8 17.6 30.6 18.2 16.7 17.6 21.9 25.2 18.5 16.6 17.5 12.8 15.6 21.8 27.1 58.3 29.7 17.0 27.7 21.1 8.0 7.1 4.6 11.1 5.4 14.3 4.9 9.1 8.7 4.2 3.6 5.4 8.7 6.5 8.1 6.9 9.8 10.9 4.4 9.2 8.9 7.2 9.4 10.3 11.1 9.6 10.3 12.3 7.8 10.6 7.9 11.5 9.6 17.3 6.8 14.2 46.9 9.1 6.0 14.2 8.1 15.8 7.7 4.8 15.7 9.0 12.9 6.2 8.0 29.1 15.5 9.8 8.6 268.7 10.8 16.0 11.8 34.3 7.8 16.4 8.2 14.6 13.9 16.3 14.1 10.2 9.9 12.1 30.4 15.8 21.9 14.0 12.5 12.2 30.7 31.6 389.5 11.5 37.6 23.2 3.7 19.4 5.5 22.6 5.5 10.7 15.6 10.3 12.0 12.2 16.1 16.0 29.7 8.6 6.4 26.3 13.6 11.0 21.5 11.6 17.7 54.3 35.8 22.0 4.3 12.8 19.9 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 91 "bone marrow: 3894.9" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 4.0;neutrophil: 12.1" "Group enriched" "Detected in many" 9 "granulocytes: 12.1;monocytes: 4.0" "Cell line enriched" "Detected in some" 91 "THP-1: 3105.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015409, HPA066836, HPA073774" Enhanced "Secreted to blood" NA NA 370000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" "CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: " "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 3.4 1.0 0.3 0.0 0.3 3894.9 3.4 0.1 0.7 0.5 0.2 2.0 0.4 1.0 0.0 1.1 1.4 0.1 4.0 0.3 0.2 0.7 3.3 19.4 0.6 0.1 0.2 0.5 0.5 0.0 1.2 0.8 0.1 2.9 0.0 0.0 2.4 0.1 1.5 5.4 1.8 0.1 0.1 42.6 1.4 0.4 0.2 6.3 3.1 0.0 0.0 2.1 1.0 0.2 2.0 0.1 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3105.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.0 34.0 0.0 0.0 4.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 27.2 0.3 0.3 0.1 0.7 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.9 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.0 4.2 0.1 0.0 1.3 16.2 0.0 0.1 0.0 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.0 3.4 11.1 0.0 6.2 1.1 7.2 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 0.0 0.0 7.4 0.0 0.7 0.2 0.0 0.0 EMB MGC71745 ENSG00000170571 Embigin Q6PCB8 5 50396192-50443248 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 152.5;intestine: 72.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 108.4;dendritic cells: 133.3;NK-cells: 153.5;Proximal enterocytes: 137.5;T-cells: 150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 281.5;U-937: 124.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.01e-3)" "unprognostic (8.65e-2)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (8.31e-2)" "unprognostic (2.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.76e-5)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (1.22e-2)" "unprognostic (8.86e-3)" 18.4 22.4 1.7 28.4 1.6 152.5 12.1 4.0 2.9 8.6 2.4 9.7 72.0 3.1 2.7 8.0 5.8 12.9 5.1 1.9 5.4 2.5 4.7 15.9 55.9 6.9 7.8 2.1 2.1 24.2 8.4 13.4 5.6 29.1 11.6 10.5 5.5 20.4 1.3 32.3 68.3 8.0 3.5 25.0 14.3 10.9 3.7 28.4 20.7 3.6 48.4 16.8 2.8 3.1 38.8 2.9 6.5 0.1 2.9 8.7 0.5 1.7 0.0 2.7 0.3 0.3 91.6 74.3 2.1 3.2 0.0 55.7 15.3 43.5 0.4 24.0 38.8 34.5 10.2 0.0 0.5 69.9 0.2 0.6 23.3 6.9 28.2 44.6 0.0 28.8 0.0 86.8 52.4 41.0 43.2 39.3 27.2 0.0 19.9 65.5 0.2 98.6 0.0 29.8 21.2 19.9 0.0 10.1 1.1 13.4 4.3 281.5 0.1 0.1 32.5 0.2 0.3 1.0 0.0 59.3 0.1 124.1 8.3 9.5 34.1 38.7 44.5 4.4 54.1 20.7 39.9 41.0 22.3 13.7 23.5 31.8 30.2 37.3 1.4 25.7 53.6 42.8 1.7 1.6 4.0 2.9 1.9 5.4 6.9 7.8 5.6 3.5 3.7 3.1 3.3 67.3 17.3 1.6 78.1 18.2 2.0 21.2 8.6 3.3 6.5 8.0 1.9 10.0 27.7 0.0 108.4 12.1 133.3 1.2 0.0 0.8 0.6 1.0 0.4 3.8 7.3 21.9 51.9 0.9 8.5 7.8 15.8 0.4 19.0 0.0 20.7 1.6 20.6 1.7 28.7 11.3 8.2 31.4 86.4 1.5 2.8 63.5 10.6 41.2 78.0 2.1 153.5 0.0 1.6 15.7 4.4 6.8 71.1 9.6 137.5 0.4 34.3 9.0 0.0 2.3 4.6 1.0 3.8 6.4 12.6 8.5 150.9 0.0 15.4 2.4 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221018 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 98.9" "Cell type enriched" "Detected in many" 33 "Erythroid cells: 480.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "HEL: 85.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 1400000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 3.1 0.0 0.0 0.0 0.0 98.9 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 1.9 1.5 0.5 0.0 4.0 0.0 0.0 0.6 1.5 0.5 0.0 6.2 4.5 0.0 1.5 0.0 0.0 14.4 0.0 0.0 1.2 0.0 480.0 0.1 0.0 2.3 0.8 0.0 0.0 4.5 0.0 2.5 1.1 1.1 6.7 0.1 0.9 4.1 2.2 2.8 10.5 2.8 1.1 1.8 0.0 3.6 2.5 14.4 0.0 0.0 0.0 1.7 0.7 0.4 1.5 2.4 0.0 0.6 8.4 6.6 1.0 1.0 13.5 4.6 0.0 2.8 6.7 3.8 0.0 0.8 2.0 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 149.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028931 Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "HPA028931: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 14.4 9.6 12.5 13.9 13.7 149.7 19.4 21.2 14.5 17.5 12.0 15.9 11.5 20.6 15.8 11.1 14.8 12.8 11.9 12.4 12.0 11.9 13.8 14.7 21.5 12.4 12.7 23.4 14.4 14.6 10.3 11.7 13.0 15.0 16.1 19.3 15.0 10.3 22.7 13.8 12.9 16.8 12.5 18.6 13.9 14.4 12.4 31.9 16.8 23.4 17.6 15.2 14.1 16.2 12.0 9.6 21.4 17.9 10.6 14.1 12.4 12.2 6.9 15.6 12.8 10.7 15.1 21.8 8.0 13.6 8.2 12.1 12.1 10.4 10.8 15.9 19.4 18.0 13.5 19.2 11.4 14.1 24.7 12.9 15.8 9.3 7.3 13.9 12.8 18.3 18.8 27.7 12.6 12.9 21.5 10.1 5.3 11.4 8.4 27.7 18.3 11.2 12.1 10.9 18.7 17.8 11.4 8.3 20.1 11.8 8.6 18.7 11.6 9.3 22.7 7.8 10.6 11.3 12.2 35.6 10.0 21.1 8.4 65.8 15.3 36.3 18.9 10.2 16.0 27.4 16.9 15.0 9.1 30.9 17.5 16.1 46.8 13.4 13.2 27.4 21.1 7.7 12.5 13.7 21.2 14.5 12.4 12.0 12.4 12.7 13.0 12.5 12.4 16.2 103.8 41.7 50.9 133.2 166.8 28.6 85.0 54.0 78.6 101.4 69.6 84.3 32.4 52.9 49.2 40.5 68.8 34.9 182.6 55.5 9.8 51.5 11.8 54.1 86.7 70.1 98.6 74.9 108.0 43.6 40.7 71.8 58.1 65.8 85.4 74.9 58.5 35.8 35.2 114.4 106.7 63.9 50.8 55.7 46.8 13.1 94.8 84.4 40.9 134.0 75.4 57.3 148.3 161.9 131.8 49.9 52.3 68.1 139.4 71.6 50.4 20.5 44.1 85.8 98.6 134.9 82.5 77.8 58.3 62.9 24.9 46.1 175.3 56.5 51.0 72.4 EPX "EPO, EPP, EPX-PEN" ENSG00000121053 "Eosinophil peroxidase" P11678 17 58192726-58205174 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "bone marrow: 33.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.5;Inhibitory neurons: 1.2;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 23 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Cell line enriched" "Detected in some" 68 "NB-4: 248.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076792 Enhanced NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA076792: " "unprognostic (5.67e-2)" "unprognostic (1.73e-2)" "unprognostic (3.36e-2)" "unprognostic (3.30e-1)" "unprognostic (2.18e-1)" "unprognostic (1.34e-3)" "unprognostic (4.83e-1)" "unprognostic (3.16e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-2)" "unprognostic (1.71e-4)" "unprognostic (7.38e-2)" "unprognostic (1.64e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.02e-2)" "unprognostic (1.73e-1)" 0.0 0.1 0.0 0.2 0.2 33.7 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.5 0.1 0.0 0.0 1.3 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 248.2 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EREG ER ENSG00000124882 Epiregulin O14944 4 74365145-74388749 "Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "bone marrow: 129.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 179.1;Kupffer cells: 133.9;Langerhans cells: 171.1;Macrophages: 570.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 270.0;CAPAN-2: 76.7;hTEC/SVTERT24-B: 83.7;U-2197: 181.4;U-87 MG: 307.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054373 Approved Vesicles "Secreted to blood" NA NA 46000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 41: Macrophages - Immune response" Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 4.5 0.0 0.3 10.3 0.3 129.0 2.5 0.2 0.5 1.9 0.2 2.0 0.2 0.2 0.2 12.6 0.8 5.7 0.7 0.3 0.1 0.1 0.2 2.7 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.6 0.4 0.1 3.4 0.1 1.3 0.0 0.2 9.3 1.6 3.0 0.0 0.5 0.2 0.1 0.6 0.1 0.1 0.0 1.0 4.9 4.0 0.3 1.4 41.1 0.0 0.0 3.8 6.6 0.1 9.2 270.0 2.6 1.6 32.5 76.7 0.0 44.1 0.0 20.1 2.4 0.0 59.3 2.7 0.0 0.0 1.2 1.6 1.2 1.1 0.1 0.1 3.9 20.2 83.7 43.5 0.0 0.0 0.0 0.1 0.5 0.2 0.4 0.1 0.1 0.1 0.2 0.6 0.1 0.0 0.1 0.6 1.6 0.0 0.0 27.0 0.2 0.0 0.0 0.1 0.0 0.0 1.6 0.6 181.4 0.0 0.0 0.0 0.2 307.0 0.0 0.2 0.4 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.5 0.3 0.1 0.2 0.1 0.4 0.0 0.6 0.3 4.9 6.4 7.2 0.0 5.7 5.4 5.6 179.1 4.0 0.0 24.4 2.3 18.2 5.7 82.4 0.0 0.0 0.4 2.2 56.3 0.0 1.8 3.7 2.4 0.7 2.5 3.6 17.0 0.1 0.2 0.7 4.4 0.5 3.9 7.0 0.1 0.4 1.9 26.8 0.0 1.8 38.2 16.2 133.9 171.1 1.0 0.3 570.7 7.2 0.0 23.2 0.0 0.0 0.0 0.0 0.8 27.1 0.0 11.7 2.5 32.4 0.2 41.9 0.0 0.0 2.5 3.1 0.5 0.3 3.8 9.2 0.7 3.3 0.2 33.1 7.4 FAM151B UNQ9217 ENSG00000152380 "Family with sequence similarity 151 member B" Q6UXP7 5 80487969-80542563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.8;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 18.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043805 Uncertain Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA043805: AB_10794287" "unprognostic (1.29e-1)" "unprognostic (7.11e-2)" "unprognostic (1.67e-3)" "unprognostic (1.28e-4)" "unprognostic (1.90e-2)" "unprognostic (4.46e-4)" "unprognostic (2.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.10e-2)" "unprognostic (9.63e-2)" "unprognostic (1.20e-1)" "unprognostic (3.44e-2)" "unprognostic (6.86e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-1)" "unprognostic (2.50e-2)" "unprognostic (1.63e-1)" 0.7 1.0 0.7 0.7 0.9 4.7 0.7 0.4 0.9 0.8 0.4 0.4 0.4 0.6 0.9 0.5 1.3 0.9 0.9 1.0 0.5 1.1 0.8 0.7 0.3 0.6 0.4 0.6 0.6 1.1 0.7 1.8 0.2 0.8 0.6 1.0 0.4 0.5 0.3 0.3 0.3 0.9 0.5 0.7 0.5 0.7 0.9 0.2 0.8 0.3 0.4 0.7 0.5 0.7 0.1 1.5 0.7 3.2 2.6 3.7 1.0 1.3 1.9 1.1 2.4 0.1 1.2 0.0 0.2 3.4 3.4 0.8 1.1 0.2 0.9 0.3 0.7 0.3 0.5 0.3 1.1 0.5 1.7 1.8 1.1 1.2 0.1 2.1 1.7 0.4 0.1 0.5 1.8 1.1 0.2 0.2 0.1 0.3 0.6 0.4 2.6 0.4 1.3 0.5 0.3 0.7 0.4 1.2 1.1 0.3 1.7 1.4 0.7 0.2 0.2 0.0 0.5 0.0 0.7 0.0 1.8 1.4 1.1 0.0 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.9 0.4 0.9 1.0 0.5 0.6 0.4 0.2 0.5 0.9 0.7 0.3 0.0 0.0 3.6 0.4 0.3 0.5 2.2 0.6 1.0 1.4 0.8 1.8 2.8 1.7 3.7 0.0 7.9 0.1 0.3 0.0 1.5 4.1 3.9 1.3 0.9 0.0 0.0 17.8 2.1 6.7 2.0 1.5 2.6 1.3 1.1 0.4 0.3 5.1 1.7 21.6 0.5 0.0 4.8 1.2 1.9 1.2 3.6 0.0 6.5 2.2 1.5 0.0 18.6 8.5 0.3 0.3 0.4 1.3 0.7 0.6 4.3 3.7 0.8 0.0 1.2 0.8 4.7 0.9 1.0 1.0 7.9 0.1 1.3 0.2 0.6 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768439-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 12.9 11.7 6.8 15.9 7.9 42.9 14.0 8.4 8.2 12.8 12.2 13.0 14.5 13.8 11.9 13.1 10.3 16.0 7.1 7.0 9.0 18.4 26.6 13.1 18.7 9.1 8.2 12.8 14.0 21.0 9.3 20.2 8.6 11.6 14.8 11.7 11.4 11.0 6.1 11.6 14.2 11.7 8.7 19.6 13.9 10.9 8.5 14.3 18.3 6.2 17.0 17.1 10.6 11.6 63.9 42.4 12.9 22.4 24.4 26.3 20.8 36.2 39.4 33.7 42.5 21.3 25.8 29.9 39.2 29.9 26.7 30.4 30.8 39.2 60.0 57.5 29.8 47.2 21.9 25.6 38.0 21.7 58.9 25.0 31.1 44.1 54.3 23.0 31.0 18.4 17.1 41.3 30.7 75.8 37.7 14.4 12.7 51.8 37.3 20.4 21.5 22.4 28.4 64.7 15.5 21.6 48.1 102.4 49.8 18.8 31.5 22.9 31.5 32.0 57.4 35.7 53.1 31.9 65.8 28.4 50.2 38.7 39.9 7.0 8.0 11.3 3.2 9.5 2.9 5.1 3.2 2.7 8.2 4.2 2.7 3.7 10.1 5.9 8.5 3.1 3.1 4.3 6.8 7.9 8.4 8.2 7.0 9.0 9.1 8.2 8.6 8.7 8.5 11.6 31.9 25.6 13.2 17.6 30.6 39.6 21.9 19.0 20.5 15.0 24.0 17.7 8.4 22.8 19.3 25.8 22.9 10.4 25.3 21.3 5.9 12.1 22.4 20.8 22.9 27.5 27.5 10.3 21.0 15.5 12.7 19.3 26.5 33.0 8.8 18.2 18.5 59.3 27.1 23.5 22.0 22.0 16.2 73.6 43.5 26.0 14.0 45.9 21.4 24.4 40.1 17.6 19.6 23.6 45.8 35.1 21.7 14.7 25.8 34.8 18.7 20.8 16.5 21.7 13.1 26.5 22.4 14.2 10.7 27.0 46.7 19.2 19.6 16.0 14.5 45.3 FOLR3 "FR-G, FRγ" ENSG00000110203 "Folate receptor gamma" P41439 11 72114869-72139892 "Metabolic proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 98.7;lymphoid tissue: 28.4" "Group enriched" "Detected in some" 10 "Distal tubular cells: 406.9;monocytes: 103.0" "Cancer enhanced" "Detected in some" "ovarian cancer: 5.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 330.8;neutrophil: 492.8" "Group enriched" "Detected in many" 11 "granulocytes: 492.8;monocytes: 330.8" "Group enriched" "Detected in some" 5 "hTERT-HME1: 72.4;U-2197: 64.7" "Secreted to blood" NA NA 12000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.47e-2)" "unprognostic (6.26e-3)" "unprognostic (1.94e-2)" "unprognostic (8.72e-3)" "unprognostic (6.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "unprognostic (3.72e-1)" "unprognostic (1.72e-1)" "unprognostic (1.54e-1)" "unprognostic (7.35e-2)" "unprognostic (7.90e-2)" "unprognostic (8.39e-2)" "unprognostic (9.99e-4)" "unprognostic (1.96e-1)" "unprognostic (2.03e-6)" "unprognostic (4.17e-1)" 5.7 0.4 0.3 10.6 0.2 98.7 0.2 0.2 0.5 0.2 0.3 0.2 0.4 0.0 0.0 1.0 0.9 0.3 0.5 0.2 0.3 8.6 0.8 5.9 0.1 0.3 0.3 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.6 0.1 0.1 0.6 0.5 0.6 0.2 28.4 0.4 0.9 0.6 1.3 1.7 0.5 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.3 10.4 13.1 3.7 9.2 0.0 0.0 0.0 1.3 2.0 0.2 1.1 0.0 6.9 8.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 8.8 5.4 72.4 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.6 0.3 64.7 0.0 0.1 0.0 0.0 2.7 0.0 0.0 15.1 330.8 30.9 0.5 26.1 1.8 0.3 0.1 0.2 36.2 0.1 0.1 0.0 492.8 0.5 1.4 6.3 0.4 294.4 0.3 0.2 0.2 0.5 0.2 0.3 0.3 0.3 0.3 0.2 0.6 0.3 0.1 0.0 7.9 0.0 1.1 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 1.9 23.9 0.0 0.1 1.3 0.0 406.9 0.1 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.8 0.0 1.1 0.0 1.6 0.0 0.0 0.0 0.0 22.4 1.7 10.9 0.0 17.4 0.0 0.0 103.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 18.1 1.5 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 1.0 0.1 0.0 0.1 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 100.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 22.8;Ductal cells: 19.3;Gastric mucus-secreting cells: 21.9;Intestinal goblet cells: 23.7;Pancreatic endocrine cells: 22.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 11.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 37.4;NB-4: 24.2;THP-1: 46.6;U-937: 32.9" "Low region specificity" "Detected in single" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 3.7 1.2 1.3 4.7 1.1 100.8 2.5 1.2 1.4 2.3 0.2 9.2 12.3 2.8 1.2 1.8 2.1 3.7 1.7 1.6 1.1 1.9 1.5 2.1 3.7 1.3 1.0 2.9 6.7 0.5 1.3 3.1 1.3 1.6 8.7 1.6 6.8 2.2 0.9 0.8 10.8 2.5 1.6 3.6 10.8 1.3 1.4 3.7 1.2 1.1 2.8 2.1 1.3 1.9 2.9 1.4 1.7 0.0 5.3 4.8 8.9 2.6 1.3 2.3 2.5 12.5 4.0 0.0 6.1 4.4 1.2 1.4 2.9 0.3 2.1 19.1 2.9 9.4 2.2 0.3 2.7 37.4 8.0 4.1 0.1 2.9 0.0 0.5 3.6 8.3 9.7 0.0 2.7 1.4 7.9 24.2 3.4 11.6 3.4 6.9 0.0 0.0 2.4 1.9 2.4 0.9 1.5 3.7 1.5 5.1 2.1 46.6 3.3 1.8 4.9 0.0 1.0 1.1 0.6 0.0 1.6 32.9 1.1 0.5 0.8 0.7 0.2 0.4 0.1 0.1 0.2 0.3 0.4 0.1 0.2 0.1 0.3 0.2 1.2 0.5 0.5 0.2 1.3 1.1 1.2 1.4 1.6 1.1 1.3 1.0 1.3 1.6 1.4 1.9 2.9 0.0 0.0 1.3 1.8 1.7 3.0 0.9 1.2 1.0 1.8 1.8 0.9 22.8 1.9 1.8 4.2 15.6 2.6 12.1 0.0 19.3 0.3 1.1 2.8 2.3 10.2 3.4 1.5 17.9 3.2 6.0 21.9 3.3 0.0 2.6 3.9 1.0 9.0 0.0 1.9 23.7 0.0 12.9 3.5 0.8 4.4 5.2 3.6 3.7 13.6 0.4 0.0 3.0 3.4 22.5 5.8 1.2 0.5 2.9 11.6 2.4 1.7 7.9 0.0 3.1 2.6 1.7 3.5 2.1 0.6 2.2 3.1 2.0 17.9 1.4 GATA1 "ERYF1, GATA-1, GF1, NF-E1, NFE1" ENSG00000102145 "GATA binding protein 1" P15976 X 48786562-48794311 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 59.9" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 165.6" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "eosinophil: 471.7" "Lineage enriched" "Detected in single" 1877 "granulocytes: 471.7" "Group enriched" "Detected in some" 9 "HEL: 221.5;HMC-1: 211.9;K-562: 238.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA000232, HPA000233, CAB009195" Enhanced Supported Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951" "unprognostic (1.93e-1)" "unprognostic (7.54e-2)" "unprognostic (8.95e-3)" "unprognostic (3.84e-3)" "unprognostic (2.25e-1)" "unprognostic (3.00e-4)" "unprognostic (4.87e-2)" "unprognostic (3.48e-2)" "unprognostic (4.44e-2)" "unprognostic (1.95e-2)" "unprognostic (6.04e-2)" "unprognostic (7.71e-3)" "unprognostic (4.13e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-1)" "unprognostic (9.10e-2)" "unprognostic (2.71e-2)" 0.2 0.1 0.0 0.1 0.2 59.9 0.1 0.2 0.1 0.2 0.0 0.2 0.5 0.3 0.0 0.2 0.1 0.6 0.1 0.0 0.2 0.2 0.3 2.0 0.1 0.3 0.2 0.0 0.0 0.0 0.2 1.0 0.2 0.3 0.3 0.4 0.1 0.1 0.0 0.3 0.5 0.3 0.2 2.0 0.5 1.4 0.2 0.1 0.1 0.4 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 221.5 0.0 0.0 0.0 0.2 211.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 238.9 0.4 0.0 0.0 0.1 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 83.6 0.2 471.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.0 0.0 4.4 0.0 0.2 0.2 0.1 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.0 0.0 1.3 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 165.6 0.1 0.0 0.5 0.3 0.0 0.0 37.9 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.4 31.5 0.0 9.2 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 1.2 0.2 0.0 0.0 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 325.7" "Cell type enhanced" "Detected in all" "Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 327.4;neutrophil: 864.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 864.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 1300000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 30.5 13.5 16.4 62.6 23.0 325.7 17.6 20.2 28.8 12.2 11.4 18.0 19.3 9.8 24.6 10.9 16.2 23.0 9.7 15.9 17.7 18.3 15.0 26.5 33.0 25.5 20.7 8.5 16.6 10.4 8.2 25.2 23.6 12.2 19.6 10.6 12.3 9.7 2.7 7.0 18.7 18.8 21.6 70.1 25.1 24.1 19.5 18.4 17.0 14.9 25.4 26.1 5.7 37.3 2.6 4.2 10.7 0.0 2.5 2.2 0.4 4.0 11.1 6.2 11.1 8.7 30.6 3.7 27.0 0.3 14.2 1.6 4.1 12.7 7.7 17.1 16.8 33.5 2.9 17.7 3.0 41.6 9.1 2.8 4.3 5.7 1.2 15.8 0.9 25.9 0.6 12.1 0.5 33.0 0.9 24.2 6.5 22.5 16.4 14.2 2.7 18.5 32.7 18.6 6.9 12.0 5.1 23.3 19.7 12.5 15.8 17.7 0.8 1.6 11.2 17.8 6.2 11.5 23.2 0.6 9.2 15.8 7.7 38.8 132.4 327.4 2.7 78.4 3.5 21.6 4.8 4.8 63.2 21.1 8.1 5.0 864.2 2.5 63.3 17.2 10.2 71.4 16.4 23.0 20.2 28.8 15.9 17.7 25.5 20.7 23.6 21.6 19.5 37.3 28.8 16.0 36.5 10.1 54.5 15.4 28.2 19.6 12.5 10.2 32.6 16.4 4.1 50.1 21.2 33.1 2.1 55.5 17.3 14.4 76.3 49.5 185.0 21.1 9.1 26.4 39.4 36.1 25.9 60.5 20.8 14.4 43.8 24.9 44.9 13.6 48.9 15.0 107.9 11.8 15.4 29.9 32.6 183.3 60.5 32.8 10.8 153.5 16.0 17.8 228.5 21.1 10.3 1.0 98.0 36.5 25.7 6.4 23.4 24.3 18.4 69.7 24.7 4.4 6.6 12.2 18.3 52.6 13.5 15.1 18.2 46.9 16.3 16.7 28.9 21.0 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "bone marrow: 4.4" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052617, HPA059403" Uncertain Approved "Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies, Vesicles" Cytosol "HPA052617: AB_2681886, HPA059403: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.0 0.1 0.1 0.3 0.2 4.4 0.0 0.6 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.9 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.6 0.2 0.1 0.2 0.3 0.2 0.3 0.1 0.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GFI1B ZNF163B ENSG00000165702 "Growth factor independent 1B transcriptional repressor" Q5VTD9 9 132944000-132991687 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "bone marrow: 39.0" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 99.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 20 "basophil: 195.6;eosinophil: 395.8" "Lineage enriched" "Detected in many" 26 "granulocytes: 395.8" "Group enriched" "Detected in some" 5 "HEL: 168.9;HMC-1: 104.6;K-562: 53.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004420, HPA006291" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Plasma membrane" "CAB004420: AB_2110132, HPA006291: " "unprognostic (1.79e-2)" "unprognostic (2.90e-4)" "unprognostic (6.54e-2)" "unprognostic (1.76e-1)" "unprognostic (2.33e-1)" "unprognostic (1.54e-2)" "unprognostic (2.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.54e-1)" "unprognostic (4.61e-2)" "unprognostic (3.71e-2)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (1.53e-2)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.3 0.1 39.0 0.0 0.2 0.2 0.0 0.2 0.5 0.9 0.0 0.1 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.2 1.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.0 0.1 0.1 0.4 0.5 1.0 0.1 0.1 1.8 0.3 2.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 1.9 0.3 23.8 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 168.9 0.2 0.1 0.0 0.1 104.6 0.0 1.4 0.0 0.2 0.0 0.0 0.0 53.0 0.2 0.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 195.6 0.3 395.8 0.1 1.9 0.1 0.1 0.1 0.0 1.9 0.2 0.5 0.1 3.9 0.5 15.1 1.0 0.0 12.5 0.0 0.1 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.4 0.2 0.0 0.6 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.3 0.0 1.8 0.0 0.0 0.1 0.1 0.8 0.0 0.1 3.8 0.0 0.3 0.4 1.2 99.1 0.4 0.0 0.2 0.3 0.0 0.1 14.5 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.0 12.9 0.0 15.8 0.0 0.0 0.6 0.0 0.0 0.5 0.2 0.0 24.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.3 0.2 1.0 0.6 0.1 GPR141 PGR13 ENSG00000187037 "G protein-coupled receptor 141" Q7Z602 7 37683796-37833788 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 27.9" "Cell type enhanced" "Detected in some" "dendritic cells: 8.9;granulocytes: 23.4;Langerhans cells: 8.2;monocytes: 7.5;NK-cells: 13.4;Oligodendrocytes: 14.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 13.0;eosinophil: 9.7;gdT-cell: 5.2;memory CD8 T-cell: 5.1;myeloid DC: 6.6;naive CD8 T-cell: 3.4;neutrophil: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 13.2;HMC-1: 49.7;NB-4: 8.0;NTERA-2: 27.1;THP-1: 8.2;U-937: 21.9" "Not detected" "Not detected" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (4.91e-2)" "unprognostic (3.44e-1)" "unprognostic (3.26e-4)" "unprognostic (4.70e-3)" "unprognostic (8.67e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.51e-2)" "unprognostic (7.93e-3)" "unprognostic (1.44e-1)" "unprognostic (1.51e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-3)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" 1.4 0.4 0.6 4.1 1.5 27.9 0.6 1.2 0.7 1.3 0.9 1.2 0.8 0.7 0.4 1.5 0.5 2.2 0.3 0.3 1.3 0.3 0.7 1.8 1.9 3.2 1.2 0.1 0.2 0.3 0.1 2.4 1.9 0.4 1.7 0.0 0.3 0.3 0.2 0.9 1.2 1.5 1.5 3.0 0.8 0.8 1.8 1.4 0.3 0.6 1.8 3.7 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 13.2 1.0 0.0 0.0 0.3 49.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 8.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 21.9 0.0 0.0 13.0 9.7 5.2 0.9 0.0 0.0 1.2 5.1 6.6 0.0 0.5 3.4 12.3 0.8 0.1 0.2 0.0 4.3 0.6 1.5 1.2 0.7 0.3 1.3 3.2 1.2 1.9 1.5 1.8 3.0 0.0 3.2 3.0 0.3 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.1 0.0 0.1 23.4 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 5.4 8.2 1.3 0.0 5.7 0.0 1.9 7.5 0.0 13.4 1.0 14.4 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.6 0.0 0.1 0.3 2.3 0.0 0.0 0.0 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705742-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 64000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: AB_2685329" "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.4 19.0 16.5 23.4 19.1 105.4 18.4 20.0 44.3 20.3 20.8 20.5 20.5 20.0 12.1 22.4 22.1 17.7 20.0 18.4 19.3 18.4 17.1 28.9 23.0 19.3 17.0 27.4 22.0 19.2 25.5 16.0 17.0 23.8 17.6 34.7 21.2 15.5 31.7 27.5 22.9 16.6 15.5 28.0 20.4 20.3 16.7 20.0 24.9 19.9 23.0 18.7 19.4 23.9 29.2 10.5 37.4 30.2 12.6 19.7 18.3 27.4 28.7 39.0 33.9 22.0 16.3 27.9 9.8 26.9 17.5 26.6 45.5 28.8 21.6 49.2 32.8 48.7 36.9 16.3 23.9 57.7 24.3 20.3 22.0 31.2 48.7 21.3 24.3 20.2 29.4 56.5 21.8 12.1 32.1 26.1 27.0 16.7 20.8 61.8 38.2 36.7 13.8 23.3 51.0 17.7 33.3 21.0 19.6 16.2 19.0 24.2 26.1 22.3 22.0 16.4 21.2 51.8 18.7 38.5 20.1 29.0 16.9 3.5 3.1 3.9 4.7 4.6 4.2 4.6 3.5 4.9 3.4 3.8 2.5 3.7 7.8 2.3 5.1 1.7 3.3 3.4 16.5 19.1 20.0 44.3 18.4 19.3 19.3 17.0 17.0 15.5 16.7 23.9 17.8 9.6 8.4 7.8 31.8 27.8 36.0 12.7 15.4 32.6 17.5 15.5 11.2 5.7 12.4 12.9 22.9 7.2 35.9 40.3 5.9 13.2 4.5 22.2 14.3 13.1 16.2 35.3 5.5 19.3 7.9 14.5 23.4 26.4 14.0 17.5 13.6 12.4 8.6 20.2 7.9 24.3 16.2 18.4 43.9 5.4 16.1 19.3 10.6 4.7 26.6 13.2 20.6 5.5 15.2 19.9 21.1 19.2 52.8 47.4 29.8 6.1 16.6 41.0 26.3 19.9 14.5 17.2 7.7 19.2 34.2 19.0 31.9 15.5 13.0 51.0 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140751 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "bone marrow: 156.3" "Cell type enriched" "Detected in some" 350 "Erythroid cells: 1995.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 203 "HEL: 149.1;K-562: 37.7" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 15000000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.1 0.1 0.0 0.1 156.3 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.7 0.0 0.0 0.0 0.0 1995.6 2.4 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 1.7 0.0 0.0 0.9 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 GYPB "CD235b, GPB, MNS, SS" ENSG00000250361 "Glycophorin B (MNS blood group)" P06028 4 143996104-144019380 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "bone marrow: 63.2" "Cell type enriched" "Detected in some" 450 "Erythroid cells: 1351.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 159.0" "Intracellular and membrane" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" 0.2 0.0 0.0 0.0 0.3 63.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.1 0.1 0.0 1351.4 3.0 0.0 1.2 0.2 0.0 0.0 0.0 2.1 0.0 0.9 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 H2AC14 "H2A/E, H2AFE, HIST1H2AJ" ENSG00000276368 "H2A clustered histone 14" Q99878 6 27814302-27814777 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "bone marrow: 7.2" "Cell type enhanced" "Detected in single" "Extravillous trophoblasts: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5" "Low region specificity" "Detected in many" HPA041189 Supported Approved Nucleoplasm NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.1 0.0 0.2 0.3 0.4 7.2 0.0 0.5 0.7 0.5 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.1 0.1 1.0 1.7 0.0 0.0 0.1 0.2 0.1 0.8 3.5 0.0 0.9 0.0 0.0 0.0 0.7 1.0 0.8 0.7 1.8 1.4 0.1 3.1 0.3 0.5 0.1 1.0 0.0 0.8 0.4 1.4 0.3 4.6 0.7 6.9 0.2 0.0 1.7 0.0 0.2 0.5 0.2 0.0 1.0 1.6 0.0 9.8 0.2 11.5 5.0 4.6 1.4 1.5 2.4 4.6 0.0 1.4 0.1 1.9 0.3 0.8 0.8 1.0 0.3 0.2 0.3 3.4 0.0 0.0 1.6 0.3 0.1 4.8 3.1 2.9 0.8 3.2 2.2 0.0 0.0 0.0 0.2 0.2 0.4 0.3 1.3 1.3 1.1 1.3 0.4 0.1 1.1 0.1 0.1 0.1 2.8 1.7 0.2 0.4 0.5 0.7 0.2 0.4 0.7 0.5 1.3 0.4 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548828-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 7.9 5.7 5.5 5.8 5.8 36.5 7.5 5.8 9.5 4.7 4.2 5.8 4.8 6.0 5.5 6.4 4.7 4.6 5.8 6.2 5.8 5.3 5.4 7.0 8.1 6.1 5.6 5.4 6.6 4.5 4.2 6.4 6.2 4.2 5.9 5.4 5.0 3.8 7.2 6.2 5.4 6.7 5.8 5.4 4.9 5.0 5.8 8.9 5.1 5.8 7.9 7.0 4.7 7.6 23.6 12.0 21.5 13.7 10.9 12.3 20.3 22.9 13.9 21.8 17.1 24.5 11.8 13.8 11.1 13.4 18.6 34.6 23.7 15.2 21.5 19.4 13.3 20.0 19.7 19.0 15.6 34.2 14.5 10.6 11.1 16.2 17.7 9.2 22.0 19.2 36.2 17.5 21.3 14.1 21.4 28.5 16.8 31.9 15.3 27.9 26.4 15.0 12.6 16.4 17.8 14.8 23.2 20.6 13.2 15.6 18.7 22.4 17.1 28.7 21.4 39.0 43.8 18.7 61.1 40.0 18.5 38.0 21.6 4.0 4.3 3.9 4.4 5.3 4.5 6.0 4.4 3.7 3.9 5.1 3.3 4.5 1.9 2.9 7.5 4.5 5.2 2.8 5.5 5.8 5.8 9.5 6.2 5.8 6.1 5.6 6.2 5.8 5.8 7.6 17.5 12.8 14.4 5.5 19.4 13.6 20.9 10.9 18.2 7.8 8.6 8.0 4.2 14.3 11.6 3.7 16.7 14.5 17.7 7.1 3.9 14.2 35.2 10.9 12.3 14.6 17.3 31.1 11.6 16.5 27.6 12.9 12.2 10.4 24.6 9.0 7.9 9.7 21.7 16.8 9.3 10.6 8.2 18.5 23.6 7.3 11.1 19.0 1.8 9.4 19.6 9.7 10.3 11.6 10.4 18.8 11.2 11.3 20.1 20.2 8.7 13.3 15.8 16.3 19.7 16.5 12.4 34.0 9.6 23.2 15.3 13.4 21.1 14.0 10.8 17.1 HBA1 HBA-T3 ENSG00000206172 "Hemoglobin subunit alpha 1" P69905 16 176680-177522 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 24344.4" "Cell type enriched" "Detected in many" 51 "Erythroid cells: 224916.4" "Group enriched" "Detected in many" 4 "endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 142.6;plasmacytoid DC: 101.1" "Group enriched" "Detected in all" 5 "dendritic cells: 101.1;granulocytes: 142.6" "Group enriched" "Detected in some" 36 "HEL: 3355.8;K-562: 2416.8" "CAB032534, HPA043780" Enhanced NA NA 14000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB032534: AB_2294993, HPA043780: AB_2678667" "unprognostic (1.16e-1)" "unprognostic (1.45e-2)" "unprognostic (8.87e-2)" "unprognostic (9.78e-3)" "unprognostic (3.02e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-1)" "unprognostic (6.21e-3)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-2)" "unprognostic (3.59e-2)" "unprognostic (3.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.67e-2)" "unprognostic (9.56e-2)" 893.7 183.0 112.1 82.0 216.3 24344.4 316.6 159.4 246.9 237.7 340.5 141.4 10.6 41.4 2.4 244.9 350.9 60.1 1766.9 56.9 92.1 1405.5 1100.4 2201.7 5.0 141.5 169.4 159.7 100.5 5.1 465.7 1992.7 183.4 170.1 11.5 3.1 138.1 43.7 234.0 194.6 85.0 7.0 211.1 5527.7 135.9 104.8 125.3 20.7 609.2 1123.2 3.6 167.2 351.2 113.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 58.1 0.0 5.7 2.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.2 3355.8 0.0 37.1 0.0 1.3 0.0 0.3 0.0 0.0 0.7 0.0 0.0 1.7 2416.8 0.0 0.0 14.7 0.5 0.3 0.4 1.0 0.0 0.1 1.4 79.1 0.0 1.0 7.4 5.3 2.8 0.0 0.0 0.0 1.1 0.0 8.3 0.0 0.0 0.9 0.0 0.0 0.4 0.8 0.0 0.2 0.0 8.5 7.4 48.2 26.3 0.2 0.7 7.5 3.1 8.7 10.0 4.5 8.3 25.7 142.6 13.4 0.8 101.1 0.3 2806.3 112.1 216.3 159.4 246.9 56.9 92.1 141.5 169.4 183.4 211.1 125.3 113.5 72.7 0.0 0.0 0.0 56.8 10.6 0.1 0.0 0.0 0.4 11.3 12.3 1.8 55.8 0.1 0.0 0.0 0.0 93.2 3.2 7.9 0.0 6.0 0.5 0.5 20.4 1.2 224916.4 0.0 0.0 0.0 57.9 0.0 0.4 0.0 0.1 151.0 78.8 0.0 0.0 0.0 5.7 0.0 436.7 64.1 22.4 0.0 234.0 4338.2 0.0 12.7 1.3 1166.9 0.0 0.0 0.1 2.8 0.4 0.5 0.2 0.2 11.1 0.0 16.5 0.0 8.7 58.7 1.5 7.6 0.0 13.2 0.0 155.7 0.0 3.2 0.0 HBA2 HBA-T2 ENSG00000188536 "Hemoglobin subunit alpha 2" P69905 16 172876-173710 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 38218.6" "Cell type enriched" "Detected in many" 22 "Erythroid cells: 198314.0" "Cancer enhanced" "Detected in all" "glioma: 59.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7" "Group enriched" "Detected in all" 7 "dendritic cells: 486.7;granulocytes: 955.3" "Group enriched" "Detected in some" 18 "HEL: 1196.2;K-562: 328.3" "CAB038417, HPA043780" Enhanced NA NA 14000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB038417: , HPA043780: AB_2678667" "unprognostic (1.57e-1)" "unprognostic (7.02e-2)" "unprognostic (2.59e-2)" "unprognostic (2.13e-1)" "unprognostic (3.59e-1)" "unprognostic (3.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (4.99e-2)" "unprognostic (4.43e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.72e-3)" "unprognostic (1.36e-1)" "unprognostic (2.11e-1)" "unprognostic (4.73e-2)" "unprognostic (8.92e-2)" 1592.0 322.5 162.6 186.3 292.4 38218.6 545.3 268.0 377.0 573.3 570.7 254.0 21.6 85.9 5.9 432.5 570.5 147.6 2590.3 86.6 156.5 2302.8 1853.6 4204.3 9.7 210.6 249.2 288.5 141.3 11.4 807.8 3618.9 260.6 302.7 26.7 4.0 305.4 131.9 568.3 188.5 154.3 12.9 316.4 8125.4 264.0 185.0 185.4 34.6 1192.5 1744.6 10.1 325.2 632.8 179.9 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.4 0.1 0.0 0.0 3.2 0.0 1.9 4.9 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.6 1196.2 0.5 0.0 0.0 0.2 1.7 0.4 0.1 0.4 0.0 0.0 0.0 0.1 328.3 0.0 0.1 0.6 0.0 0.3 0.1 0.5 0.0 0.0 0.0 43.4 0.0 0.9 11.9 9.7 1.1 0.0 0.0 0.1 1.4 0.2 5.6 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.2 119.6 28.1 315.1 99.6 1.7 3.7 39.2 8.5 7.1 42.5 19.1 22.8 73.9 955.3 49.5 3.3 486.7 1.0 15003.3 162.6 292.4 268.0 377.0 86.6 156.5 210.6 249.2 260.6 316.4 185.4 179.9 184.7 3.2 1.5 0.0 97.6 44.4 0.4 0.1 0.6 1.7 20.2 22.2 6.8 70.1 0.7 0.0 0.0 0.0 162.2 6.9 54.8 0.0 3.4 0.6 0.8 50.9 3.0 198314.0 0.0 0.0 0.0 241.0 4.1 0.9 1.3 0.3 142.8 131.2 0.0 0.0 0.0 7.5 4.1 770.6 149.6 16.9 0.0 402.9 8790.3 0.0 37.5 2.3 954.7 0.0 0.0 0.0 3.6 0.0 0.3 0.2 0.1 29.6 2.5 58.6 0.0 25.2 171.5 1.0 9.9 1.1 44.6 0.0 306.3 0.1 5.0 0.1 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 133301.6" "Cell type enriched" "Detected in many" 24 "Erythroid cells: 672352.3" "Group enriched" "Detected in all" 4 "cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1" "Region enriched" "Detected in all" 11 "cerebral cortex: 3368.5" "Group enriched" "Detected in all" 5 "neutrophil: 658.1;plasmacytoid DC: 379.7" "Group enriched" "Detected in all" 11 "dendritic cells: 379.7;granulocytes: 658.1" "Cell line enhanced" "Detected in some" "HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2" "CAB009526, HPA043234" Enhanced NA NA 10000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB009526: AB_2143058, HPA043234: AB_2678378" "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 1641.5 481.4 155.7 217.3 219.2 133301.6 637.4 235.7 3368.5 546.2 384.6 278.2 28.8 78.8 45.6 505.7 829.6 792.7 2658.8 108.9 154.4 2333.1 1907.3 4039.6 26.8 209.6 243.5 289.0 158.5 50.5 808.2 6345.0 303.0 312.0 148.9 31.0 548.1 290.6 578.8 135.3 169.8 66.3 316.2 9225.9 269.1 170.6 171.4 196.8 1152.0 12902.5 40.3 320.1 633.5 180.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.4 0.3 0.0 0.0 5.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.1 4.2 0.0 0.0 0.0 0.0 99.5 25.3 73.7 37.8 1.3 4.0 21.5 6.8 1.1 35.2 13.8 13.7 39.9 658.1 47.9 5.0 379.7 1.4 22388.9 155.7 219.2 235.7 3368.5 108.9 154.4 209.6 243.5 303.0 316.2 171.4 180.7 441.7 3.2 8.4 0.0 280.5 157.0 2.3 5.1 0.0 4.0 54.7 72.0 3.4 217.3 4.5 7.3 4.2 2.2 369.9 5.2 50.9 0.0 0.0 6.8 6.6 151.7 3.6 672352.3 0.0 0.0 11.3 276.1 0.0 5.1 0.0 4.6 443.4 420.5 7.3 3.3 0.0 7.2 6.1 1452.1 702.6 0.0 0.0 1091.0 27383.1 0.0 72.7 9.7 38.1 0.0 0.0 0.1 3.5 0.0 1.9 0.0 0.1 272.4 84.9 117.8 0.0 126.0 396.8 0.0 0.0 0.0 252.5 2.2 769.8 0.3 3.0 0.1 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 57 "bone marrow: 2797.6" "Cell type enriched" "Detected in some" 318 "Erythroid cells: 22112.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5" "CAB037087, HPA043234" Supported NA NA 6600000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB037087: AB_260051, HPA043234: AB_2678378" "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 2.2 0.3 0.5 0.6 0.6 2797.6 0.7 0.8 2.7 0.1 0.7 0.5 0.0 0.1 0.0 0.3 2.8 0.1 2.5 0.5 0.4 3.2 7.5 6.2 0.5 0.6 0.5 0.3 0.2 4.5 2.2 19.5 0.7 0.2 0.3 0.1 2.2 0.3 0.5 0.6 0.2 0.0 0.6 49.1 0.3 0.1 0.5 4.3 1.0 11.5 0.2 0.2 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 74.5 0.0 0.0 0.0 0.3 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.4 25.5 0.0 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.2 0.0 1.6 0.0 105.0 0.5 0.6 0.8 2.7 0.5 0.4 0.6 0.5 0.7 0.6 0.5 1.0 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 22112.3 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 13.6 13.4 0.1 0.0 0.0 0.0 0.0 16.9 1.9 0.1 0.0 6.2 69.4 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 HBM "HBAP2, HBK" ENSG00000206177 "Hemoglobin subunit mu" Q6B0K9 16 153892-166764 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "bone marrow: 459.9" "Cell type enriched" "Detected in some" 504 "Erythroid cells: 8988.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 980000 "Cluster 48: NK-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 6: Erythroid cells - Oxygen transport" "unprognostic (1.30e-1)" "unprognostic (7.59e-2)" 1.2 0.1 0.2 0.0 0.4 459.9 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 1.4 0.3 0.0 1.9 3.1 3.9 0.0 0.1 0.0 0.2 0.1 0.0 1.2 6.3 0.1 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 17.5 0.1 0.2 0.0 0.2 0.7 0.9 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 6.9 0.2 0.4 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8988.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 3.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.6 0.0 3.3 17.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 2.1 0.0 0.1 0.0 1.9 0.0 0.0 0.0 HBQ1 HBQ ENSG00000086506 "Hemoglobin subunit theta 1" P09105 16 180459-181179 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 25.6" "Cell type enriched" "Detected in some" 9 "Erythroid cells: 399.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "granulocytes: 1.3;T-cells: 1.3" "Group enriched" "Detected in some" 8 "HEL: 22.4;Hep G2: 15.8;K-562: 56.5" "Low region specificity" "Detected in all" HPA062473 Enhanced Approved "Lipid droplets" NA NA 160000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Lipid droplets" "HPA062473: AB_2684774" "unprognostic (4.24e-1)" "unprognostic (3.38e-1)" "unprognostic (2.11e-2)" "unprognostic (2.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.33e-1)" "unprognostic (8.92e-2)" "unprognostic (2.02e-3)" "unprognostic (8.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (5.55e-1)" 0.3 0.1 3.1 0.0 3.2 25.6 0.1 0.8 4.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.6 2.8 1.7 0.5 0.4 0.9 0.0 0.8 1.2 0.1 0.0 0.0 0.7 0.8 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 3.6 0.1 1.9 3.1 0.0 0.2 0.0 0.0 0.0 0.2 2.2 0.0 1.3 0.4 4.1 0.0 0.0 0.7 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 22.4 1.0 15.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.3 56.5 0.0 0.0 0.2 2.5 0.0 2.9 0.0 0.2 0.2 0.0 0.4 0.8 0.0 0.5 2.9 0.0 0.0 0.7 0.0 0.1 0.9 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.2 0.4 0.9 0.0 0.0 0.2 0.6 1.3 0.0 0.0 0.1 0.0 4.3 3.1 3.2 0.8 4.7 2.8 1.7 0.8 1.2 1.3 0.6 3.1 2.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 399.8 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 4.1 0.3 7.6 3.6 0.0 0.6 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 6.0 36.1 0.0 0.1 0.3 0.6 1.2 0.3 0.0 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 246.7" "Group enriched" "Detected in some" 27 "Early spermatids: 1329.5;Erythroid cells: 1206.7;Late spermatids: 1439.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.1" "Group enriched" "Detected in many" 28 "granulocytes: 2.2;NK-cells: 2.0;T-cells: 5.1" "Cell line enriched" "Detected in some" 5 "K-562: 290.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.1 0.0 0.1 0.8 0.1 246.7 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.6 0.9 1.5 0.4 0.0 0.0 0.2 0.0 0.1 5.9 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.1 0.0 0.0 3.2 0.2 50.5 0.1 12.6 0.2 0.1 1.5 0.1 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.3 64.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.2 290.9 0.3 0.0 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.2 0.0 1.5 0.5 1.8 0.0 0.0 0.1 2.2 0.1 0.0 0.2 0.0 0.5 0.0 1.5 0.7 0.1 0.0 5.1 2.1 0.6 2.0 0.0 0.0 0.9 2.7 0.1 0.1 0.2 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.2 0.4 0.1 0.0 0.0 1329.5 0.2 0.0 0.5 0.0 1206.7 0.4 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.7 0.7 1.0 0.0 0.2 0.0 0.0 1.6 0.0 1439.7 5.9 47.4 1.8 0.0 2.1 0.0 4.1 0.0 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.1 10.0 4.4 0.0 0.0 0.5 2.3 0.0 0.0 0.0 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "HIVEP zinc finger 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 7.2 2.3 0.8 8.0 3.0 16.7 5.5 0.7 3.0 7.4 6.5 6.4 5.0 5.9 4.5 7.4 6.1 7.3 3.8 2.2 0.8 4.5 11.7 6.3 8.0 1.3 2.8 6.5 6.7 10.5 3.3 4.9 0.5 6.9 6.6 5.8 4.8 5.8 2.8 5.7 5.2 6.2 0.0 6.0 4.9 4.8 1.2 9.1 4.9 6.2 8.3 9.3 3.3 1.6 8.1 5.9 7.5 4.2 5.8 7.3 7.2 6.4 5.5 5.2 5.7 3.8 4.2 6.7 13.6 7.8 12.4 7.6 7.4 9.2 7.1 14.6 4.3 3.1 5.6 3.7 4.7 3.7 2.5 5.1 9.0 10.6 16.3 11.0 15.5 4.6 32.9 7.5 11.5 6.0 5.9 3.3 6.4 2.8 2.7 3.2 9.8 10.7 3.1 8.7 7.1 5.2 15.9 12.8 4.3 16.6 7.6 4.7 25.2 13.0 5.8 12.3 7.4 30.0 27.3 12.0 4.0 4.8 5.5 2.4 1.8 2.1 1.2 2.0 0.9 3.1 2.0 0.8 1.2 4.8 3.4 2.1 11.7 3.3 5.2 9.0 4.4 0.7 0.8 3.0 0.7 3.0 2.2 0.8 1.3 2.8 0.5 0.0 1.2 1.6 40.2 28.9 16.9 74.7 35.6 32.2 25.4 7.4 30.7 20.4 12.3 10.9 10.4 17.2 17.6 7.3 12.5 3.4 18.7 17.5 3.9 5.6 2.5 37.7 16.4 20.3 10.8 6.5 94.6 7.2 1.8 25.2 22.4 51.0 7.6 7.0 6.4 12.3 5.9 21.9 68.3 14.4 4.1 9.6 47.9 1.8 3.7 23.1 19.6 44.0 29.6 13.1 5.2 59.3 25.0 11.5 10.3 4.5 33.6 25.2 6.7 2.5 16.7 9.7 0.0 21.0 17.1 3.9 3.5 18.7 33.4 5.2 18.8 6.6 8.6 23.7 HMBS "PBGD, PORC, UPS" ENSG00000256269 "Hydroxymethylbilane synthase" P08397 11 119084866-119093549 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 170.8" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 935.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006114, HPA050659" Supported Approved "Lipid droplets" NA NA 21000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Lipid droplets" "HPA006114: AB_1079067, HPA050659: AB_2681206" "unprognostic (6.24e-2)" "unprognostic (9.10e-3)" "unprognostic (1.42e-2)" "unprognostic (4.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (2.29e-3)" "unprognostic (2.81e-1)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (2.90e-3)" "unprognostic (3.91e-3)" "unprognostic (9.53e-2)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" 10.3 15.9 9.3 9.3 10.4 170.8 9.4 11.5 10.4 7.9 10.1 13.7 12.5 10.2 11.9 14.4 7.7 4.0 17.3 9.1 10.0 12.3 22.8 8.8 9.2 10.7 10.2 3.8 16.2 9.2 8.5 10.6 10.6 8.6 14.9 5.9 9.9 8.6 30.4 10.5 10.1 10.5 10.4 15.2 11.7 5.7 10.7 7.6 8.9 23.9 11.9 9.6 8.0 12.6 40.0 59.9 27.7 47.5 21.6 27.2 41.7 31.1 34.8 45.0 38.2 74.4 60.2 59.4 68.3 40.1 42.0 53.7 41.6 60.1 28.2 42.0 42.4 97.2 22.5 55.0 40.8 37.6 31.2 29.8 38.0 71.5 53.1 18.7 21.5 55.9 154.6 25.7 35.9 158.4 36.3 72.6 32.1 72.8 36.5 41.9 27.8 59.5 45.3 36.2 31.1 41.4 24.6 38.4 29.3 19.3 64.7 52.3 20.0 33.0 25.5 32.9 36.0 14.2 16.7 36.6 22.7 47.4 40.0 48.5 38.5 4.4 13.6 35.2 17.8 21.4 12.5 15.1 52.8 24.4 19.7 14.7 1.3 11.5 22.2 35.1 14.2 26.6 9.3 10.4 11.5 10.4 9.1 10.0 10.7 10.2 10.6 10.4 10.7 12.6 5.2 9.6 9.0 4.2 12.1 7.9 11.0 26.7 13.6 5.6 14.5 16.8 13.7 18.6 12.8 11.0 27.1 57.8 12.1 12.4 19.6 25.6 1.7 5.8 10.4 6.2 13.2 935.9 3.8 31.2 61.1 9.0 5.6 5.8 2.5 6.3 4.6 23.7 29.1 10.1 5.7 19.1 14.2 13.0 10.4 3.0 5.9 9.5 14.2 1.9 15.3 7.5 8.2 4.5 8.6 23.3 13.0 8.6 25.0 14.5 9.2 24.5 13.6 25.9 0.0 8.6 11.7 1.7 32.0 18.8 8.1 23.3 6.1 16.7 31.0 10.5 IFIH1 "Hlcd, IDDM19, MDA-5, MDA5" ENSG00000115267 "Interferon induced with helicase C domain 1" Q9BYX4 2 162267074-162318684 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.1" "Cell type enhanced" "Detected in many" "Early spermatids: 55.6;Late spermatids: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 62.3;BJ hTERT+ SV40 Large T+ RasG12V: 71.5;Karpas-707: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002656 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA002656: AB_1079344" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (5.51e-2)" "unprognostic (3.85e-3)" "unprognostic (3.34e-1)" "unprognostic (1.39e-1)" "unprognostic (5.65e-2)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.62e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.41e-2)" "unprognostic (7.29e-2)" 6.2 6.4 3.1 12.7 4.3 38.1 5.9 3.2 3.0 6.5 4.4 7.4 13.1 6.4 4.3 7.5 7.2 9.5 5.1 2.3 3.3 5.6 8.5 10.9 11.7 7.2 3.4 7.0 7.1 8.1 5.9 8.3 5.0 5.5 6.8 1.1 17.5 4.7 1.7 5.0 10.0 5.7 8.1 16.4 9.6 2.4 4.2 10.9 6.0 3.2 9.7 6.4 5.2 4.4 6.7 0.3 0.2 0.0 7.4 6.0 2.8 1.2 17.7 62.3 71.5 1.2 16.7 13.3 10.5 1.0 31.9 8.5 1.1 9.8 6.3 35.4 4.5 7.1 0.8 2.8 5.0 8.2 6.4 5.3 4.8 8.9 1.7 6.5 4.9 6.9 0.3 38.9 1.0 12.5 9.3 6.4 0.0 5.4 3.8 7.5 0.0 18.8 5.9 7.3 0.4 0.1 3.7 20.7 34.0 0.3 5.7 7.1 4.1 1.9 1.7 1.1 2.7 15.2 26.8 1.9 3.5 6.5 5.6 4.4 11.5 4.4 6.6 12.5 9.2 12.4 8.2 7.2 11.1 12.8 6.7 6.9 15.2 4.0 12.7 1.6 10.3 7.8 3.1 4.3 3.2 3.0 2.3 3.3 7.2 3.4 5.0 8.1 4.2 4.4 24.7 32.1 12.0 4.6 20.1 6.8 11.2 7.7 6.2 0.0 4.8 5.2 5.0 12.8 11.1 7.3 0.0 6.4 10.2 10.9 5.9 18.7 55.6 17.3 7.9 22.3 15.7 8.2 2.8 18.7 17.5 8.8 10.7 20.2 13.3 10.4 13.6 6.5 14.4 0.0 0.7 11.5 8.2 12.8 8.7 53.3 13.7 20.0 5.4 28.1 23.9 7.3 10.3 0.5 4.0 13.4 10.1 13.2 16.0 9.1 11.8 4.8 17.5 0.1 0.0 10.9 4.9 1.6 1.3 10.2 5.8 3.4 13.1 6.9 6.7 11.1 IFIT1B "bA149I23.6, IFIT1L" ENSG00000204010 "Interferon induced protein with tetratricopeptide repeats 1B" Q5T764 10 89378056-89385205 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 25.7" "Cell type enriched" "Detected in single" 320 "Erythroid cells: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062924 Approved NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA062924: AB_2684906" "unprognostic (2.59e-1)" "unprognostic (3.13e-1)" "unprognostic (6.62e-3)" "unprognostic (4.55e-2)" "unprognostic (4.11e-2)" "unprognostic (9.34e-2)" "unprognostic (1.76e-1)" "unprognostic (6.86e-2)" 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLL1 "14.1, CD179B, IGL5, IGLL, IGVPB" ENSG00000128322 "Immunoglobulin lambda like polypeptide 1" P15814 22 23573125-23580302 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 70.0;testis: 25.2" "Group enriched" "Detected in some" 6 "Early spermatids: 78.0;Late spermatids: 140.7;Melanocytes: 119.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 0.5;lung cancer: 0.5;stomach cancer: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "memory B-cell: 12.0;naive B-cell: 14.8" "Lineage enriched" "Detected in many" 11 "B-cells: 14.8" "Cell line enriched" "Detected in some" 32 "REH: 787.7" "HPA051134, HPA071406" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 48000000000 "Cluster 24: B-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 14: REH - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA051134: AB_2681356, HPA071406: AB_2686393" "unprognostic (6.21e-2)" "unprognostic (5.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.91e-6)" "unprognostic (1.08e-1)" "unprognostic (5.27e-2)" "unprognostic (6.17e-3)" "unprognostic (5.89e-2)" "unprognostic (9.07e-2)" "unprognostic (1.99e-4)" "unprognostic (2.35e-2)" "unprognostic (5.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.3 0.3 0.3 70.0 0.0 0.3 0.4 0.0 0.4 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.1 1.4 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.2 25.2 0.2 10.1 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 24.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 14.3 2.6 0.0 0.0 0.0 787.7 0.3 17.3 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.1 6.2 0.0 0.0 0.3 0.3 0.0 0.6 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.8 0.3 0.3 0.3 0.4 0.4 0.3 0.3 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.9 0.0 78.0 0.2 0.3 0.3 0.0 10.5 0.3 0.0 0.4 0.6 0.0 0.5 0.0 0.2 0.7 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 140.7 1.2 0.4 119.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 6.2 0.0 0.0 0.0 1.5 0.3 17.1 0.6 0.0 0.3 0.0 17.9 0.1 0.0 0.2 IRF2BP2 IRF-2BP2 ENSG00000168264 "Interferon regulatory factor 2 binding protein 2" Q7Z5L9 1 234604269-234610178 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 277.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027815, HPA062269" Approved Enhanced Nucleoplasm NA NA 13000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA027815: AB_10609994, HPA062269: AB_2684732" "unprognostic (1.15e-3)" "unprognostic (1.02e-1)" "unprognostic (3.90e-1)" "unprognostic (2.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.74e-3)" "unprognostic (1.97e-2)" "unprognostic (8.77e-2)" "unprognostic (2.19e-1)" "unprognostic (3.69e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.25e-1)" "unprognostic (2.70e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" 35.6 39.6 43.3 25.6 50.2 157.2 45.0 48.5 49.1 50.0 43.3 42.5 39.6 55.8 26.5 47.0 45.1 40.7 45.0 40.5 45.4 34.2 53.6 43.7 36.3 55.2 49.0 54.8 49.5 45.5 24.1 29.6 51.1 39.2 49.3 26.9 55.0 33.5 47.4 64.2 42.2 31.7 48.9 28.4 44.4 18.0 44.7 29.6 57.3 40.5 30.3 38.7 43.7 61.1 28.0 41.5 29.8 45.7 61.2 48.1 35.1 21.8 18.4 12.7 14.2 24.5 33.5 0.0 49.4 21.2 43.3 37.4 16.2 28.3 20.2 45.2 36.8 26.7 32.9 72.3 49.4 101.0 91.0 57.0 65.8 28.3 53.4 74.4 33.0 24.5 23.0 55.6 33.2 8.4 25.5 107.2 27.1 65.1 15.7 49.6 13.8 66.8 25.1 22.9 58.8 41.8 35.2 46.7 72.7 29.8 45.1 277.5 36.8 45.5 19.0 34.7 41.6 122.9 33.8 9.1 23.1 89.6 63.4 10.1 4.5 8.5 3.9 3.6 4.0 4.3 4.8 4.6 4.7 4.0 4.9 4.1 2.3 3.0 1.9 17.8 4.0 2.5 43.3 50.2 48.5 49.1 40.5 45.4 55.2 49.0 51.1 48.9 44.7 61.1 96.0 134.6 191.3 28.1 75.6 325.9 440.4 142.3 139.5 34.6 126.6 109.7 63.6 133.0 143.8 51.5 10.4 44.6 168.3 84.2 13.7 65.8 24.9 180.8 126.2 101.9 145.5 76.6 14.3 50.0 58.0 97.3 47.4 285.2 107.5 39.6 117.4 185.7 88.9 58.9 22.9 117.1 71.2 131.8 271.2 27.1 69.6 159.7 110.3 30.9 83.2 87.7 38.1 20.6 64.2 68.9 92.0 81.3 39.2 138.2 81.7 40.2 95.1 19.5 78.9 117.1 102.9 29.5 24.1 182.1 396.2 79.4 91.3 15.5 162.7 370.6 ITGAM "CD11B, CR3A, MAC-1" ENSG00000169896 "Integrin subunit alpha M" P11215 16 31259967-31332892 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Innate immunity" "Integrin, Receptor" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 182.8" "Group enriched" "Detected in many" 4 "dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HMC-1: 50.0;NB-4: 19.9;U-937: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002274, CAB025091, CAB072870" Enhanced NA NA 1000000 "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435" "unprognostic (1.82e-2)" "unprognostic (1.70e-2)" "unprognostic (8.78e-2)" "unprognostic (2.54e-2)" "unprognostic (2.40e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.86e-1)" "unprognostic (1.73e-1)" "unprognostic (3.29e-3)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.93e-5)" "unprognostic (9.89e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (3.99e-2)" "unprognostic (5.03e-2)" 13.4 4.7 3.4 24.7 3.5 182.8 3.0 4.5 4.2 3.3 4.8 3.0 2.2 2.0 0.7 2.6 2.3 5.9 2.9 3.6 5.1 1.0 3.5 16.4 7.4 6.7 5.7 1.6 2.3 1.3 0.1 7.7 7.3 1.5 3.4 0.3 2.4 2.2 1.4 1.7 3.5 11.2 6.5 13.1 3.1 1.4 8.6 5.2 1.0 3.1 10.4 8.0 0.2 10.8 0.8 1.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.5 0.8 1.3 0.9 0.0 0.4 0.1 0.0 0.4 0.0 7.6 0.0 1.0 0.0 0.0 0.0 1.8 50.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.3 0.1 1.0 0.0 2.2 0.0 0.0 0.0 0.5 0.4 0.0 0.2 4.3 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 22.6 0.1 93.3 55.7 70.2 31.1 20.9 1.9 4.8 3.3 9.5 9.5 1.0 0.9 7.7 58.4 54.4 3.2 0.6 1.2 27.0 3.4 3.5 4.5 4.2 3.6 5.1 6.7 5.7 7.3 6.5 8.6 10.8 1.4 3.2 9.8 0.7 9.3 1.1 0.3 1.5 0.0 0.0 1.8 3.8 2.3 4.3 1.8 0.0 0.0 0.3 45.4 0.0 0.0 1.2 0.5 0.3 0.4 1.6 3.6 9.4 1.0 0.0 0.7 1.1 1.1 0.5 35.5 0.5 2.2 1.2 47.2 0.0 1.0 0.1 0.0 117.7 45.5 1.8 0.3 83.2 0.0 41.2 87.4 0.0 75.2 3.0 0.3 0.9 0.0 0.0 4.5 0.5 0.0 0.2 0.9 0.0 13.1 1.2 0.5 0.7 0.9 0.5 1.0 0.8 14.9 0.0 0.3 0.2 IVNS1ABP "ARA3, HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317273 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 452.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 309.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 250.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 43.9 17.8 16.7 46.6 26.5 452.5 50.5 21.1 20.8 24.9 26.9 40.2 38.4 22.4 18.1 27.0 19.6 36.4 28.9 15.2 19.7 94.1 23.0 27.7 26.4 20.9 18.3 28.4 25.5 32.4 17.3 26.0 22.3 22.2 51.1 15.0 55.2 26.4 23.1 33.5 34.8 16.9 18.3 27.3 42.2 15.9 20.0 24.9 34.3 21.6 24.1 37.7 29.8 35.0 24.6 22.1 79.2 31.6 27.1 9.0 68.4 46.6 15.3 30.1 27.5 26.2 39.7 36.8 36.8 24.0 13.4 32.9 29.0 31.8 32.1 24.9 21.6 36.8 39.1 22.6 10.9 26.2 13.9 6.7 35.7 23.1 73.2 67.6 39.6 38.6 23.6 21.2 54.6 18.0 44.6 18.1 48.7 61.8 5.6 24.7 20.2 21.0 250.7 31.4 52.5 44.5 40.6 35.4 31.4 103.4 16.2 13.3 27.2 41.9 24.5 10.4 34.9 28.0 23.8 22.8 32.1 26.0 19.4 7.9 10.9 10.5 10.5 7.1 9.6 6.1 8.0 7.7 12.6 3.7 8.5 8.3 33.0 10.4 10.3 3.4 8.9 12.1 16.7 26.5 21.1 20.8 15.2 19.7 20.9 18.3 22.3 18.3 20.0 35.0 159.1 44.8 59.0 13.7 61.3 188.9 90.4 40.9 163.4 14.5 74.0 51.3 56.0 22.8 57.4 128.8 52.1 17.3 102.0 288.3 164.4 41.6 34.4 93.2 36.7 85.8 60.4 52.8 18.2 41.5 67.5 50.3 90.7 159.7 41.1 309.2 26.4 23.3 34.8 21.9 26.2 109.6 36.7 107.2 242.3 34.9 5.9 141.5 101.4 33.7 41.3 11.3 63.8 37.7 72.9 24.0 56.4 2.6 62.7 60.9 103.2 86.3 45.8 32.7 6.6 51.4 52.6 33.2 19.8 108.9 181.6 18.3 120.0 54.2 102.7 91.7 KEL "CD238, ECE3" ENSG00000197993 "Kell metallo-endopeptidase (Kell blood group)" P23276 7 142941114-142962363 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 56.3;testis: 32.3" "Cell type enhanced" "Detected in some" "Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "HEL: 31.7;K-562: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 1.8 0.8 2.7 56.3 0.3 1.7 2.2 0.9 1.4 0.1 0.0 0.2 0.0 0.8 0.5 0.0 0.3 2.0 1.5 0.6 0.3 0.5 10.6 2.5 2.2 0.2 0.2 0.0 0.2 0.4 2.4 0.3 0.0 0.1 0.6 0.1 0.2 0.1 0.9 0.0 1.9 4.9 0.2 32.3 2.4 1.3 0.3 0.0 6.7 0.1 0.4 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 1.7 2.2 2.0 1.5 2.5 2.2 2.4 1.9 2.4 2.8 0.2 0.0 0.0 0.3 0.0 0.0 1.3 0.2 4.0 0.0 0.3 0.1 0.4 0.0 1.4 3.7 0.0 0.1 0.1 0.0 1.9 0.3 2.4 0.2 0.1 0.1 0.0 79.7 3.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 3.1 0.0 1.4 0.2 16.8 0.0 0.1 0.0 0.0 0.0 0.9 KLF1 EKLF ENSG00000105610 "Kruppel like factor 1" Q13351 19 12884422-12887201 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "bone marrow: 41.2" "Cell type enriched" "Detected in some" 199 "Erythroid cells: 519.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 8 "monocytes: 1.9" "Group enriched" "Detected in some" 29 "HEL: 61.6;K-562: 150.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051850 Enhanced Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "HPA051850: AB_2616460" "unprognostic (1.17e-1)" "unprognostic (1.38e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-3)" "unprognostic (7.13e-2)" "unprognostic (3.90e-4)" "unprognostic (3.25e-2)" "unprognostic (3.19e-2)" "unprognostic (1.97e-1)" "unprognostic (1.08e-2)" "unprognostic (6.51e-2)" "unprognostic (7.71e-2)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (2.44e-1)" 0.0 0.0 0.1 0.0 0.1 41.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 61.6 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 150.5 0.0 0.0 0.2 0.3 0.4 0.7 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 3.6 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 519.2 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.1 0.0 0.1 0.1 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol Aggresome "HPA065730: AB_2685547" "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 4.8 9.6 2.9 3.7 3.7 53.1 3.3 4.0 3.6 4.1 3.9 3.1 2.9 5.1 8.0 8.7 4.2 4.5 3.3 3.3 3.8 5.0 12.8 3.4 4.0 2.8 3.2 5.9 6.4 7.3 3.3 3.4 2.5 5.8 3.1 5.5 2.5 3.9 3.6 2.1 2.9 5.1 2.8 4.0 4.0 18.3 3.2 6.2 5.1 3.2 3.4 3.5 1.8 2.9 5.0 4.8 5.2 7.7 7.6 5.4 5.4 7.9 6.9 3.6 4.3 4.4 4.4 13.2 2.7 5.2 5.6 3.7 8.4 4.3 8.7 5.2 17.2 8.4 13.4 2.3 4.8 11.0 5.6 5.7 2.2 6.2 6.0 3.2 2.6 7.7 5.4 18.0 6.7 1.7 9.9 10.7 9.9 2.5 5.8 7.8 9.5 8.2 3.3 4.4 13.7 6.5 11.0 2.6 9.2 6.5 3.6 9.7 3.3 5.4 3.3 10.9 5.2 9.9 10.6 14.8 4.3 7.0 4.4 0.2 0.2 0.5 0.3 0.4 0.4 0.1 0.3 0.3 0.3 0.2 0.4 0.4 0.2 0.2 0.4 0.3 0.3 0.2 2.9 3.7 4.0 3.6 3.3 3.8 2.8 3.2 2.5 2.8 3.2 2.9 20.1 6.4 7.9 4.2 10.4 18.0 4.5 4.0 18.8 8.1 18.7 16.9 11.5 5.7 5.4 3.7 12.5 0.5 12.2 3.9 0.0 1.4 3.1 15.5 20.7 10.5 8.4 6.9 7.0 1.4 1.3 12.7 6.6 31.4 8.2 6.3 8.9 11.9 3.6 20.2 9.1 5.0 2.0 9.1 14.1 2.8 3.4 19.8 12.4 3.7 3.9 7.9 3.1 6.0 5.4 1.6 0.7 4.1 8.8 5.6 3.8 2.4 2.8 7.6 0.0 22.6 16.4 2.8 17.7 15.3 9.9 1.4 11.7 13.3 4.8 3.3 LTF HLF2 ENSG00000012223 Lactotransferrin P02788 3 46435645-46485234 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport" "Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 4255.5;salivary gland: 1162.5" "Cell type enriched" "Detected in many" 5 "Breast glandular cells: 1519.6" "Group enriched" "Detected in all" 5 "breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 23 "neutrophil: 5.4;non-classical monocyte: 17.0" "Group enriched" "Detected in many" 23 "granulocytes: 5.4;monocytes: 17.0" "Group enriched" "Detected in some" 11 "RPMI-8226: 43.2;TIME: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB008646, CAB016201, HPA057177, HPA059976" Enhanced "Secreted to blood" NA NA 350000000 "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185" "unprognostic (7.24e-3)" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (3.41e-2)" "unprognostic (7.14e-3)" "unprognostic (3.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (3.43e-1)" "unprognostic (1.04e-1)" "prognostic favorable (6.30e-5)" "unprognostic (1.66e-2)" "unprognostic (3.53e-1)" "unprognostic (2.05e-1)" "unprognostic (9.09e-3)" 6.9 1.2 2.5 36.1 3.4 4255.5 333.3 4.6 4.2 658.3 2.2 2.8 1.2 4.1 157.5 23.0 4.3 7.5 5.7 3.7 6.2 105.3 3.3 29.4 8.6 4.8 21.5 0.5 18.6 6.2 7.0 3.1 12.6 154.2 2.2 0.9 1162.5 378.9 1.7 11.8 5.1 1.9 7.1 70.5 331.6 0.4 14.5 29.8 10.1 1.6 345.7 2.4 1.2 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.6 43.2 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 14.3 0.0 0.3 1.2 0.1 0.6 0.0 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 17.0 0.4 0.0 29.5 2.5 3.4 4.6 4.2 3.7 6.2 4.8 21.5 12.6 7.1 14.5 9.9 15.5 0.0 2.8 0.7 4.3 1.1 8.6 82.8 0.0 0.0 1519.6 198.4 1.0 2.8 298.0 71.7 0.0 0.0 6.2 0.1 0.0 1.4 1.2 0.3 0.2 8.8 0.0 3.0 0.1 0.9 0.2 2.5 56.1 2.3 1.3 0.1 5.0 0.0 0.0 0.0 0.0 0.2 14.2 0.0 0.7 1.5 5.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.1 78.6 0.0 18.6 14.9 0.0 0.0 0.3 9.9 0.2 0.1 15.4 0.1 0.1 4.0 0.1 0.1 101.7 LY6G6F "C6orf21, G6f, LY6G6D, NG32" ENSG00000204424 "Lymphocyte antigen 6 family member G6F" Q5SQ64 6 31706866-31710679 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.7;lymphoid tissue: 1.2;skin 1: 1.3" "Cell type enriched" "Detected in some" 9 "Macrophages: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enriched" "Detected in single" 379 "HEL: 37.8" "Low region specificity" "Detected in many" HPA008053 Uncertain NA NA 380000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "HPA008053: AB_1840160" "unprognostic (3.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.66e-3)" 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 0.0 0.0 0.5 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 9.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MFSD2B ENSG00000205639 "Major facilitator superfamily domain containing 2B" A6NFX1 2 24010081-24063321 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "bone marrow: 11.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 25.1;Erythroid cells: 65.2;Prostatic glandular cells: 41.0;Urothelial cells: 30.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "basophil: 2.9" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.9" "Group enriched" "Detected in some" 14 "HEL: 8.3;K-562: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044145 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "HPA044145: AB_2678833" "unprognostic (5.67e-2)" "unprognostic (1.25e-3)" "unprognostic (1.84e-1)" "unprognostic (5.35e-5)" "unprognostic (2.82e-1)" "unprognostic (1.74e-1)" "unprognostic (4.26e-2)" "unprognostic (7.47e-2)" "unprognostic (2.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.21e-3)" "unprognostic (1.90e-2)" "unprognostic (6.87e-6)" "unprognostic (7.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.72e-1)" 0.0 0.0 0.2 0.0 0.4 11.8 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.3 0.2 0.4 0.5 0.3 0.1 0.3 0.2 0.1 0.1 0.0 0.3 0.2 0.1 0.0 1.3 0.3 1.6 10.1 25.1 0.7 0.0 0.9 0.3 0.3 4.6 1.5 0.5 0.0 4.2 6.9 0.2 0.9 3.9 5.0 0.6 0.1 0.3 1.7 1.2 65.2 0.3 1.8 4.4 1.6 0.0 0.3 5.1 0.3 0.4 0.0 3.1 0.0 0.5 2.9 2.0 1.4 5.9 0.8 0.0 4.5 0.0 1.0 0.6 0.1 0.0 0.0 0.3 10.6 2.3 0.0 0.2 41.0 3.1 0.2 0.0 1.5 0.0 1.1 0.7 0.9 2.1 0.0 11.2 7.5 1.1 0.0 5.5 30.3 MIER1 "hMI-ER1, KIAA1610, MI-ER1" ENSG00000198160 "MIER1 transcriptional regulator" Q8N108 1 66924895-66988619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 97.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019589, HPA050306" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA019589: AB_1853953, HPA050306: AB_2681080" "unprognostic (3.38e-3)" "unprognostic (1.34e-1)" "prognostic favorable (4.96e-4)" "unprognostic (1.63e-1)" "prognostic favorable (3.44e-8)" "unprognostic (1.61e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-3)" "unprognostic (4.48e-3)" "unprognostic (2.57e-2)" "unprognostic (2.81e-2)" "unprognostic (2.25e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (2.45e-2)" 18.6 20.8 10.7 18.4 12.4 97.9 16.5 12.8 13.8 19.7 10.4 27.5 15.5 18.7 13.5 16.6 13.1 18.8 11.4 8.9 11.6 16.2 24.6 16.3 20.7 11.4 10.8 20.7 9.1 12.3 7.8 20.2 12.1 14.4 23.5 18.9 11.3 17.1 8.2 12.6 16.1 17.9 11.0 20.0 18.8 18.2 10.9 24.4 14.1 13.1 19.6 18.5 11.8 14.8 29.7 16.8 20.4 36.8 41.9 27.2 22.7 30.3 33.5 29.7 32.1 13.7 17.7 29.8 11.1 34.3 26.7 19.2 24.9 33.1 42.5 34.6 19.3 65.2 44.0 21.8 33.2 52.5 36.9 28.2 24.5 33.3 34.3 34.5 32.9 35.6 34.6 25.6 35.6 9.4 76.0 18.8 29.2 13.4 10.8 32.7 49.1 20.4 25.5 32.6 12.0 23.7 45.5 27.9 29.8 19.3 14.4 34.2 39.7 34.5 24.2 33.7 28.4 31.8 31.6 42.5 28.1 22.5 21.2 43.7 10.9 26.8 18.5 12.4 21.5 11.2 16.4 16.5 8.6 13.1 16.6 16.3 37.1 15.8 20.8 11.7 15.1 8.7 10.7 12.4 12.8 13.8 8.9 11.6 11.4 10.8 12.1 11.0 10.9 14.8 77.4 16.0 45.7 40.8 65.7 48.3 40.5 37.3 51.2 37.7 45.9 44.7 32.9 35.8 35.0 27.6 25.0 41.6 92.1 125.7 45.0 36.8 55.3 54.3 56.8 54.7 42.1 50.1 50.6 40.6 26.8 62.8 34.1 70.6 92.4 48.9 40.4 50.3 22.2 40.4 48.6 54.6 34.6 45.6 38.3 49.3 81.4 56.1 14.2 46.9 69.8 68.7 86.5 40.7 83.8 54.1 77.7 93.3 48.1 52.4 41.3 34.1 35.2 48.5 78.9 64.7 77.5 53.0 62.9 42.0 34.7 34.3 97.1 35.7 53.5 60.4 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453033-140479536 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 129.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytosol" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 39.5 36.8 50.9 47.9 50.7 202.6 47.8 52.6 57.1 43.0 46.6 97.9 69.2 46.7 43.3 49.0 51.3 37.5 64.6 51.0 53.7 47.9 42.7 46.9 49.7 57.6 50.7 56.5 58.1 66.8 42.3 43.0 58.9 48.6 80.1 58.6 56.5 44.4 84.0 51.7 65.8 43.5 50.2 52.7 53.9 123.2 55.6 47.1 46.9 58.5 56.4 45.7 38.9 50.9 96.5 72.3 55.6 83.1 86.5 75.5 78.2 64.6 83.3 49.8 57.2 30.0 98.8 69.4 98.4 63.4 99.2 45.7 63.2 71.2 62.8 138.0 55.6 72.1 43.5 55.9 69.4 62.5 107.1 75.4 105.1 56.2 52.8 81.9 50.8 46.9 58.0 84.8 49.1 82.6 73.4 114.2 143.3 80.7 53.6 52.4 47.4 107.6 80.8 109.2 76.6 79.1 80.8 108.5 120.6 81.6 53.3 53.5 71.9 34.9 27.4 85.8 59.8 200.2 159.2 60.9 99.3 96.1 73.3 58.6 22.5 100.4 15.4 21.3 18.0 33.6 29.5 23.0 18.0 32.9 39.9 25.5 42.5 31.1 26.5 6.0 35.3 15.3 50.9 50.7 52.6 57.1 51.0 53.7 57.6 50.7 58.9 50.2 55.6 50.9 28.4 51.3 37.2 13.4 76.8 82.1 66.6 57.1 57.5 61.5 60.9 36.2 57.7 67.2 71.1 42.3 35.5 75.8 54.0 172.1 103.7 69.8 328.0 58.4 30.6 34.2 97.3 424.2 28.9 67.8 96.6 43.3 38.7 65.7 37.4 79.5 45.7 45.0 59.5 119.5 28.0 107.7 89.5 95.9 93.3 340.6 66.5 86.3 69.4 22.5 119.0 61.4 92.7 15.1 22.1 57.6 140.3 62.4 41.8 101.2 112.4 54.4 70.0 46.4 46.0 34.7 53.3 303.0 60.1 62.4 95.5 138.0 62.9 39.6 103.5 145.9 MMP8 CLG1 ENSG00000118113 "Matrix metallopeptidase 8" P22894 11 102711796-102727050 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "bone marrow: 501.1" "Group enriched" "Detected in some" 6 "Hofbauer cells: 4.0;Macrophages: 1.5" "Cancer enriched" "Detected in single" 17 "melanoma: 5.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 1.7" "Cell line enriched" "Detected in some" 8 "WM-115: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021221, HPA021763, HPA022935" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 360000 "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 17: WM-115 - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "HPA021221: AB_1854043, HPA021763: , HPA022935: AB_1854044" "unprognostic (3.03e-1)" "unprognostic (8.49e-5)" "unprognostic (1.08e-2)" "unprognostic (3.95e-3)" "unprognostic (1.80e-1)" "unprognostic (1.01e-2)" "unprognostic (7.68e-3)" "unprognostic (1.27e-1)" "unprognostic (4.92e-2)" "unprognostic (6.64e-3)" "unprognostic (2.45e-6)" "unprognostic (2.33e-4)" "unprognostic (1.33e-1)" "unprognostic (4.97e-1)" "unprognostic (2.30e-2)" 0.5 0.0 0.0 0.3 0.1 501.1 0.2 0.1 0.2 0.0 0.2 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.6 4.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.2 0.0 13.8 0.1 0.0 0.6 2.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269855-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "bone marrow: 4023.1" "Cell type enriched" "Detected in some" 30 "Erythroid cells: 87.4" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 94 "HL-60: 3517.4;NB-4: 4589.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 24000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.5 0.4 0.8 0.6 0.6 4023.1 0.3 0.6 1.1 0.0 0.3 0.2 0.0 0.2 1.1 0.1 0.1 0.3 1.1 0.8 0.7 0.2 1.8 8.4 1.7 0.9 1.0 0.1 0.1 0.0 1.5 1.4 0.9 0.2 0.2 0.4 66.3 0.1 1.1 4.3 0.2 0.3 0.8 21.7 0.1 0.4 0.8 10.9 0.3 0.3 0.2 0.5 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3517.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4589.9 0.0 0.0 0.0 5.3 3.2 0.6 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 4.0 0.0 0.0 6.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 7.5 0.8 0.6 0.6 1.1 0.8 0.7 0.9 1.0 0.9 0.8 0.8 0.7 0.0 0.0 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.9 0.0 0.5 0.1 0.0 0.1 0.0 87.4 0.3 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.7 0.3 0.9 0.0 0.2 0.0 0.0 1.2 0.0 1.3 0.0 2.9 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.3 0.1 0.0 0.1 0.6 0.0 0.0 0.0 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071115 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "bone marrow: 420.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 1478 "basophil: 2686.3" "Lineage enriched" "Detected in single" 4507 "granulocytes: 2686.3" "Cell line enhanced" "Detected in some" "HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.3 0.0 420.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.9 0.0 0.0 0.0 17.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 319.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 126.2 0.0 2686.3 0.1 1.8 0.1 0.1 0.3 0.2 0.4 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.5 0.2 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.8 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 MTF1 ENSG00000188786 "Metal regulatory transcription factor 1" Q14872 1 37809574-37859592 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 20.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028604, HPA028689" Uncertain Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA028604: AB_10600304, HPA028689: AB_10611384" "unprognostic (5.74e-2)" "unprognostic (2.10e-1)" "unprognostic (2.56e-2)" "unprognostic (2.89e-1)" "unprognostic (8.33e-2)" "unprognostic (8.15e-3)" "unprognostic (1.34e-2)" "unprognostic (5.07e-2)" "unprognostic (1.91e-1)" "unprognostic (4.58e-2)" "unprognostic (3.20e-2)" "unprognostic (2.30e-2)" "unprognostic (3.70e-2)" "unprognostic (4.37e-3)" "unprognostic (2.98e-1)" "unprognostic (6.32e-2)" "unprognostic (2.19e-1)" 4.7 3.5 4.6 5.2 6.0 20.5 4.1 4.7 5.4 4.7 5.5 4.4 2.8 4.2 2.6 8.4 5.6 3.5 2.7 4.2 4.3 3.8 2.5 4.3 4.0 5.6 5.6 5.5 4.0 6.1 3.4 3.3 5.2 3.3 4.6 4.8 3.2 3.1 5.3 4.5 3.0 4.6 4.6 4.5 3.3 6.6 5.1 4.3 3.8 6.4 5.8 5.3 4.0 6.2 7.5 4.5 4.4 3.9 11.0 7.6 8.4 7.2 7.4 8.4 8.0 4.9 4.2 7.9 5.4 8.2 5.5 6.8 7.6 6.0 9.7 27.5 4.7 7.5 6.4 3.8 6.2 8.9 8.0 7.1 10.4 11.9 12.0 6.0 5.4 5.6 4.9 6.2 6.3 4.2 4.5 4.6 6.2 3.9 4.4 4.7 10.4 4.8 5.6 7.3 6.7 4.9 8.6 6.9 6.2 6.1 4.2 7.3 7.7 5.2 5.9 6.0 9.6 11.4 13.8 4.4 7.1 9.1 4.6 2.8 3.7 2.4 1.8 3.6 1.5 1.3 1.5 1.3 2.3 1.6 1.6 1.3 3.7 1.1 6.0 0.8 1.1 1.8 4.6 6.0 4.7 5.4 4.2 4.3 5.6 5.6 5.2 4.6 5.1 6.2 9.7 9.6 10.3 10.7 15.4 20.6 11.4 11.0 15.9 0.0 13.2 10.8 12.7 8.6 8.8 7.3 0.0 10.0 11.2 20.4 1.9 11.8 50.0 30.0 14.2 13.0 23.8 9.9 16.3 15.6 23.2 10.7 9.2 30.4 16.5 9.2 13.2 7.2 10.2 0.0 14.3 8.8 16.2 20.1 9.1 18.2 9.6 22.6 7.2 8.4 26.8 0.0 11.3 9.5 20.7 12.9 8.6 11.7 15.7 14.8 11.5 6.2 28.8 0.0 6.6 18.2 12.1 33.7 22.5 23.2 29.7 17.1 12.9 7.1 9.2 16.0 MTMR3 "FYVE-DSP1, KIAA0371, ZFYVE10" ENSG00000100330 "Myotubularin related protein 3" Q13615 22 29883169-30030868 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.6" "Cell type enhanced" "Detected in many" "Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034515, HPA034516, HPA061399" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm Cytosol "HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: " "unprognostic (4.39e-3)" "unprognostic (7.84e-2)" "unprognostic (2.46e-2)" "unprognostic (1.76e-2)" "unprognostic (5.61e-2)" "unprognostic (4.51e-3)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (3.42e-1)" "unprognostic (4.39e-1)" "unprognostic (8.33e-4)" "unprognostic (1.28e-1)" "unprognostic (5.35e-4)" "unprognostic (7.96e-2)" "unprognostic (7.64e-2)" "unprognostic (2.49e-1)" "unprognostic (8.38e-2)" 17.8 18.4 18.5 13.0 19.4 81.6 17.0 21.2 18.6 18.9 17.0 15.5 11.1 16.0 12.8 22.4 16.4 12.5 13.9 20.8 19.3 11.7 10.8 20.7 11.5 19.2 19.8 20.4 16.5 18.3 17.0 15.0 17.3 16.0 12.7 21.2 17.2 11.3 36.7 25.5 14.5 14.8 18.6 21.7 15.7 26.2 21.6 16.2 17.2 30.0 13.9 15.1 19.4 16.6 13.4 11.7 17.0 18.3 16.7 12.1 12.8 12.2 17.4 15.7 18.2 10.0 7.9 10.2 7.6 22.1 12.4 16.0 18.5 14.3 16.6 21.0 15.4 18.6 10.6 10.1 15.3 15.9 45.0 12.8 22.9 14.9 26.9 14.7 15.3 10.7 11.6 17.5 10.3 16.2 10.7 11.1 6.5 13.7 7.5 12.5 23.3 10.4 14.1 24.3 19.2 13.1 22.1 19.7 11.7 14.1 11.2 15.3 16.8 25.3 16.7 5.5 8.3 14.7 11.1 9.3 11.0 7.5 11.8 8.3 7.4 11.2 3.2 4.9 4.0 2.3 2.5 3.4 4.1 2.4 3.1 2.7 17.8 4.1 5.4 1.5 2.9 4.3 18.5 19.4 21.2 18.6 20.8 19.3 19.2 19.8 17.3 18.6 21.6 16.6 15.9 3.2 14.8 111.3 13.3 16.7 9.8 11.5 14.8 0.0 13.7 11.0 4.2 10.0 17.7 12.9 0.0 13.6 10.4 21.5 1.9 9.5 14.0 16.8 14.9 10.6 12.5 21.0 61.2 8.8 7.0 12.6 31.6 24.5 7.6 14.7 13.9 10.1 10.9 0.0 78.3 9.2 46.8 20.6 11.7 16.7 13.7 20.8 14.2 90.9 22.3 0.0 12.3 96.5 73.2 12.3 11.1 11.3 13.0 14.6 12.2 7.3 16.4 0.0 6.6 15.3 11.0 26.8 28.0 18.1 13.8 13.7 13.0 8.9 11.5 21.2 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.7;Granulosa cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.7" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 16.7;monocytes: 10.9" "Cell line enhanced" "Detected in many" "HDLM-2: 176.0" "Group enriched" "Detected in many" 5 "amygdala: 1.8;basal ganglia: 2.0;cerebral cortex: 1.1;hippocampal formation: 1.0;white matter: 2.4" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 5.8 5.1 1.9 6.5 2.1 39.3 6.1 1.6 4.6 7.1 2.0 9.4 7.1 5.6 1.4 13.2 7.9 1.0 4.8 1.7 2.0 6.3 14.2 8.3 7.8 2.7 2.0 5.5 12.1 0.4 8.5 1.9 2.6 9.9 0.8 0.4 6.7 1.8 4.0 10.8 10.8 1.2 1.6 19.0 8.1 6.8 2.7 10.5 7.1 0.4 2.4 6.8 7.8 4.0 24.2 16.8 9.9 27.3 0.6 1.3 16.8 31.2 10.0 13.6 13.0 11.9 24.6 12.9 12.6 4.2 7.8 12.1 1.1 3.6 0.7 176.0 22.1 7.7 25.5 16.3 1.4 7.5 21.3 1.1 1.8 0.9 0.6 1.2 12.7 55.1 4.6 39.0 2.8 31.2 64.9 19.7 3.7 7.8 28.2 31.5 30.9 18.7 3.1 3.7 24.3 20.3 19.9 19.9 11.1 1.6 31.3 18.4 9.5 16.5 41.6 13.1 17.0 51.1 18.6 14.8 12.9 24.3 9.7 4.1 3.1 9.9 0.7 9.1 0.0 1.8 0.2 0.1 2.1 4.1 0.1 0.4 16.7 1.0 10.9 1.3 0.9 1.7 1.9 2.1 1.6 4.6 1.7 2.0 2.7 2.0 2.6 1.6 2.7 4.0 1.9 3.2 3.6 5.2 4.9 5.6 2.5 4.9 0.6 2.6 7.0 5.1 2.2 2.8 4.6 5.5 0.0 16.7 4.8 8.9 0.0 1.3 15.5 3.8 3.7 4.1 1.8 45.7 3.4 3.9 6.6 6.0 8.6 3.4 9.5 24.5 4.6 4.3 10.3 3.3 3.0 10.9 4.1 6.0 5.0 2.2 1.8 6.5 3.6 1.9 5.2 1.7 2.1 2.0 3.6 2.3 3.4 1.5 18.5 3.9 4.4 0.8 6.6 2.3 0.0 2.1 4.4 1.0 6.2 10.2 5.7 13.1 5.6 1.9 12.5 3.4 NFKBIZ "FLJ34463, INAP, MAIL" ENSG00000144802 "NFKB inhibitor zeta" Q9BYH8 3 101827991-101861022 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 406.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 33.9" "Group enriched" "Detected in many" 5 "granulocytes: 24.7;monocytes: 33.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.1;RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010547, HPA075363" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 41: Macrophages - Immune response" "Nuclear speckles" "Cytoplasmic bodies" "HPA010547: AB_1854442, HPA075363: AB_2686745" "unprognostic (2.20e-2)" "unprognostic (1.11e-2)" "unprognostic (6.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-2)" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (5.96e-2)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" "prognostic unfavorable (4.30e-8)" "unprognostic (2.69e-1)" "unprognostic (8.90e-2)" "unprognostic (3.30e-1)" "unprognostic (8.52e-3)" 57.5 12.0 2.8 44.4 5.2 406.0 31.7 4.7 6.0 13.4 19.1 24.5 52.6 36.3 3.7 26.9 64.8 51.3 23.6 3.4 4.8 29.2 52.4 48.2 27.2 6.7 4.2 19.1 27.0 3.6 12.5 22.3 5.5 26.6 30.6 8.0 80.8 7.4 4.6 45.7 23.2 54.6 6.2 26.9 30.5 3.7 6.8 18.8 24.7 10.2 22.7 71.3 18.3 5.0 6.5 5.2 3.5 4.4 9.7 16.7 5.3 26.2 72.1 11.3 10.7 6.3 7.8 12.2 32.4 7.2 34.8 20.5 2.5 11.4 29.2 35.9 2.3 11.7 10.2 3.4 14.7 0.8 0.7 11.6 17.3 30.5 13.7 27.8 8.4 0.3 2.0 24.6 16.2 8.1 0.2 6.9 6.0 2.3 15.3 1.5 15.7 1.5 71.0 42.7 1.5 1.9 4.4 5.3 29.6 7.4 6.3 4.8 10.6 18.1 18.0 6.9 8.6 20.4 7.8 8.1 32.9 2.2 2.5 11.7 5.9 1.7 1.4 13.1 1.7 2.9 2.1 1.6 3.8 4.6 6.0 4.2 24.7 0.8 33.9 6.0 1.3 2.3 2.8 5.2 4.7 6.0 3.4 4.8 6.7 4.2 5.5 6.2 6.8 5.0 199.5 86.6 266.6 10.7 91.3 281.7 61.2 123.0 103.0 9.0 108.7 105.8 20.6 84.4 143.0 66.2 2.1 19.3 98.6 157.8 0.0 213.0 4.6 116.1 221.4 135.3 73.6 21.0 23.7 132.1 41.0 214.2 277.8 291.9 381.8 17.9 82.1 65.2 56.5 10.1 20.2 69.7 59.0 150.6 291.5 1.3 20.2 318.4 71.2 16.9 79.0 25.7 12.3 17.1 79.3 127.6 115.8 0.7 128.5 88.8 91.2 5.6 117.3 8.9 19.7 218.4 131.1 0.6 2.6 136.4 251.7 25.6 134.0 19.2 111.7 70.5 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372701 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 602.6;lymphoid tissue: 154.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3163.4;NK-cells: 7721.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8" "Group enriched" "Detected in all" 44 "NK-cells: 4796.8;T-cells: 6827.0" "Group enriched" "Detected in some" 5 "NB-4: 180.8;THP-1: 54.5;U-937: 46.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 12.5 7.9 3.7 23.2 3.6 602.6 7.7 3.6 6.3 5.9 4.2 9.5 11.0 12.5 6.1 7.2 7.9 21.4 6.7 3.5 3.6 6.5 23.5 49.2 136.4 4.9 3.9 4.2 2.2 2.2 3.2 7.9 4.2 4.9 7.3 0.4 9.6 4.5 6.5 2.7 14.6 7.7 4.1 154.6 10.6 3.3 4.3 9.4 6.6 3.3 21.9 16.7 4.4 4.2 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.9 7.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.6 2.0 0.8 0.2 0.0 20.1 3.6 0.0 0.0 0.3 0.0 0.2 0.0 2.5 0.5 0.8 0.0 0.0 2.4 180.8 0.0 0.2 0.3 4.4 9.4 0.4 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.3 0.0 54.5 0.4 0.1 0.2 0.6 0.1 2.6 0.9 0.9 0.1 46.6 0.0 76.9 34.1 15.2 6827.0 131.7 2871.2 37.9 811.1 4295.0 87.1 15.4 261.0 3114.2 111.7 4796.8 104.8 67.1 17.5 4929.2 3.7 3.6 3.6 6.3 3.5 3.6 4.9 3.9 4.2 4.1 4.3 4.2 17.2 3.2 8.0 0.0 24.5 5.0 0.1 0.0 0.0 0.0 5.7 3.7 0.7 28.6 1.3 5.5 0.0 1.0 3163.4 1.9 3.9 1.0 0.2 2.7 3.6 7.1 0.0 186.5 0.0 0.0 0.8 5.2 17.3 4.2 24.1 0.2 55.3 9.9 15.0 0.0 0.0 0.5 0.0 132.9 10.2 0.3 0.0 55.5 17.8 1.0 49.4 0.0 7721.0 0.0 0.2 0.0 1.2 0.0 120.4 0.0 0.6 9.2 0.7 0.0 0.0 6.4 4.7 0.0 0.5 1.1 6.5 1.1 1321.5 0.0 1.1 0.1 NLRP3 "AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS, FCU, MWS, NALP3, PYPAF1" ENSG00000162711 "NLR family pyrin domain containing 3" Q96P20 1 247416156-247449108 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" Activator "Amyloidosis, Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 53.8" "Cell type enriched" "Detected in many" 6 "Macrophages: 254.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 129.4" "Group enriched" "Detected in many" 23 "dendritic cells: 37.3;granulocytes: 129.4;monocytes: 35.6" "Cell line enriched" "Detected in some" 4 "THP-1: 78.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012878 Uncertain "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "HPA012878: AB_1846752" "unprognostic (3.56e-2)" "unprognostic (1.33e-1)" "unprognostic (6.23e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (7.86e-2)" "unprognostic (4.46e-2)" "unprognostic (3.84e-1)" "unprognostic (7.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" "unprognostic (4.88e-3)" "unprognostic (2.17e-4)" "unprognostic (1.10e-1)" "unprognostic (6.10e-2)" 8.3 1.4 1.0 10.0 0.8 53.8 3.5 0.8 1.0 1.8 0.8 1.5 0.8 0.9 0.4 2.7 1.4 6.5 1.0 0.9 1.6 0.6 2.1 4.6 2.5 2.0 1.4 0.7 1.6 0.9 0.5 3.4 2.1 0.8 1.8 0.3 0.8 0.7 0.5 0.4 2.4 4.8 1.9 4.6 1.4 0.3 1.6 1.7 1.0 0.5 1.7 6.4 0.4 3.4 7.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.2 0.4 0.0 0.3 0.0 0.3 0.0 0.5 0.0 0.0 2.2 2.9 0.5 0.0 1.3 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 13.8 0.0 0.0 0.4 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 78.4 0.1 3.2 2.5 0.0 0.2 0.0 0.0 0.0 7.2 18.9 2.4 129.4 35.6 0.2 0.6 21.7 1.7 0.0 2.9 1.2 37.3 0.1 1.1 0.7 8.6 0.0 11.5 1.8 0.1 12.2 1.0 0.8 0.8 1.0 0.9 1.6 2.0 1.4 2.1 1.9 1.6 3.4 2.2 0.0 0.5 0.3 2.6 1.0 0.1 0.0 0.6 0.3 0.6 1.1 0.6 0.0 0.0 0.0 0.0 0.7 6.0 0.0 0.0 0.0 0.3 0.1 0.5 2.3 0.0 1.7 2.6 0.0 0.4 1.2 1.5 0.1 2.5 0.2 0.4 0.3 16.2 0.0 1.2 0.2 0.0 35.4 41.4 0.2 0.0 254.2 0.0 17.8 14.5 0.7 1.0 1.0 0.4 0.1 0.0 0.4 4.0 0.0 0.0 0.2 0.0 0.4 0.0 1.0 1.1 0.4 0.4 1.3 0.6 1.4 10.2 0.1 0.0 0.0 NME8 "CILD6, NM23-H8, SPTRX2, TXNDC3" ENSG00000086288 "NME/NM23 family member 8" Q8N427 7 37848597-37900397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "bone marrow: 12.3;testis: 10.4" "Cell type enhanced" "Detected in some" "dendritic cells: 22.8;Early spermatids: 46.3;Late spermatids: 23.4;NK-cells: 17.5;Oligodendrocytes: 9.8;Spermatocytes: 26.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;NB-4: 2.0;NTERA-2: 1.7;THP-1: 1.7;U-937: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016416, HPA019259, HPA029572" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nuclear speckles" "CAB016416: , HPA019259: AB_1858475, HPA029572: " "unprognostic (7.44e-3)" "unprognostic (2.32e-2)" "unprognostic (9.11e-2)" "unprognostic (2.97e-2)" "unprognostic (6.05e-2)" "unprognostic (1.20e-2)" "unprognostic (6.56e-2)" "unprognostic (4.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (2.34e-2)" "unprognostic (8.13e-8)" "unprognostic (5.90e-2)" "unprognostic (3.36e-1)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" 0.1 0.1 0.4 0.6 0.9 12.3 0.1 0.5 0.7 0.1 0.5 0.3 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.3 0.7 0.0 0.1 0.4 0.5 1.1 0.6 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.7 1.0 0.2 10.4 0.9 0.3 0.0 0.0 0.3 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.1 0.9 0.3 0.2 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.3 2.1 0.1 0.0 4.6 0.0 0.4 0.4 0.9 0.5 0.7 0.3 0.7 1.1 0.6 0.9 0.7 0.9 1.0 0.1 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 22.8 0.0 0.0 0.0 46.3 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 1.9 5.1 23.4 0.0 3.3 0.0 0.0 2.6 0.0 17.5 0.0 9.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.5 0.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "Nuclear FMR1 interacting protein 2" Q7Z417 17 29255839-29294148 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 79.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 15.3 14.9 4.4 22.7 3.6 79.9 12.5 10.3 20.4 12.7 11.7 14.9 16.2 11.5 11.9 17.2 10.9 14.0 13.6 5.1 19.9 13.0 24.0 21.0 19.8 12.1 14.7 12.0 14.7 18.4 11.0 29.6 11.0 12.1 13.0 23.1 15.5 9.8 15.9 12.1 13.2 10.3 2.1 20.7 18.7 14.2 10.8 18.0 13.5 17.6 17.5 16.4 14.2 14.1 42.5 67.1 38.9 27.2 32.8 38.0 65.1 41.3 24.8 31.1 28.4 75.0 22.5 68.5 60.1 28.5 27.7 58.6 31.4 28.9 39.3 74.0 55.9 51.8 64.7 19.8 30.3 66.6 53.8 33.1 34.5 34.4 36.7 35.9 23.2 24.8 86.2 49.5 32.1 34.8 70.6 30.1 40.2 32.2 24.9 57.2 66.8 29.4 26.1 68.4 37.1 23.5 73.6 136.6 44.6 51.5 47.3 44.2 38.5 59.1 59.1 35.0 71.3 68.4 68.9 79.3 39.0 34.9 51.6 13.6 6.1 8.5 5.6 5.9 4.3 8.5 5.5 6.2 5.2 7.6 7.0 5.9 25.4 5.1 9.6 12.1 3.2 2.3 4.4 3.6 10.3 20.4 5.1 19.9 12.1 14.7 11.0 2.1 10.8 14.1 139.7 80.1 67.0 58.1 76.8 99.5 78.2 40.0 118.4 55.3 105.0 124.8 81.7 38.6 69.3 31.3 95.9 69.2 124.3 72.6 15.6 33.9 35.2 108.2 139.0 85.9 48.3 55.6 47.4 27.9 31.3 86.4 82.6 154.2 46.2 41.2 55.0 54.6 44.6 57.2 47.1 62.5 20.3 74.7 108.8 24.9 35.4 122.9 40.9 41.2 50.0 35.2 37.0 44.7 85.9 37.4 43.1 35.0 65.2 91.8 26.5 27.6 88.8 60.6 19.7 171.7 78.5 36.6 29.8 120.8 97.7 182.0 93.8 51.8 57.1 111.9 OR10Z1 ENSG00000198967 "Olfactory receptor family 10 subfamily Z member 1" Q8NGY1 1 158605268-158612514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "bone marrow: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "K-562: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" 0.0 0.0 0.5 0.0 0.5 7.6 0.0 0.6 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.7 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6N2 ENSG00000188340 "Olfactory receptor family 6 subfamily N member 2" Q8NGY6 1 158774222-158781204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056637 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "HPA056637: AB_2683198" 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSM MGC20461 ENSG00000099985 "Oncostatin M" P13725 22 30262829-30266851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Cytokine, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 118.2" "Group enriched" "Detected in some" 4 "Hofbauer cells: 74.4;Macrophages: 51.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basophil: 65.2;neutrophil: 34.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 65.2" "Cell line enhanced" "Detected in some" "HDLM-2: 15.7;HL-60: 3.8;HMC-1: 11.1;Karpas-707: 3.5;NB-4: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 39700 "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "unprognostic (5.15e-2)" "unprognostic (8.80e-3)" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (7.37e-2)" "unprognostic (2.61e-2)" "unprognostic (6.78e-2)" "unprognostic (3.77e-2)" "unprognostic (2.81e-2)" "unprognostic (4.60e-2)" "unprognostic (1.58e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.00e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" 7.2 3.6 0.8 14.3 1.0 118.2 0.8 0.8 4.2 1.2 2.0 1.0 0.5 1.1 0.1 0.8 2.3 6.2 1.4 0.6 1.5 2.0 1.9 7.8 1.6 1.8 0.9 0.5 1.2 0.9 1.5 5.5 1.7 1.0 0.5 0.1 1.1 0.2 0.2 0.2 0.7 3.1 1.6 5.0 0.9 0.4 4.7 2.6 0.8 2.9 0.8 12.7 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.7 0.0 0.3 0.0 0.0 0.0 3.8 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 3.5 0.0 0.0 0.5 6.6 0.0 0.0 0.0 0.6 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.0 65.2 0.5 2.0 2.0 0.3 6.5 0.0 4.8 2.6 0.8 0.2 0.9 2.4 34.9 4.3 0.1 0.2 1.4 1.6 0.8 1.0 0.8 4.2 0.6 1.5 1.8 0.9 1.7 1.6 4.7 2.9 0.9 9.6 10.6 0.0 3.2 0.8 0.2 0.0 0.0 0.0 0.7 1.8 0.6 0.0 3.7 0.0 0.0 0.8 13.2 0.0 0.0 0.1 0.1 0.6 0.2 1.9 0.0 1.3 0.1 0.0 0.9 1.4 0.0 1.1 15.2 0.0 0.4 0.0 74.4 0.0 0.1 0.1 0.0 6.1 12.4 0.0 0.0 51.6 0.0 0.0 1.8 0.1 1.0 0.0 0.1 0.1 0.1 0.0 2.5 0.1 0.0 0.1 0.7 0.2 0.0 0.7 0.4 0.0 0.0 0.3 0.3 0.8 14.2 0.1 0.0 0.0 PADI4 "PAD, PADI5, PDI4, PDI5" ENSG00000159339 "Peptidyl arginine deiminase 4" Q9UM07 1 17308195-17364004 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "bone marrow: 105.1;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in some" "dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0" "Group enriched" "Detected in all" 9 "granulocytes: 183.0;monocytes: 71.3" "Cell line enhanced" "Detected in some" "HEL: 1.2;RPMI-8226: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017007, HPA042825" Enhanced NA NA 29000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA017007: AB_1854921, HPA042825: AB_2678189" "unprognostic (1.70e-1)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (2.98e-1)" "unprognostic (1.27e-1)" "unprognostic (1.13e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (8.49e-2)" "unprognostic (5.22e-2)" "unprognostic (8.55e-2)" "unprognostic (1.81e-1)" "unprognostic (1.66e-3)" "unprognostic (1.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.56e-2)" "unprognostic (1.80e-1)" 1.8 0.1 0.2 0.7 0.4 105.1 0.3 0.2 0.8 0.1 0.2 0.1 0.1 0.1 0.0 0.4 1.0 0.4 1.1 0.3 0.2 0.5 1.7 7.9 0.3 0.3 0.1 0.1 0.3 0.0 0.2 0.5 0.3 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.4 0.0 29.9 0.4 0.1 0.1 1.6 0.3 0.3 0.2 0.7 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 79.9 71.3 97.5 0.4 5.7 0.2 1.1 0.5 0.7 13.9 1.8 2.6 4.5 183.0 4.5 1.8 6.2 0.4 35.8 0.2 0.4 0.2 0.8 0.3 0.2 0.3 0.1 0.3 0.0 0.1 0.4 0.0 0.0 3.7 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.6 0.6 0.0 0.0 12.6 0.1 0.0 0.4 0.2 0.0 0.4 0.0 0.0 3.3 0.4 0.2 0.0 14.6 0.0 0.0 22.3 0.0 20.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 4.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375440 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 73.0" "Cell type enhanced" "Detected in all" "Early spermatids: 208.7;Late spermatids: 477.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 124.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 7.1 7.0 8.9 4.7 12.1 73.0 4.7 15.7 8.6 7.9 17.9 9.3 14.0 9.1 14.1 10.8 6.8 9.7 5.1 8.1 11.8 13.1 15.8 6.0 3.2 11.9 13.8 8.9 14.1 28.3 4.2 5.4 12.2 6.4 11.2 14.1 12.9 10.6 4.9 5.5 10.6 6.9 11.3 3.7 10.4 13.2 12.5 5.8 6.8 5.8 3.6 6.6 5.8 13.2 12.6 21.1 7.6 14.7 12.8 11.4 4.3 11.9 10.2 5.2 4.2 10.7 16.4 14.7 10.5 18.1 6.0 18.4 13.4 12.6 10.3 9.4 11.8 124.3 8.6 10.6 9.4 52.4 11.2 11.2 14.7 9.5 27.9 19.3 9.3 12.1 11.5 15.0 13.0 5.1 10.2 6.7 6.0 6.6 18.8 8.2 29.2 6.4 15.5 9.0 6.0 9.6 12.6 5.4 9.7 6.9 3.7 7.6 15.1 8.6 9.4 15.8 20.5 8.0 7.2 10.5 10.8 23.6 7.7 1.4 0.5 2.6 0.9 0.5 0.9 0.3 0.7 0.7 0.7 0.4 0.5 0.7 2.3 1.2 0.9 0.5 0.3 0.2 8.9 12.1 15.7 8.6 8.1 11.8 11.9 13.8 12.2 11.3 12.5 13.2 22.1 12.8 30.7 32.3 13.7 29.7 24.4 10.3 24.5 31.9 16.4 17.0 19.8 40.0 21.0 18.4 22.9 9.8 36.1 26.9 9.8 31.9 208.7 78.3 46.7 24.0 33.7 82.0 49.2 81.9 7.2 27.3 48.4 111.2 44.2 14.6 18.9 58.6 7.5 32.0 61.0 38.8 10.2 16.0 31.8 477.6 23.6 25.2 23.2 30.0 15.5 29.0 23.7 51.8 56.4 57.6 23.1 28.6 28.1 41.1 27.0 26.5 28.5 45.0 26.3 46.3 24.5 25.8 29.1 36.3 32.4 6.7 28.4 90.8 50.2 44.6 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144420 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 228.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 76.9" "Group enriched" "Detected in all" 4 "granulocytes: 76.9;monocytes: 23.2" "Cell line enhanced" "Detected in many" "CACO-2: 58.8;U-698: 146.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 27.6 7.9 10.2 28.1 14.4 228.5 25.7 11.9 13.5 17.9 9.2 18.6 17.6 17.3 8.6 42.9 12.7 26.1 11.8 13.8 11.2 10.6 13.5 31.0 24.7 12.2 11.2 5.5 9.3 37.9 15.8 15.6 12.2 8.9 20.1 5.1 18.9 7.7 7.1 29.7 23.2 13.9 12.6 21.8 18.1 10.7 10.9 28.3 9.7 10.0 29.0 22.4 23.7 15.6 3.6 2.8 36.5 24.6 4.2 3.2 8.3 4.8 5.4 4.3 6.8 58.8 4.1 48.3 11.3 1.7 1.6 5.8 11.1 10.5 8.6 12.2 8.9 4.4 1.7 9.5 12.4 4.8 8.3 4.2 8.1 6.4 21.6 4.5 24.3 18.2 2.7 11.7 3.7 0.3 10.6 6.9 23.8 11.1 1.7 13.2 12.6 28.1 17.7 10.8 16.7 23.3 3.6 5.5 12.9 11.3 3.0 3.3 17.5 4.0 5.7 4.0 7.1 27.0 2.8 146.7 2.1 4.3 10.9 15.0 15.6 15.0 0.9 14.1 1.7 8.5 4.8 1.9 5.4 6.6 5.6 2.5 76.9 3.0 23.2 0.5 11.6 6.6 10.2 14.4 11.9 13.5 13.8 11.2 12.2 11.2 12.2 12.6 10.9 15.6 94.5 28.9 49.2 4.6 84.4 224.1 74.6 48.2 105.9 1.7 60.9 50.3 5.7 15.7 52.0 5.5 0.0 1.7 16.9 57.9 1.9 5.3 10.6 34.6 26.4 52.1 25.7 3.4 23.4 26.7 8.6 24.5 75.4 58.7 15.2 6.3 37.5 7.5 22.8 3.3 19.1 23.4 30.5 67.6 103.7 11.2 1.5 107.0 112.1 119.9 30.6 5.5 3.1 82.9 67.9 20.9 45.9 1.9 318.8 44.7 32.7 9.6 43.6 2.0 0.0 10.1 51.9 8.4 9.6 208.0 217.5 4.0 49.4 3.2 32.4 145.8 PGLYRP1 "PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L" ENSG00000008438 "Peptidoglycan recognition protein 1" O75594 19 46019153-46023053 "Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 629.4" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Excitatory neurons: 1.7;Inhibitory neurons: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.4" "Group enriched" "Detected in some" 202 "eosinophil: 443.7;neutrophil: 494.6" "Lineage enriched" "Detected in many" 213 "granulocytes: 494.6" "Cell line enhanced" "Detected in some" "A549: 3.1;HEK 293: 1.8;HeLa: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045702, HPA070227" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 35000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "Nucleoplasm, Cytosol" "HPA045702: AB_10960204, HPA070227: " "unprognostic (2.87e-2)" "unprognostic (4.26e-1)" "unprognostic (1.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.58e-1)" "unprognostic (4.93e-3)" "unprognostic (2.20e-1)" "unprognostic (6.46e-2)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (8.51e-3)" "unprognostic (7.18e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (4.37e-3)" 1.5 0.3 0.3 1.8 1.1 629.4 0.3 3.4 1.5 0.1 0.0 0.3 0.6 0.2 0.0 0.5 0.6 0.2 1.7 0.6 0.0 0.8 2.5 8.7 0.5 0.0 0.1 0.1 0.5 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.5 0.0 0.3 1.0 0.7 0.1 0.0 42.5 0.4 1.0 0.0 3.3 0.5 2.3 0.0 0.4 0.2 0.0 0.3 3.1 0.5 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.2 0.8 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.8 1.8 0.3 1.7 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.3 0.0 0.2 0.2 0.9 0.2 0.0 1.2 0.7 0.1 0.0 0.0 1.2 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.7 0.6 0.3 0.4 0.7 0.0 0.2 0.4 443.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 494.6 0.0 2.3 0.0 0.1 3.9 0.3 1.1 3.4 1.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 PLAUR "CD87, UPAR, URKR" ENSG00000011422 "Plasminogen activator, urokinase receptor" Q03405 19 43646095-43670547 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 688.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 820.7;Langerhans cells: 1833.9;Macrophages: 864.3;Urothelial cells: 2274.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1172.3" "Group enriched" "Detected in all" 4 "granulocytes: 1172.3;monocytes: 550.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 311.7;U-251 MG: 413.1;U-87 MG: 346.9;WM-115: 346.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050843, CAB073533" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA 4100000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "CAB073533: , HPA050843: AB_2681255" "unprognostic (9.28e-2)" "unprognostic (9.65e-3)" "unprognostic (1.39e-1)" "unprognostic (1.29e-3)" "unprognostic (3.59e-3)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "prognostic unfavorable (2.33e-5)" "unprognostic (8.08e-3)" "unprognostic (4.30e-2)" "unprognostic (2.29e-3)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.83e-9)" "unprognostic (4.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.45e-2)" "unprognostic (9.33e-2)" 52.1 10.4 7.5 81.7 9.8 688.4 14.5 11.2 32.4 30.9 10.3 26.7 10.0 30.2 4.8 11.6 22.8 78.1 23.0 8.1 10.4 18.2 19.8 69.5 10.6 12.2 9.8 14.9 13.6 5.4 9.1 35.9 13.3 11.5 20.1 2.8 21.7 5.8 3.6 7.8 10.6 26.2 9.7 20.4 28.4 3.1 24.8 10.2 9.5 4.7 8.6 109.7 15.8 13.8 83.9 31.0 26.1 1.9 23.4 83.3 16.2 180.7 189.6 114.6 141.4 2.4 95.1 2.4 43.0 116.9 66.8 35.2 7.0 46.4 127.9 5.3 5.3 15.8 44.7 3.9 30.6 18.8 195.2 87.4 9.0 311.7 46.5 160.6 129.0 19.1 16.4 2.2 107.7 6.1 21.0 55.3 8.7 156.1 64.7 24.0 17.4 5.6 35.9 3.8 1.3 22.2 82.0 17.4 25.0 12.6 3.2 59.4 129.7 230.0 121.1 109.8 413.1 3.0 9.0 0.6 346.9 36.0 346.5 87.7 476.5 745.5 6.8 427.9 8.3 2.7 8.9 5.7 213.6 1.4 3.2 4.0 1172.3 6.7 550.7 69.3 3.6 253.9 7.5 9.8 11.2 32.4 8.1 10.4 12.2 9.8 13.3 9.7 24.8 13.8 23.1 73.7 76.6 2.3 15.5 105.2 820.7 274.2 72.3 0.7 45.8 22.5 4.5 24.3 151.9 20.2 0.0 6.5 17.4 314.5 1.9 219.3 0.9 188.1 68.0 64.9 14.8 5.2 2.5 106.5 58.8 145.4 156.0 519.1 305.2 4.2 19.2 1.7 428.9 10.1 3.3 85.3 22.4 155.4 1833.9 2.0 6.8 864.3 72.9 5.6 52.1 1.2 4.1 1.5 0.9 558.8 435.5 4.1 14.5 479.4 12.7 2.7 52.7 0.7 6.6 38.5 90.0 1.2 4.7 202.6 63.1 13.1 33.2 3.1 29.3 2274.4 PLEK P47 ENSG00000115956 Pleckstrin P08567 2 68365282-68397453 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 604.8" "Cell type enhanced" "Detected in many" "dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031838, HPA057341" Enhanced Approved Nucleoli NA NA 380000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoli "HPA031838: AB_10602146, HPA057341: AB_2732609" "unprognostic (2.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.52e-3)" "unprognostic (3.52e-1)" "unprognostic (3.08e-2)" "unprognostic (4.67e-2)" "unprognostic (3.40e-2)" "unprognostic (4.00e-2)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.57e-1)" "unprognostic (4.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" 36.4 9.8 4.9 99.4 7.1 604.8 8.2 6.0 10.0 6.9 6.5 13.2 10.4 4.7 3.3 6.0 7.2 21.0 5.4 4.9 5.3 4.0 27.5 35.6 129.9 8.0 6.1 2.6 2.7 2.7 1.9 29.2 8.1 4.2 18.8 0.5 5.7 3.1 1.7 3.4 13.0 22.2 7.3 93.5 11.3 3.2 7.2 33.7 3.8 5.2 118.2 52.3 2.5 12.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 93.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 552.9 0.0 0.0 0.0 126.7 202.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 58.9 0.0 0.0 0.2 187.5 0.0 0.0 0.0 1.5 0.1 27.3 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 215.6 0.1 0.0 0.4 0.1 0.5 7.9 147.8 147.1 0.2 342.5 0.1 231.9 297.5 429.2 298.5 351.6 157.6 157.7 52.2 218.7 229.6 103.6 14.5 161.8 573.9 249.5 390.8 474.8 5.7 606.9 4.9 7.1 6.0 10.0 4.9 5.3 8.0 6.1 8.1 7.3 7.2 12.3 3.4 19.2 24.6 0.0 77.0 6.5 0.3 0.0 0.0 0.0 1.4 3.7 2.3 1.5 15.5 1.8 0.0 1.2 310.7 0.0 0.0 0.2 1.5 0.2 0.3 6.3 0.0 21.9 0.6 0.6 1.8 10.2 1.5 0.3 62.0 0.0 5.7 1.5 220.3 0.0 0.2 0.0 0.0 213.9 456.5 5.1 0.6 412.7 17.8 20.6 178.3 0.0 355.3 0.0 0.1 0.1 0.1 0.4 48.4 0.0 0.0 0.7 13.1 0.1 13.1 1.1 1.8 0.8 0.9 0.6 6.7 2.6 78.3 0.4 0.0 0.3 PMAIP1 "APR, NOXA" ENSG00000141682 "Phorbol-12-myristate-13-acetate-induced protein 1" Q13794 18 59899996-59904305 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 88.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 169.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 169.8" "Cell line enhanced" "Detected in many" "GAMG: 207.5;U-138 MG: 202.1" HPA051063 Uncertain Uncertain Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" Vesicles "HPA051063: AB_2681330" "unprognostic (1.35e-3)" "unprognostic (5.02e-2)" "unprognostic (5.57e-2)" "unprognostic (4.88e-2)" "unprognostic (6.65e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.41e-2)" "unprognostic (6.12e-2)" "unprognostic (8.47e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.53e-1)" "unprognostic (7.68e-2)" "unprognostic (8.74e-2)" "unprognostic (1.09e-1)" 2.0 0.7 2.8 8.0 2.7 88.1 3.9 2.6 5.1 6.5 3.0 2.5 3.7 5.4 0.2 13.7 2.9 8.0 0.9 2.6 2.8 2.3 2.1 3.8 14.7 2.8 2.7 0.7 1.2 14.8 16.7 13.4 3.0 3.6 3.4 2.0 3.6 1.3 1.5 24.1 3.9 1.9 2.7 4.6 2.5 3.1 3.7 12.1 2.1 1.5 14.2 17.3 7.9 2.4 26.6 17.4 5.2 1.6 8.8 69.0 19.8 125.4 84.1 71.5 70.7 1.7 32.5 104.6 17.0 23.5 207.5 38.4 21.0 11.8 70.4 33.7 154.5 19.4 26.0 4.6 87.6 67.1 28.2 28.7 30.8 93.8 48.5 26.1 24.0 46.7 26.7 17.5 24.1 2.6 53.8 20.1 151.7 2.7 32.7 54.1 28.8 39.1 41.9 24.2 39.7 32.7 6.1 3.2 71.5 56.1 5.3 54.6 90.6 202.1 54.0 10.3 141.4 2.8 0.3 92.1 16.8 37.6 48.5 169.8 16.7 103.6 10.9 26.2 9.6 33.8 5.0 6.8 12.1 25.0 4.1 5.9 53.5 6.3 32.1 10.2 25.2 15.1 2.8 2.7 2.6 5.1 2.6 2.8 2.8 2.7 3.0 2.7 3.7 2.4 29.2 32.1 25.7 0.7 175.3 803.1 316.2 236.4 415.4 0.2 111.8 82.0 4.7 12.8 129.6 3.7 2.1 120.3 125.3 141.1 0.0 54.7 0.8 463.6 48.8 48.5 133.4 5.5 0.0 67.0 14.7 32.9 168.2 529.8 31.8 11.8 7.9 0.5 89.5 0.0 0.0 146.8 181.0 37.2 363.3 1.1 0.9 140.6 74.7 7.5 142.4 0.3 34.0 0.0 0.2 100.1 123.6 1.2 63.1 265.7 94.7 0.5 101.5 0.7 0.0 10.8 32.0 0.3 19.8 474.5 691.2 315.2 117.0 19.8 122.2 569.2 PRAM1 PML-RAR ENSG00000133246 "PML-RARA regulated adaptor molecule 1" Q96QH2 19 8490056-8502640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 97.0" "Group enriched" "Detected in many" 4 "Hofbauer cells: 30.0;Kupffer cells: 71.5;Macrophages: 49.0;monocytes: 70.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 95.4;intermediate monocyte: 101.3;myeloid DC: 58.6;neutrophil: 54.0;non-classical monocyte: 121.4" "Group enriched" "Detected in many" 7 "dendritic cells: 58.6;granulocytes: 54.0;monocytes: 121.4" "Cell line enhanced" "Detected in some" "HL-60: 23.3;NB-4: 19.4;THP-1: 39.4;U-937: 127.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045236, HPA050161" Approved Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "HPA045236: AB_2679267, HPA050161: AB_2681036" "unprognostic (1.68e-2)" "unprognostic (3.79e-3)" "unprognostic (1.15e-2)" "unprognostic (3.91e-3)" "unprognostic (1.25e-1)" "unprognostic (6.54e-3)" "unprognostic (3.36e-1)" "unprognostic (1.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.28e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.73e-1)" "unprognostic (2.15e-3)" "unprognostic (2.72e-1)" "unprognostic (6.12e-3)" 1.8 1.4 2.8 10.9 3.5 97.0 1.2 3.5 3.9 2.2 1.3 0.9 2.7 1.4 0.2 0.8 2.0 2.0 0.8 2.7 7.2 1.0 2.6 9.8 1.3 11.1 5.8 1.4 1.2 0.3 1.6 1.0 7.4 3.3 0.5 0.8 1.4 0.4 0.6 1.5 2.9 2.2 4.8 12.8 1.1 1.0 7.0 1.0 1.7 0.3 0.4 1.2 1.2 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 23.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.1 19.4 0.2 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.4 0.3 0.0 0.1 0.1 0.1 0.7 0.8 0.3 0.0 127.6 0.0 2.8 95.4 3.3 0.2 101.3 0.3 0.1 0.1 0.2 58.6 0.0 0.0 0.4 54.0 11.5 121.4 3.0 0.1 41.9 2.8 3.5 3.5 3.9 2.7 7.2 11.1 5.8 7.4 4.8 7.0 6.3 0.3 6.4 5.0 1.3 0.9 0.4 1.1 0.3 0.0 3.2 0.4 1.0 0.8 4.3 3.2 0.0 0.0 0.3 3.1 0.1 0.0 0.0 0.0 0.3 0.4 1.3 0.0 3.8 0.9 0.0 0.4 0.5 0.0 0.3 2.5 0.6 2.9 0.2 30.0 1.7 1.1 0.2 2.0 71.5 2.0 0.4 0.6 49.0 0.0 12.2 70.1 0.4 3.1 0.0 1.6 0.0 0.0 1.5 0.3 0.3 0.0 0.2 0.2 1.3 0.0 0.5 0.2 0.2 1.8 0.4 0.1 0.3 1.9 1.1 0.0 0.8 PRG3 "MBP2, MBPH" ENSG00000156575 "Proteoglycan 3, pro eosinophil major basic protein 2" Q9Y2Y8 11 57376769-57381150 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "bone marrow: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 46 "HMC-1: 198.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory bulb: 3.5" HPA064183 Enhanced "Secreted in other tissues" NA NA 680000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "HPA064183: AB_2685205" 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 198.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS57 "PRSSL1, UNQ782" ENSG00000185198 "Serine protease 57" Q6UWY2 19 685546-695498 "Enzymes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "bone marrow: 165.3" "Cell type enriched" "Detected in some" 9 "Erythroid cells: 77.8" "Cancer enriched" "Detected in single" 10 "pancreatic cancer: 2.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "NB-4: 377.2;THP-1: 184.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" "unprognostic (2.89e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (3.99e-4)" "unprognostic (3.07e-1)" "unprognostic (1.33e-2)" "unprognostic (3.50e-2)" "unprognostic (4.04e-2)" "unprognostic (7.70e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (8.16e-2)" "unprognostic (2.56e-2)" 0.1 0.0 0.0 0.0 0.0 165.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 7.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 377.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.4 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 3.2 0.0 5.9 1.1 0.0 0.4 0.2 0.0 0.0 0.0 3.1 1.5 0.0 0.0 0.5 0.7 2.5 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 77.8 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 2.5 1.0 8.2 0.0 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840999-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "bone marrow: 2098.1" "Cell type enriched" "Detected in some" 17 "Erythroid cells: 26.5" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.0" "Cell line enriched" "Detected in some" 6 "THP-1: 2054.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced Approved Vesicles,Cytosol "Secreted to blood" NA NA 390000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Vesicles "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.8 0.2 0.6 0.0 0.7 2098.1 0.4 0.2 1.3 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.6 0.6 0.4 0.3 2.8 11.7 0.4 0.3 0.4 0.1 0.1 0.2 1.3 0.6 0.4 0.3 0.0 0.0 1.6 0.0 0.3 1.3 0.0 0.0 0.2 38.2 0.1 0.2 0.6 7.1 0.4 0.0 0.0 0.0 0.1 0.4 1.2 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 343.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2054.4 0.0 0.0 0.0 0.2 0.9 0.0 0.2 0.3 0.0 14.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.9 0.6 0.7 0.2 1.3 0.6 0.4 0.3 0.4 0.4 0.2 0.6 0.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.8 1.3 0.4 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 26.5 0.4 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.5 0.0 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 RAB44 "dJ431A14.3, RASD3, RASL13" ENSG00000255587 "RAB44, member RAS oncogene family" Q7Z6P3 6 36697826-36733184 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "bone marrow: 58.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.4;granulocytes: 14.5;monocytes: 2.3;Squamous epithelial cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "basophil: 10.6;eosinophil: 7.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.6" "Cell line enhanced" "Detected in some" "HEL: 21.9;HL-60: 30.9;HMC-1: 88.9;NB-4: 76.7;THP-1: 30.1;U-937: 60.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA079390 Approved Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" Vesicles "HPA079390: " "unprognostic (8.86e-2)" "unprognostic (5.58e-3)" "unprognostic (5.09e-2)" "unprognostic (4.66e-2)" "unprognostic (1.37e-1)" "unprognostic (1.28e-3)" "unprognostic (9.56e-2)" "unprognostic (6.35e-4)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" "unprognostic (2.57e-1)" "unprognostic (3.02e-2)" "unprognostic (3.13e-3)" "unprognostic (3.03e-2)" "unprognostic (9.67e-3)" "unprognostic (5.79e-2)" 0.5 0.0 0.0 0.6 0.1 58.9 0.4 0.0 0.1 0.4 0.0 0.4 0.6 0.3 0.2 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.1 0.1 0.5 0.9 0.4 0.0 0.5 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 30.9 88.9 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 76.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 10.6 0.8 7.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.2 4.4 0.7 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.0 1.3 0.3 0.2 0.0 0.3 0.0 0.5 14.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.3 0.0 1.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.3 0.0 0.0 2.2 0.0 0.0 0.4 0.1 0.0 0.1 RABGEF1 "rabex-5, RABEX5" ENSG00000154710 "RAB guanine nucleotide exchange factor 1" Q9UJ41 7 66682164-66811464 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 76.7" "Cell type enhanced" "Detected in many" "Astrocytes: 91.4;Excitatory neurons: 124.5;Inhibitory neurons: 151.1;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 244.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001407 Supported Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Nucleoli "HPA001407: AB_1856024" "unprognostic (6.65e-2)" "unprognostic (6.44e-4)" "unprognostic (7.32e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (3.77e-1)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (3.32e-1)" "unprognostic (4.64e-4)" "unprognostic (6.45e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.43e-1)" "unprognostic (5.55e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" 16.2 14.1 15.0 11.2 14.9 76.7 13.0 14.9 18.8 13.1 15.6 10.7 8.0 11.5 10.0 19.6 8.8 14.2 9.8 15.2 16.1 11.5 14.8 10.5 11.5 15.6 14.7 12.0 9.7 14.8 4.4 13.2 15.3 12.0 11.9 49.8 8.6 17.3 13.0 23.9 9.2 12.4 14.3 9.4 10.5 25.1 15.5 13.2 15.9 13.3 16.9 19.1 14.1 17.6 47.5 10.2 10.0 16.9 32.1 45.2 10.4 40.9 52.8 42.6 40.2 12.2 28.5 22.4 13.9 60.7 28.2 17.7 16.8 22.3 59.0 14.9 11.2 12.5 14.6 11.8 25.5 21.5 16.9 22.2 28.5 54.9 60.4 33.2 11.3 13.7 21.6 13.9 42.9 19.2 13.2 27.7 15.0 20.2 19.3 12.2 20.1 14.7 37.4 19.5 12.2 17.8 16.8 37.5 19.6 15.6 19.4 12.3 14.0 65.8 12.2 42.4 32.0 19.8 28.7 25.1 31.6 23.0 18.6 18.3 6.5 7.8 7.4 5.7 8.1 9.1 6.3 8.9 6.1 12.5 6.3 6.3 11.8 13.8 12.9 8.1 5.1 6.4 15.0 14.9 14.9 18.8 15.2 16.1 15.6 14.7 15.3 14.3 15.5 17.6 7.3 12.8 12.8 91.4 11.5 4.1 11.4 3.2 10.2 9.9 11.5 7.7 4.8 4.3 10.9 5.5 16.7 3.8 13.2 10.0 11.7 5.4 5.4 13.6 12.5 5.7 18.0 3.0 124.5 5.5 3.8 14.6 8.6 22.0 14.0 8.8 5.7 8.0 4.8 8.4 151.1 4.3 2.0 15.2 5.0 2.8 5.9 19.9 1.8 60.9 6.2 5.5 7.2 100.5 244.1 18.1 13.4 9.4 15.2 13.4 4.4 5.5 11.9 18.9 0.0 10.6 8.5 8.4 6.5 8.3 6.7 13.5 9.5 7.0 5.5 12.3 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT TNF receptor" Q969Z4 11 73376399-73397474 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 154.7" "Cell type enhanced" "Detected in many" "Langerhans cells: 43.9;Macrophages: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 4.9 2.2 3.4 12.9 6.5 154.7 2.5 6.7 7.7 1.4 0.4 2.3 2.3 1.4 0.5 3.9 1.9 4.5 6.2 3.6 7.0 3.7 2.1 10.9 11.9 8.9 6.8 1.8 0.8 1.1 3.5 4.6 8.1 2.1 1.4 2.2 1.9 0.4 24.3 3.2 7.1 2.6 7.0 20.8 2.2 3.2 6.9 4.6 2.2 6.4 6.9 4.8 2.3 12.6 9.1 8.9 7.0 6.8 0.8 1.0 7.5 9.6 6.2 11.1 6.7 8.5 3.9 16.4 30.9 6.4 8.8 13.1 4.4 4.7 4.3 9.9 8.3 15.4 12.4 3.1 1.8 15.6 26.3 1.1 2.0 11.9 3.5 2.6 4.1 8.4 11.8 21.0 3.1 8.5 11.5 16.5 6.1 6.9 11.0 21.9 11.7 14.2 2.3 3.9 8.9 8.5 8.3 7.5 10.0 1.7 4.1 13.9 5.4 13.8 9.7 23.1 17.6 7.5 6.1 18.2 8.5 15.5 14.8 0.7 12.5 22.2 0.9 25.4 2.0 7.6 1.0 1.7 11.8 5.8 1.3 0.6 19.9 0.4 35.3 11.7 0.5 6.3 3.4 6.5 6.7 7.7 3.6 7.0 8.9 6.8 8.1 7.0 6.9 12.6 5.7 6.4 2.2 3.6 24.2 26.5 15.4 2.8 2.8 3.5 6.1 5.5 2.7 1.5 3.4 0.0 12.5 1.6 33.0 4.7 0.0 3.6 0.9 5.4 5.2 7.2 3.5 5.7 3.1 0.9 10.7 10.1 11.2 10.8 24.8 6.8 1.8 0.2 23.0 30.3 4.5 2.8 6.1 24.2 43.9 1.2 0.0 43.9 5.4 2.8 32.8 8.9 3.1 1.5 4.8 6.7 2.4 0.0 19.2 9.9 1.0 0.5 1.4 2.8 6.6 7.2 14.5 11.7 10.5 4.6 18.3 21.1 16.1 0.6 3.1 17.8 RETN "ADSF, FIZZ3, RETN1" ENSG00000104918 Resistin Q9HD89 19 7669049-7670455 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Hormone "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 247.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 118.2;Kupffer cells: 47.0;Macrophages: 90.4;monocytes: 58.2" "Group enriched" "Detected in many" 4 "lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4" "Group enriched" "Detected in many" 11 "dendritic cells: 118.7;monocytes: 170.4" "Group enriched" "Detected in some" 11 "NB-4: 524.3;U-937: 243.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 5120000 1200000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "unprognostic (5.61e-2)" "unprognostic (6.20e-3)" "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (5.19e-4)" "unprognostic (1.53e-4)" "unprognostic (7.34e-2)" "unprognostic (3.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.35e-2)" "unprognostic (1.20e-1)" "unprognostic (4.02e-1)" "unprognostic (7.16e-5)" "unprognostic (4.23e-2)" "unprognostic (2.26e-1)" "unprognostic (8.91e-2)" "unprognostic (1.20e-1)" 3.4 1.0 0.1 5.2 0.1 247.2 1.4 0.0 0.9 0.6 0.0 0.8 6.1 0.7 0.0 0.5 2.4 0.3 2.3 0.4 0.1 1.7 3.3 34.0 0.1 0.1 0.1 0.4 0.9 0.1 0.5 1.1 0.1 1.0 0.2 0.0 1.1 0.0 0.6 0.7 0.7 4.3 0.0 53.3 1.0 0.2 0.0 4.0 0.8 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.9 524.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 243.2 0.0 0.1 170.4 0.1 0.4 91.7 1.2 0.0 1.9 1.5 118.7 0.1 4.4 9.0 13.6 0.3 47.4 4.5 0.0 64.3 0.1 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 12.8 9.9 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.5 0.0 0.0 1.1 0.6 0.0 0.0 3.8 0.0 0.4 0.1 118.2 0.0 0.0 0.0 0.0 47.0 8.7 0.2 0.0 90.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.5 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.1 2.2 0.0 0.0 0.1 RGL4 Rgr ENSG00000159496 "Ral guanine nucleotide dissociation stimulator like 4" Q8IZJ4 22 23688136-23699176 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "bone marrow: 164.4" "Group enriched" "Detected in some" 4 "dendritic cells: 23.8;Early spermatids: 18.1;NK-cells: 52.5;T-cells: 51.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "eosinophil: 393.6;neutrophil: 516.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 516.3" "Group enriched" "Detected in many" 5 "MOLT-4: 26.3;U-937: 61.0" HPA035979 Uncertain Approved Centrosome "Intracellular and membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Centrosome "HPA035979: AB_10673227" "unprognostic (1.48e-4)" "unprognostic (2.75e-4)" "unprognostic (4.44e-2)" "unprognostic (1.11e-4)" "unprognostic (3.10e-1)" "unprognostic (2.93e-4)" "unprognostic (4.92e-2)" "unprognostic (2.06e-2)" "unprognostic (2.78e-1)" "unprognostic (3.11e-1)" "unprognostic (4.25e-2)" "unprognostic (3.80e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-3)" 3.8 3.1 0.1 7.6 0.2 164.4 0.5 2.0 0.8 0.3 0.3 1.2 4.1 3.1 0.0 1.9 0.9 4.6 2.8 0.2 0.0 1.5 1.3 4.8 11.5 0.6 0.1 3.9 3.4 0.1 0.5 1.7 1.0 1.4 1.1 10.6 4.6 0.2 3.0 5.6 4.1 0.6 0.1 19.8 2.4 3.8 0.1 8.4 3.1 0.9 8.1 3.8 0.5 1.1 1.6 0.5 5.8 2.5 0.0 0.0 2.5 1.8 0.0 0.0 0.0 1.3 1.1 1.9 0.4 0.0 1.0 2.8 0.0 0.0 0.0 2.0 3.6 0.9 2.5 0.3 0.0 3.4 3.8 0.0 0.0 0.0 0.0 2.9 0.0 2.0 2.1 3.0 0.0 1.0 26.3 3.6 0.4 0.6 0.8 9.3 2.0 1.4 0.0 1.7 1.8 2.7 1.7 3.7 0.6 3.1 1.2 2.0 2.5 3.2 1.9 2.2 1.1 5.3 0.8 1.3 1.9 61.0 1.6 98.0 2.9 393.6 57.4 20.8 59.6 6.5 74.1 66.2 5.4 5.2 104.6 93.8 516.3 35.2 84.6 0.7 114.2 37.4 0.1 0.2 2.0 0.8 0.2 0.0 0.6 0.1 1.0 0.1 0.1 1.1 0.7 0.0 4.4 0.3 5.9 0.9 0.0 0.0 0.0 0.5 0.4 0.5 0.5 1.5 1.3 0.0 2.1 0.0 23.8 0.0 0.0 2.4 18.1 0.1 0.3 0.3 0.0 8.8 0.4 1.7 0.1 0.6 2.6 0.2 1.3 0.1 0.4 0.3 0.1 1.7 0.5 0.0 0.0 1.6 0.7 2.0 0.0 3.5 1.8 0.0 2.5 0.0 52.5 0.5 0.4 2.2 0.0 0.0 3.4 0.0 0.0 0.3 0.0 2.8 0.0 0.3 0.5 5.9 0.0 0.0 0.3 0.0 51.8 0.1 0.1 0.1 RHAG "CD241, RH50A, SLC42A1" ENSG00000112077 "Rh associated glycoprotein" Q02094 6 49605175-49636839 "CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "bone marrow: 119.6" "Cell type enriched" "Detected in some" 170 "Erythroid cells: 494.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 202 "HEL: 506.0;K-562: 491.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA046051, HPA055331" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Endoplasmic reticulum" "HPA046051: , HPA055331: AB_2682785" "unprognostic (8.16e-2)" "unprognostic (6.86e-2)" "unprognostic (1.25e-3)" "unprognostic (1.65e-1)" 0.2 0.0 0.0 0.0 0.0 119.6 0.0 0.0 0.0 0.7 0.0 0.5 0.1 0.1 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.1 0.4 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 506.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 491.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.4 0.1 0.3 0.0 494.2 0.2 0.2 0.6 0.3 0.0 0.6 2.5 0.0 1.1 0.1 0.5 0.0 0.1 0.0 0.0 0.6 0.3 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.1 0.0 0.0 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 48.5" "Cell type enriched" "Detected in some" 67 "Erythroid cells: 511.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HEL: 81.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.3 0.6 1.5 0.1 1.9 48.5 0.3 1.6 3.3 0.3 1.2 0.2 0.2 0.2 4.2 0.6 1.0 0.3 1.2 1.5 1.4 0.4 1.7 0.4 0.5 1.9 1.6 0.5 1.2 0.1 3.4 1.1 1.9 1.0 0.3 2.2 5.5 0.2 1.5 0.6 0.1 0.0 1.5 1.1 0.4 2.2 1.6 0.8 0.6 0.9 0.3 0.1 0.5 2.2 0.2 0.1 0.2 0.5 0.9 0.6 0.1 0.3 0.3 0.4 0.1 0.1 1.5 0.7 1.1 1.0 0.1 0.3 0.0 0.2 0.2 0.4 0.1 81.3 0.0 0.0 1.1 0.0 0.6 1.9 1.5 0.6 0.5 0.0 0.0 0.6 17.5 0.4 0.5 0.8 0.0 0.6 1.7 0.7 0.5 0.2 0.2 2.6 0.0 0.0 0.7 0.8 0.3 0.3 1.0 0.8 0.5 0.0 0.1 0.2 0.0 0.9 0.0 5.1 1.4 1.0 2.9 0.9 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 1.9 1.6 3.3 1.5 1.4 1.9 1.6 1.9 1.5 1.6 2.2 0.8 0.0 0.0 5.5 0.8 0.5 0.5 0.3 0.6 4.2 1.1 2.5 0.7 1.5 0.2 0.0 0.0 0.8 1.2 0.5 0.0 0.3 1.1 1.2 0.7 0.4 0.0 511.8 2.9 0.2 0.7 0.4 3.6 0.8 4.5 0.6 0.0 0.7 0.2 6.7 2.3 0.0 0.0 0.6 0.4 0.5 0.6 1.7 0.0 0.0 0.0 4.7 1.0 2.0 2.7 0.5 0.0 0.7 3.0 0.3 0.1 0.0 0.9 2.4 6.6 0.5 0.5 3.0 7.6 0.6 1.4 0.8 0.8 0.7 0.3 0.7 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "bone marrow: 15.8" "Cell type enriched" "Detected in some" 21 "Erythroid cells: 153.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 6.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.3" "Group enriched" "Detected in some" 7 "HEL: 43.0;K-562: 13.0" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.1 0.4 0.4 0.5 1.0 15.8 0.1 1.4 0.7 0.3 0.1 0.1 0.3 0.4 0.1 0.3 0.2 0.4 0.3 0.4 0.1 0.1 0.1 0.2 0.7 0.3 0.1 0.5 0.4 0.0 0.2 0.3 0.2 0.3 0.1 1.9 2.4 0.0 3.8 2.0 0.3 0.0 0.0 0.6 0.2 0.5 0.5 0.1 0.3 0.0 0.1 0.1 0.1 1.2 0.2 0.0 0.3 0.3 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.3 0.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.2 43.0 1.0 0.2 0.0 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.2 13.0 0.9 0.1 0.2 0.2 0.3 4.0 0.0 0.2 0.3 0.2 0.1 0.0 0.1 0.6 0.4 0.1 0.2 0.1 0.1 0.2 0.6 0.4 0.7 0.2 0.5 0.2 0.4 0.2 0.2 0.6 0.2 0.2 4.3 0.9 2.0 0.6 0.4 0.7 1.0 0.8 0.5 0.1 1.3 0.9 0.8 6.3 1.0 0.6 0.4 0.7 0.6 0.4 1.0 1.4 0.7 0.4 0.1 0.3 0.1 0.2 0.0 0.5 1.2 0.2 0.0 0.5 1.0 0.6 0.1 0.2 0.0 0.0 0.3 0.1 0.1 1.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.3 1.0 0.0 153.0 5.2 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.1 0.0 4.3 0.0 0.0 0.3 0.3 0.0 0.0 3.0 0.0 3.7 0.0 0.4 0.0 7.1 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 1.2 0.4 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.0 0.1 RIOK3 SUDD ENSG00000101782 "RIO kinase 3" O14730 18 23453287-23486603 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 174.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 338.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001620, HPA024184" Approved Approved "Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "Golgi apparatus, Centriolar satellite" "HPA001620: AB_1079815, HPA024184: AB_1856289" "unprognostic (7.99e-2)" "unprognostic (1.71e-2)" "unprognostic (2.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.05e-1)" "unprognostic (7.48e-2)" "unprognostic (8.98e-3)" "unprognostic (1.01e-1)" "unprognostic (5.10e-2)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.10e-4)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.90e-2)" "unprognostic (1.46e-1)" "unprognostic (5.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.71e-2)" 23.1 18.5 5.5 20.4 7.1 174.3 19.2 7.9 10.2 17.4 8.3 47.5 51.6 16.7 12.4 65.5 14.8 24.3 32.7 5.9 6.7 29.6 55.6 22.7 22.8 9.3 7.3 15.7 27.6 22.8 5.4 34.9 8.9 20.1 43.5 19.6 23.2 14.5 52.9 33.3 62.5 19.7 7.5 21.5 38.5 36.6 6.9 21.5 22.2 48.8 30.2 25.8 27.0 10.6 41.9 15.7 17.8 25.0 31.8 37.7 28.5 38.9 29.8 27.6 28.4 17.3 47.5 27.6 52.3 43.7 26.9 57.6 25.9 45.4 38.9 29.5 12.0 25.9 26.9 22.2 71.7 74.7 25.8 39.0 91.2 44.1 66.7 36.7 38.4 19.2 39.8 34.7 45.0 19.4 25.8 15.6 17.6 59.0 31.3 31.3 33.2 41.2 39.3 50.0 39.5 28.9 50.1 28.4 37.4 41.0 21.9 45.0 63.7 48.4 10.9 21.2 28.9 66.1 56.0 38.2 31.0 36.7 38.2 50.1 24.5 14.8 15.0 34.6 10.8 14.0 12.3 12.6 19.1 18.5 9.8 11.2 17.2 15.0 39.0 8.6 19.4 20.7 5.5 7.1 7.9 10.2 5.9 6.7 9.3 7.3 8.9 7.5 6.9 10.6 49.7 80.1 57.7 23.2 46.4 120.4 92.4 78.6 113.8 44.1 49.3 35.6 69.1 51.5 81.5 25.8 56.3 43.0 74.6 338.1 25.4 51.0 271.5 130.1 85.5 44.1 62.8 259.8 35.5 52.7 64.6 48.8 93.8 267.2 63.3 40.0 29.6 88.5 41.1 28.6 34.2 119.9 50.8 59.9 51.2 305.8 22.4 85.7 42.7 15.9 80.6 18.3 53.5 34.2 49.5 148.4 210.7 30.1 63.4 118.5 199.5 52.5 72.3 46.4 6.6 43.9 51.6 28.4 10.1 164.2 143.6 88.4 57.3 71.1 77.2 244.4 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74582976-74614624 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.20e-1)" 11.3 11.8 10.6 10.4 11.7 41.2 10.5 5.9 9.9 10.0 10.0 6.8 5.9 9.5 5.6 8.7 8.4 9.6 8.8 11.2 15.1 10.0 8.3 12.1 8.9 8.5 10.3 10.6 7.5 11.7 10.3 9.8 10.3 9.8 6.6 10.7 7.4 7.1 9.6 9.4 6.1 9.3 7.3 9.3 7.4 6.5 12.6 11.0 11.7 8.6 9.5 8.5 8.0 8.2 23.7 24.2 22.8 18.7 20.1 22.5 22.4 22.4 26.0 19.9 24.4 18.9 24.4 12.8 25.4 28.6 26.7 19.9 45.9 26.7 30.1 11.7 23.9 22.7 43.2 10.7 17.4 34.6 38.6 21.7 14.4 28.2 46.5 15.6 23.3 20.9 19.9 22.9 24.6 18.1 26.0 16.8 35.0 12.9 22.5 24.3 48.0 21.5 16.1 28.6 16.4 19.5 42.3 19.0 24.5 20.4 11.2 24.9 31.0 23.4 23.1 24.8 19.6 12.0 24.6 20.3 25.5 33.1 23.2 22.8 6.0 5.9 3.1 7.5 3.1 3.0 3.9 3.8 4.9 3.3 4.2 3.8 11.5 5.3 5.6 2.6 4.8 3.2 10.6 11.7 5.9 9.9 11.2 15.1 8.5 10.3 10.3 7.3 12.6 8.2 44.8 16.0 17.0 13.4 22.4 35.8 29.6 16.1 23.3 13.8 18.3 13.5 30.5 18.6 20.4 25.8 14.6 16.3 27.6 10.3 11.7 13.7 7.9 32.3 35.3 30.1 23.2 12.8 19.2 10.7 21.5 27.7 27.0 41.0 38.0 24.6 21.0 14.8 18.2 21.9 18.9 10.6 10.2 20.7 34.1 4.4 9.9 29.1 17.8 15.9 12.7 13.2 12.3 11.1 16.4 14.8 8.5 18.8 16.3 25.5 6.8 12.0 25.2 14.6 6.6 31.1 24.1 9.7 18.2 21.6 38.8 26.3 22.0 19.0 11.4 37.2 RNASE2 "EDN, RAF3, RNS2" ENSG00000169385 "Ribonuclease A family member 2" P10153 14 20955487-20956436 "Enzymes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "bone marrow: 1713.7" "Cell type enhanced" "Detected in some" "Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6" "Cancer enriched" "Detected in many" 7 "glioma: 14.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 457.5;eosinophil: 1352.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 1352.6" "Group enriched" "Detected in some" 303 "HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9" HPA044983 Enhanced "Secreted to blood" NA NA 200000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA044983: AB_10963689" "unprognostic (6.66e-2)" "unprognostic (3.00e-1)" "unprognostic (6.85e-2)" "unprognostic (7.68e-2)" "unprognostic (2.73e-2)" "unprognostic (9.26e-2)" "unprognostic (4.94e-3)" "unprognostic (6.77e-2)" "unprognostic (9.54e-2)" "unprognostic (3.24e-2)" "unprognostic (3.25e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.28e-13)" "unprognostic (2.27e-2)" "unprognostic (7.14e-3)" "unprognostic (5.33e-2)" "unprognostic (1.50e-1)" 7.1 6.0 3.0 9.1 2.8 1713.7 1.7 2.9 5.5 2.3 4.4 2.2 0.2 2.1 0.3 0.9 5.7 2.6 4.0 2.8 4.2 1.7 4.6 12.2 1.9 5.4 4.1 1.5 1.7 0.5 1.7 1.8 4.4 1.7 0.7 1.7 1.9 0.2 0.7 2.9 1.4 9.7 4.5 35.1 2.1 0.7 4.2 14.8 0.9 0.6 0.6 5.2 1.4 6.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.1 0.0 539.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 539.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 1405.4 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.7 0.0 1295.9 0.0 457.5 109.0 1352.6 0.4 19.3 0.8 0.3 0.4 0.0 191.8 0.4 0.4 0.4 9.8 0.1 2.8 2.6 0.1 39.9 3.0 2.8 2.9 5.5 2.8 4.2 5.4 4.1 4.4 4.5 4.2 6.3 0.2 3.2 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.4 0.0 1.9 0.0 0.5 0.0 0.0 1.3 0.0 30.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.4 2.2 13.0 0.0 0.0 0.0 0.0 174.3 0.7 1.7 0.3 82.2 0.0 0.0 54.6 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 19.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RNASE3 "ECP, RAF1, RNS3" ENSG00000169397 "Ribonuclease A family member 3" P12724 14 20891399-20892348 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "bone marrow: 934.3" "Cell type enhanced" "Detected in some" "Early spermatids: 22.9;Erythroid cells: 5.9;Kupffer cells: 4.5;Late spermatids: 10.9;Macrophages: 3.0;Rod photoreceptor cells: 3.5" "Cancer enriched" "Detected in single" 8 "glioma: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 22 "eosinophil: 304.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 304.6" "Cell line enhanced" "Detected in some" "HL-60: 150.4;NB-4: 51.1;THP-1: 63.6;U-937: 301.8" HPA056183 Enhanced "Secreted to blood" NA NA 4200000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA056183: AB_2683059" "unprognostic (2.54e-2)" "unprognostic (6.61e-2)" "unprognostic (1.84e-1)" "unprognostic (2.50e-1)" "unprognostic (1.37e-2)" "unprognostic (8.21e-2)" "unprognostic (6.45e-2)" "unprognostic (9.20e-3)" "unprognostic (1.20e-1)" "unprognostic (9.21e-2)" "unprognostic (8.62e-7)" "unprognostic (6.29e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (2.37e-1)" 0.4 0.4 0.5 0.5 0.5 934.3 0.1 0.5 1.2 0.1 0.3 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.2 0.5 1.0 0.2 2.0 2.7 0.7 1.1 0.7 0.2 0.1 0.0 0.3 0.6 0.9 0.2 0.1 3.8 1.2 0.1 0.1 1.7 0.1 1.0 1.0 9.8 0.1 1.8 0.5 9.4 0.1 0.0 0.0 0.3 0.1 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 150.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 301.8 0.0 11.3 8.8 304.6 0.0 1.2 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 4.3 0.0 0.5 1.6 0.0 4.4 0.5 0.5 0.5 1.2 0.5 1.0 1.1 0.7 0.9 1.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 10.9 0.3 3.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RNF40 "BRE1B, KIAA0661, RBP95, STARING" ENSG00000103549 "Ring finger protein 40" O75150 16 30761745-30776307 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041330, HPA054227" Approved Supported Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 14: REH - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA041330: AB_10793872, HPA054227: AB_2682422" "unprognostic (1.61e-1)" "unprognostic (1.74e-2)" "unprognostic (3.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.21e-1)" "unprognostic (4.01e-1)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-2)" "prognostic favorable (8.11e-8)" "unprognostic (9.96e-2)" "unprognostic (1.36e-1)" "unprognostic (6.55e-3)" "unprognostic (6.60e-3)" 24.4 28.7 23.4 26.7 25.9 55.3 21.5 25.5 24.8 26.7 26.2 26.0 24.9 29.3 15.5 31.8 25.4 26.0 16.3 25.8 22.4 19.9 20.9 22.5 26.9 25.9 24.3 35.2 29.8 35.2 21.7 21.4 23.0 22.6 17.6 18.1 33.7 22.5 17.5 27.4 24.7 21.5 22.3 24.7 23.4 38.0 26.1 24.6 29.0 16.0 22.3 21.4 22.7 28.8 58.5 87.9 53.0 52.7 41.9 43.3 58.6 58.7 47.4 66.8 52.4 72.4 53.7 46.5 82.9 50.5 45.5 62.1 99.2 55.5 53.0 66.7 120.9 45.2 99.9 77.2 53.3 79.8 54.0 41.3 43.5 83.3 48.8 44.2 57.7 40.6 101.3 46.1 42.5 98.3 76.4 74.4 55.6 47.7 55.4 149.9 58.8 91.6 29.8 52.0 89.9 65.0 45.0 58.7 41.8 27.9 88.9 88.5 60.8 74.6 37.4 53.8 67.7 66.1 87.2 93.0 62.3 70.6 77.1 6.5 13.6 17.1 13.1 14.1 13.1 8.1 7.1 10.0 13.9 5.9 5.3 8.8 16.1 11.1 17.1 6.6 6.7 16.2 23.4 25.9 25.5 24.8 25.8 22.4 25.9 24.3 23.0 22.3 26.1 28.8 13.5 12.8 24.9 18.3 17.2 13.9 12.3 10.2 16.5 12.8 18.9 15.6 3.2 28.6 11.5 22.0 4.2 16.0 20.7 27.7 88.0 15.2 23.7 24.7 20.8 14.9 13.9 37.4 10.3 13.3 16.9 14.5 26.0 29.2 4.5 19.3 10.8 22.9 21.5 5.0 11.2 23.2 10.2 23.0 12.6 22.0 18.0 16.9 17.8 4.7 16.7 16.5 11.3 13.0 8.7 16.3 15.4 17.7 21.8 15.8 24.2 26.5 12.4 13.7 13.1 15.8 13.3 27.1 11.3 20.6 19.7 22.7 16.0 22.2 25.8 11.2 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 90.9;skeletal muscle: 38.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 26.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: AB_2680965, HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 8.1 10.2 2.6 9.2 3.4 90.9 5.6 1.1 7.6 5.6 2.4 4.9 6.0 7.4 3.6 8.5 7.3 7.2 11.4 3.2 2.7 6.8 5.7 6.7 6.7 4.3 4.4 6.1 16.0 9.3 10.2 4.3 4.1 6.3 3.8 3.4 8.3 4.0 38.5 10.3 4.7 6.0 0.2 7.6 6.3 10.9 3.7 4.7 5.5 9.7 6.1 9.3 5.7 4.6 38.9 50.8 13.2 28.6 10.0 11.6 28.9 24.2 14.4 24.2 18.7 55.6 35.0 42.3 30.4 15.1 21.6 48.7 36.3 28.0 16.3 23.1 44.2 32.8 19.5 43.6 16.5 51.7 41.5 12.2 38.6 59.9 54.6 27.0 13.7 23.5 47.7 27.4 14.0 50.8 35.0 33.0 57.0 20.4 34.0 38.1 18.0 42.1 16.8 21.4 17.7 37.9 19.2 18.1 24.1 10.4 43.7 26.5 18.2 16.1 27.9 36.5 76.4 55.7 52.7 48.6 23.2 64.9 17.9 0.4 11.2 6.9 2.7 13.6 3.3 3.9 1.6 2.2 6.2 4.2 2.5 2.8 26.7 1.9 16.9 5.0 1.2 6.0 2.6 3.4 1.1 7.6 3.2 2.7 4.3 4.4 4.1 0.2 3.7 4.6 8.8 35.3 31.1 5.9 18.5 23.5 14.2 5.1 25.0 5.8 12.7 9.9 11.6 7.2 21.5 14.7 41.7 5.2 7.7 10.6 0.0 8.7 7.2 17.1 10.6 10.6 21.5 7.2 15.1 8.7 7.5 13.5 27.0 20.1 41.7 12.9 3.9 8.9 11.5 5.0 9.5 13.8 4.1 12.5 7.1 4.8 3.7 30.3 7.2 2.8 12.3 1.9 3.1 5.0 4.4 8.5 6.4 2.6 31.8 17.1 3.7 6.8 24.6 12.7 0.0 19.4 6.7 10.6 20.6 22.7 19.6 9.2 11.0 13.5 11.5 13.6 S100A12 "CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6" ENSG00000163221 "S100 calcium binding protein A12" P80511 1 153373711-153375621 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3489.7" "Group enriched" "Detected in many" 20 "Kupffer cells: 711.7;Macrophages: 475.0;monocytes: 998.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 51.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "classical monocyte: 1321.1;neutrophil: 1781.4" "Group enriched" "Detected in many" 13 "granulocytes: 1781.4;monocytes: 1321.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.6;THP-1: 1.6" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "HPA002881, CAB025872" Enhanced "Secreted to blood" NA NA 28500000 8300000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "CAB025872: , HPA002881: AB_1848175" "unprognostic (1.33e-1)" "unprognostic (4.51e-2)" "unprognostic (7.49e-2)" "unprognostic (1.36e-1)" "unprognostic (7.30e-2)" "unprognostic (4.36e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-3)" "unprognostic (9.04e-2)" "unprognostic (3.14e-2)" "unprognostic (1.58e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (5.03e-4)" "unprognostic (3.68e-3)" "unprognostic (1.05e-1)" "unprognostic (1.31e-2)" "unprognostic (7.70e-2)" 54.9 3.2 2.6 82.0 3.1 3489.7 7.0 2.9 7.7 21.9 3.2 5.5 1.7 2.1 0.0 52.4 19.3 6.7 16.6 2.7 2.6 15.2 25.6 148.4 1.9 3.2 2.9 2.1 3.6 1.3 4.3 19.8 3.9 3.5 0.4 0.3 11.4 0.2 4.0 3.7 4.4 40.4 3.0 523.2 8.9 0.9 2.9 30.2 6.0 14.8 46.5 41.9 33.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 1321.1 5.2 1.9 44.9 1.0 3.2 0.8 1.5 122.7 1.0 1.1 0.5 1781.4 0.4 9.6 8.3 2.0 1031.8 2.6 3.1 2.9 7.7 2.7 2.6 3.2 2.9 3.9 3.0 2.9 2.9 0.0 19.2 24.4 0.0 6.1 0.1 0.3 9.8 0.0 0.0 0.1 0.0 1.1 8.6 9.2 1.8 0.0 0.5 2.9 0.0 0.0 0.1 1.4 0.0 0.0 2.1 0.0 14.1 0.1 0.2 0.9 4.1 1.1 0.0 13.9 0.0 6.8 3.8 8.6 0.0 0.1 0.0 0.0 711.7 0.8 1.8 0.0 475.0 0.0 1.0 998.3 0.0 36.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 7.8 0.0 0.0 0.8 0.4 0.0 0.2 5.7 0.0 0.5 6.9 0.0 0.1 0.2 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "bone marrow: 74.7" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.3;eosinophil: 1.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-937: 104.1" "Not detected" "Not detected" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol NA NA 59000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: AB_2684072" "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 0.3 0.1 0.1 0.1 0.2 74.7 0.0 0.5 0.4 0.3 0.1 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 1.2 0.1 0.1 0.1 0.7 0.1 0.0 0.3 0.9 0.0 0.0 0.6 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.7 0.1 1.5 0.1 0.0 0.0 0.1 0.1 104.1 0.1 0.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.5 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 4.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.2 SHLD3 "AC008560.1, CTC-534A2.2, FLJ26957, RINN1" ENSG00000253251 "Shieldin complex subunit 3" Q6ZNX1 5 65625027-65630928 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 17.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 2.3 2.7 2.4 2.7 2.5 17.5 4.2 2.8 3.6 1.8 1.8 2.8 2.8 2.3 3.1 1.5 1.9 2.4 1.8 2.3 2.1 2.9 2.6 2.5 4.8 2.4 2.1 1.5 3.4 2.1 2.5 2.5 2.3 4.3 3.0 3.7 2.0 2.5 1.8 2.9 2.7 1.7 2.4 2.5 2.4 3.2 2.4 3.9 2.4 1.9 3.6 2.5 1.3 3.2 2.6 3.6 5.0 10.8 2.9 3.5 6.3 3.8 3.5 5.8 7.0 5.9 8.0 4.9 4.2 4.6 6.5 3.1 5.1 4.7 8.5 6.7 6.5 4.3 10.3 8.3 2.5 5.0 7.5 2.1 6.8 6.0 6.1 1.6 3.7 7.7 6.4 11.5 4.7 6.9 6.7 7.7 4.0 1.5 2.2 4.4 4.9 7.9 4.9 6.0 6.7 5.5 3.2 3.3 11.0 3.4 3.8 4.6 3.0 5.0 6.8 4.1 6.6 7.2 14.3 10.7 3.7 6.1 4.7 15.9 3.0 6.4 3.8 2.9 4.0 3.9 4.5 4.0 2.8 3.1 6.1 5.6 3.3 4.9 3.1 3.2 6.2 2.1 2.4 2.5 2.8 3.6 2.3 2.1 2.4 2.1 2.3 2.4 2.4 3.2 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 3.6 0.0 0.0 0.0 0.0 0.0 4.0 5.9 0.0 3.9 3.1 0.0 1.9 1.8 0.8 0.0 0.0 0.0 2.9 3.8 0.9 0.0 2.1 0.0 2.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.1 1.8 2.1 0.0 0.0 SLC22A4 "DFNB60, MGC34546, OCTN1" ENSG00000197208 "Solute carrier family 22 member 4" Q9H015 5 132294394-132344190 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 57.0;Proximal enterocytes: 25.6;Respiratory ciliated cells: 78.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 36.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.1;U-138 MG: 24.4" "Region enhanced" "Detected in all" "cerebellum: 64.5" "Low region specificity" "Detected in all" "CAB015468, HPA036974" Approved Approved Mitochondria NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "CAB015468: , HPA036974: AB_2732474" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (8.42e-3)" "unprognostic (6.17e-2)" "unprognostic (6.22e-3)" "unprognostic (4.17e-3)" "unprognostic (3.33e-1)" "unprognostic (1.30e-1)" "unprognostic (9.79e-2)" "unprognostic (1.95e-3)" "unprognostic (7.82e-2)" "unprognostic (1.74e-2)" "unprognostic (2.31e-3)" "unprognostic (1.20e-1)" "unprognostic (1.95e-2)" "unprognostic (4.06e-2)" 1.9 3.0 2.1 2.9 1.9 20.7 2.2 3.7 1.8 1.5 1.1 2.0 3.5 1.4 1.4 0.4 11.3 1.9 1.9 1.9 3.6 7.1 0.8 2.9 0.3 4.0 3.7 2.1 0.6 2.6 2.6 1.0 3.4 4.0 2.2 2.2 1.7 1.4 7.2 1.3 9.1 1.0 3.6 5.1 1.4 0.6 3.4 0.4 0.7 2.7 0.2 1.4 0.9 2.9 1.9 3.0 0.2 0.7 1.3 1.0 0.9 12.9 59.1 9.7 10.1 1.1 3.3 0.6 3.6 7.6 7.2 3.2 0.0 2.1 6.8 2.6 0.3 0.1 5.6 0.2 1.0 4.1 0.0 2.3 0.4 5.3 4.9 3.5 4.3 0.3 5.3 6.7 7.6 1.1 0.0 9.5 0.3 0.3 3.2 0.0 0.8 0.4 1.5 0.2 0.8 0.4 14.0 0.9 0.4 0.4 0.6 2.4 5.2 24.4 2.4 9.7 3.3 0.0 2.7 0.0 7.2 4.7 2.9 0.0 5.6 5.8 0.0 1.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 36.2 0.0 0.4 0.3 0.0 1.2 2.1 1.9 3.7 1.8 1.9 3.6 4.0 3.7 3.4 3.6 3.4 2.9 1.1 3.2 0.0 5.5 0.1 0.8 1.0 3.8 1.8 2.0 1.9 1.3 0.8 1.5 10.0 0.0 0.0 1.0 0.1 8.8 0.0 3.2 0.0 4.7 1.8 3.8 1.2 57.0 7.2 0.4 2.3 3.1 0.5 2.2 0.0 0.6 1.4 0.0 4.0 3.3 8.0 0.8 4.1 0.8 0.8 0.3 0.6 3.7 0.0 1.9 2.2 1.6 0.0 4.5 2.3 1.9 1.7 0.0 0.1 1.7 25.6 8.6 78.5 0.4 0.0 9.3 1.8 0.3 0.4 0.2 0.4 2.5 0.2 0.1 1.0 0.9 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528956-23575463 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 138.4" "Cell type enhanced" "Detected in all" "Early spermatids: 707.8;Erythroid cells: 4197.2;Late spermatids: 1087.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 19 "neutrophil: 57.7" "Lineage enriched" "Detected in all" 19 "granulocytes: 57.7" "Cell line enhanced" "Detected in all" "HEL: 118.7;hTERT-RPE1: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria Cytosol "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 14.5 41.9 13.5 16.5 16.9 138.4 17.9 13.4 21.0 26.8 15.2 11.4 50.6 9.8 6.0 9.9 17.2 6.7 15.3 13.4 14.0 20.1 25.2 26.4 6.0 15.0 14.1 23.0 29.5 10.9 15.0 8.0 15.4 35.5 5.7 10.3 36.7 7.5 16.2 10.1 21.8 5.7 13.0 46.1 11.1 6.8 15.0 2.8 14.6 12.7 5.0 13.4 20.4 14.6 9.6 10.3 10.7 9.9 13.7 16.8 15.7 7.4 9.6 5.3 5.9 10.4 19.9 15.3 8.7 6.3 34.5 12.0 9.9 20.0 7.2 2.3 4.9 118.7 19.4 3.7 11.5 6.7 4.4 14.5 19.2 11.6 11.5 65.9 8.4 12.3 26.3 7.5 8.5 4.2 8.1 28.1 5.4 11.6 7.5 8.3 5.3 6.0 16.4 5.2 3.2 4.6 10.1 15.2 7.6 10.0 4.4 10.3 13.3 25.6 3.8 15.3 14.5 5.9 2.4 9.4 24.1 16.1 16.5 1.4 3.0 2.7 1.1 1.1 0.9 2.3 0.6 0.5 2.8 1.5 2.1 1.2 57.7 1.3 1.5 0.6 1.3 1.4 13.5 16.9 13.4 21.0 13.4 14.0 15.0 14.1 15.4 13.0 15.0 14.6 43.5 38.5 61.7 36.6 45.5 93.3 125.2 95.8 28.5 35.6 120.0 49.1 35.6 61.5 75.8 77.3 68.8 44.6 19.1 78.4 15.6 93.8 707.8 33.1 68.6 94.5 20.4 4197.2 44.0 226.4 76.4 95.4 43.8 50.0 36.8 49.7 151.3 38.8 41.7 6.7 37.3 44.7 36.7 59.0 141.2 1087.9 52.5 86.8 69.4 73.1 45.5 30.5 10.3 16.1 21.9 176.9 47.7 37.2 24.0 347.1 189.0 34.1 42.5 59.7 19.7 55.9 52.3 24.6 42.3 23.3 53.8 18.3 32.4 86.7 70.3 137.6 SLC4A1 "AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR" ENSG00000004939 "Solute carrier family 4 member 1 (Diego blood group)" P02730 17 44248390-44268141 "Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Blood group antigen" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "bone marrow: 407.2" "Cell type enriched" "Detected in some" 80 "Erythroid cells: 1629.2" "Cancer enriched" "Detected in single" 91 "renal cancer: 16.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 3.0;neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "K-562: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015584, CAB034438, HPA063911" Enhanced NA NA 22000000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-2)" "unprognostic (2.32e-2)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (6.72e-3)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (1.93e-2)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (2.13e-1)" 0.5 0.3 0.7 0.3 0.7 407.2 0.2 2.2 1.4 0.1 1.7 0.2 0.3 0.1 0.3 0.3 0.1 0.3 0.9 0.6 0.5 72.1 2.2 1.8 0.4 0.8 0.6 0.1 0.2 0.0 0.6 10.9 0.9 0.1 0.1 0.7 0.4 0.1 2.2 0.5 0.2 0.0 0.3 12.8 0.3 0.3 1.1 0.7 0.3 1.5 0.1 0.1 0.1 1.7 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.4 0.4 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.6 0.0 0.3 0.1 0.1 0.4 0.2 0.3 0.3 0.1 0.1 0.6 0.6 0.1 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.4 0.5 0.2 3.0 0.3 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 2.7 1.1 0.4 0.3 0.1 0.2 0.7 0.7 2.2 1.4 0.6 0.5 0.8 0.6 0.9 0.3 1.1 1.7 0.8 6.4 0.6 0.3 2.0 0.0 1.3 0.0 0.0 0.4 1.0 1.1 0.7 0.0 0.6 20.2 0.0 0.4 0.1 0.2 3.9 0.1 0.8 0.2 0.4 0.7 0.0 1629.2 0.2 0.0 1.6 0.5 0.0 0.5 0.0 0.1 0.7 0.9 1.4 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 1.9 0.0 1.0 0.6 0.2 2.1 0.0 0.0 0.0 0.0 0.4 0.3 0.9 0.2 0.4 0.0 0.2 0.0 1.2 0.2 0.7 0.5 0.0 0.0 0.8 1.5 0.7 0.1 0.6 SLC9A8 "KIAA0939, NHE8" ENSG00000197818 "Solute carrier family 9 member A8" Q9Y2E8 20 49812713-49892242 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "SK-BR-3: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033682 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB033682: AB_2270441" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (6.11e-2)" "unprognostic (2.73e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-2)" "unprognostic (4.49e-2)" "unprognostic (3.22e-1)" "unprognostic (3.96e-2)" "unprognostic (5.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.19e-2)" "unprognostic (1.96e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (5.28e-2)" 5.3 6.8 3.9 7.0 3.7 20.3 4.5 3.0 3.4 4.4 2.0 5.4 5.7 4.2 3.9 8.6 4.8 4.8 3.8 3.5 4.5 3.9 6.4 5.5 6.7 5.4 4.4 3.9 5.6 5.5 5.0 3.7 4.0 5.0 5.0 4.0 6.5 4.2 11.4 4.2 5.7 3.3 4.1 8.1 7.6 6.7 5.0 6.8 6.5 4.8 5.8 5.4 4.4 3.9 5.7 10.3 4.5 4.5 5.6 3.5 11.4 5.8 7.8 10.8 5.1 7.3 12.7 6.8 7.3 8.3 8.9 12.5 4.8 5.9 5.5 6.0 2.7 3.4 7.1 3.8 7.8 6.1 8.0 6.7 6.6 5.7 11.5 5.6 4.7 8.9 6.7 6.9 6.7 6.3 5.6 4.1 3.7 8.6 4.8 4.1 5.3 4.9 6.4 6.1 4.5 3.9 9.6 35.3 7.0 3.0 11.5 9.8 7.1 14.7 8.1 7.2 5.7 10.5 4.9 4.9 20.1 8.0 6.2 1.9 0.6 1.6 0.9 0.4 0.9 0.7 0.7 0.8 0.6 0.8 0.7 0.4 2.9 0.4 0.7 0.3 0.5 0.7 3.9 3.7 3.0 3.4 3.5 4.5 5.4 4.4 4.0 4.1 5.0 3.9 6.3 12.8 8.8 24.5 9.9 2.5 4.4 9.2 4.0 5.7 5.7 5.0 4.9 7.2 14.8 3.7 14.6 6.1 10.6 17.9 1.9 7.1 2.7 12.3 6.5 5.4 6.7 9.3 13.8 6.4 4.1 5.1 19.4 18.7 22.2 7.0 8.6 15.5 5.1 6.7 20.0 7.0 6.1 9.2 4.1 8.4 3.7 11.8 1.8 19.7 5.8 5.7 5.2 15.1 25.3 9.4 9.0 4.9 8.0 5.2 7.6 3.4 21.5 9.6 0.0 5.9 5.2 8.9 6.7 10.2 1.8 3.4 9.8 4.7 7.3 9.4 SLFN14 ENSG00000236320 "Schlafen family member 14" P0C7P3 17 35543985-35560819 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "bone marrow: 3.9" "Group enriched" "Detected in some" 41 "Erythroid cells: 16.8;Macrophages: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA022994, HPA023065" Uncertain NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "HPA022994: AB_10670035, HPA023065: AB_2671055" "unprognostic (4.27e-3)" "unprognostic (4.72e-4)" "unprognostic (1.21e-1)" "unprognostic (6.43e-2)" "unprognostic (1.07e-3)" "unprognostic (6.50e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-1)" "unprognostic (5.33e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-1)" "unprognostic (7.59e-8)" "unprognostic (1.21e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-1)" "unprognostic (1.13e-3)" 0.0 0.0 0.1 0.3 0.1 3.9 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 18.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SON "BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP" ENSG00000159140 "SON DNA and RNA binding protein" P18583 21 33543038-33577481 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, mRNA processing, mRNA splicing" "DNA-binding, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023535, HPA031755, HPA031756" Supported Enhanced "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear speckles" "HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030" "unprognostic (1.58e-2)" "unprognostic (2.08e-1)" "unprognostic (4.69e-1)" "unprognostic (2.30e-1)" "unprognostic (5.63e-2)" "unprognostic (2.75e-1)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (2.02e-1)" "unprognostic (1.24e-1)" "unprognostic (9.75e-2)" "unprognostic (4.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.19e-1)" "unprognostic (2.54e-1)" 69.1 62.5 45.6 57.8 52.1 161.9 65.0 56.4 58.6 59.4 71.9 64.1 44.9 66.9 61.5 60.7 68.5 43.2 60.3 43.7 45.7 49.4 60.3 65.2 81.0 49.8 46.8 76.7 63.4 92.8 63.9 60.9 51.3 61.2 56.4 91.8 64.3 52.6 89.4 64.1 67.8 51.1 47.6 71.5 66.8 48.0 47.8 92.8 64.4 53.8 76.2 62.9 55.9 65.8 105.7 59.7 126.1 72.7 108.1 98.3 89.2 77.2 88.1 73.0 69.6 89.5 75.2 163.8 45.9 114.8 86.6 76.4 152.4 113.0 109.7 85.4 77.9 220.0 78.2 111.3 79.3 215.0 110.8 100.6 128.7 88.0 124.5 91.3 110.1 91.2 172.9 150.9 101.1 101.6 121.0 112.9 136.0 108.5 60.7 121.5 133.8 118.1 109.7 102.1 84.1 77.6 124.2 100.3 91.3 103.6 93.6 128.3 116.0 83.4 73.1 66.6 87.0 144.8 143.2 193.9 84.7 172.3 78.9 33.7 20.3 28.7 20.7 18.4 20.8 30.4 22.9 22.1 15.8 28.2 22.7 22.3 37.4 22.3 24.5 38.5 22.1 15.8 45.6 52.1 56.4 58.6 43.7 45.7 49.8 46.8 51.3 47.6 47.8 65.8 374.1 410.3 298.2 201.4 355.2 433.1 312.2 310.6 250.4 389.7 213.1 219.2 351.5 320.3 298.0 301.6 221.0 224.1 423.2 276.8 193.7 209.7 97.0 296.9 412.2 342.1 186.8 375.8 93.1 207.3 164.7 333.4 208.0 335.8 418.2 216.1 304.8 344.6 170.1 455.9 105.8 256.0 219.7 237.2 307.4 66.0 393.9 261.0 218.7 146.1 256.8 335.7 347.1 131.7 162.3 190.0 217.2 393.4 294.4 250.7 198.0 225.7 288.3 372.0 381.3 505.0 399.2 470.1 334.6 197.8 394.2 327.1 378.2 183.2 246.3 226.5 SPNS3 "MGC29671, SLC62A3" ENSG00000182557 "Sphingolipid transporter 3 (putative)" Q6ZMD2 17 4433940-4488208 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "bone marrow: 31.2" "Cell type enhanced" "Detected in many" "dendritic cells: 30.9;Langerhans cells: 16.4;Proximal tubular cells: 51.8;T-cells: 23.7" "Cancer enhanced" "Detected in many" "renal cancer: 2.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "eosinophil: 354.8;plasmacytoid DC: 127.7" "Group enriched" "Detected in many" 37 "dendritic cells: 127.7;granulocytes: 354.8" "Group enriched" "Detected in some" 4 "JURKAT: 29.5;NB-4: 46.8;THP-1: 35.5;U-937: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023928 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA023928: AB_1844393" "unprognostic (4.39e-2)" "unprognostic (8.10e-5)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.94e-4)" "unprognostic (2.86e-2)" "unprognostic (1.96e-2)" "unprognostic (1.81e-2)" "unprognostic (6.46e-2)" "unprognostic (1.37e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (6.18e-2)" "unprognostic (6.57e-2)" "unprognostic (4.13e-2)" "unprognostic (9.69e-2)" 0.1 0.1 0.3 1.4 0.2 31.2 0.3 0.4 0.4 0.2 0.0 0.2 0.4 0.0 0.0 0.1 0.7 0.7 0.2 0.2 0.7 0.2 0.1 0.2 2.0 0.8 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.7 0.1 0.6 2.1 0.3 0.0 0.5 3.6 0.0 0.0 1.1 0.3 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 2.4 0.0 0.0 8.1 46.8 0.0 0.2 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 6.6 0.0 22.1 0.0 0.3 6.5 354.8 1.1 1.3 0.7 0.2 0.0 1.5 47.6 0.3 0.4 1.7 1.0 0.2 0.1 127.7 0.0 6.2 0.3 0.2 0.4 0.4 0.2 0.7 0.8 0.4 0.5 0.6 0.5 0.7 0.5 3.2 1.1 0.0 4.3 1.3 0.1 0.4 0.0 0.0 1.0 0.8 0.8 1.5 1.6 0.0 0.0 0.3 30.9 0.5 3.9 2.0 1.1 0.8 0.0 0.6 0.0 4.8 0.9 0.0 6.1 0.3 2.0 0.1 0.0 0.0 0.7 0.3 1.4 0.0 0.8 2.1 6.1 5.5 16.4 2.6 0.0 9.8 1.8 3.7 6.7 0.0 11.3 0.0 0.1 1.1 1.4 0.0 0.6 0.5 10.9 51.8 5.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.4 0.3 23.7 0.0 2.5 2.1 SPTA1 EL2 ENSG00000163554 "Spectrin alpha, erythrocytic 1" P02549 1 158610704-158686715 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin capping, Actin-binding" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "bone marrow: 75.7" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 255.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "K-562: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016193, HPA028048, HPA028253, CAB037246" Enhanced NA NA 11000000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.99e-1)" "unprognostic (1.34e-1)" "unprognostic (3.65e-3)" "unprognostic (1.50e-3)" "unprognostic (9.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-1)" "unprognostic (9.09e-2)" "unprognostic (6.73e-8)" "unprognostic (6.08e-2)" "unprognostic (6.33e-2)" "unprognostic (1.76e-2)" "unprognostic (5.85e-3)" 0.1 0.0 0.0 0.0 0.0 75.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 8.7 0.0 0.0 0.3 0.0 255.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606403-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 7.5 8.7 2.3 8.6 2.4 34.3 10.0 3.6 5.9 10.6 4.3 7.8 7.0 7.6 5.6 8.1 6.6 10.1 4.9 3.0 2.7 8.9 10.3 7.3 8.2 2.3 2.9 9.7 7.8 8.1 4.0 8.7 2.4 8.7 8.2 4.5 9.4 5.6 7.9 7.4 6.5 7.8 2.4 7.3 7.5 4.2 2.7 8.5 10.0 7.5 9.6 9.4 5.3 3.1 11.8 11.2 9.0 12.7 14.3 15.1 13.5 17.3 18.9 14.2 16.8 10.4 5.2 27.0 9.3 16.3 11.0 12.1 15.3 13.4 20.5 14.1 14.0 10.6 6.4 9.5 14.1 22.6 20.4 12.7 13.6 9.3 17.8 10.1 15.3 15.8 15.3 41.7 15.9 12.2 15.5 9.3 8.5 22.8 12.6 14.2 25.1 11.4 14.9 16.9 8.8 12.3 15.1 17.8 12.3 11.7 11.0 9.6 13.7 13.7 11.7 27.1 10.8 14.3 19.0 21.0 16.4 12.6 11.8 4.7 1.9 2.9 2.7 2.9 4.1 1.2 2.6 2.8 1.7 1.1 2.4 2.6 2.2 3.7 2.8 1.4 3.1 1.8 2.3 2.4 3.6 5.9 3.0 2.7 2.3 2.9 2.4 2.4 2.7 3.1 42.3 25.6 47.7 5.2 38.0 55.8 19.6 17.1 32.5 13.7 55.0 39.5 21.6 18.6 29.9 27.6 10.4 14.3 75.3 31.7 17.6 25.3 2.4 47.4 53.8 29.1 44.3 15.4 9.9 24.9 26.5 35.3 40.2 74.1 57.7 20.5 22.9 28.5 16.3 11.8 9.6 39.4 24.4 33.4 49.6 3.2 19.0 44.3 16.0 15.0 24.4 12.4 49.4 9.0 8.9 27.7 29.8 13.9 83.6 28.0 21.0 17.4 47.5 11.4 32.9 42.9 28.2 14.2 17.3 41.6 66.3 27.5 69.7 27.1 24.4 29.2 SRGN "PPG, PRG, PRG1" ENSG00000122862 Serglycin P10124 10 69088103-69104805 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Biomineralization" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 8096.7" "Cell type enhanced" "Detected in many" "dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 5714.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 5714.1" "Cell line enhanced" "Detected in many" "HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000759 Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 100000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA000759: AB_1079675" "unprognostic (3.61e-2)" "unprognostic (1.62e-2)" "unprognostic (2.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (4.50e-2)" "unprognostic (1.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.63e-1)" "unprognostic (8.22e-2)" "unprognostic (5.80e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.65e-1)" "unprognostic (2.32e-2)" "unprognostic (4.07e-2)" "unprognostic (4.08e-2)" 404.6 114.9 48.8 799.8 50.5 8096.7 136.4 55.5 99.6 93.2 70.1 101.8 77.9 63.5 25.9 91.0 96.8 316.4 111.9 48.2 67.8 98.3 239.4 347.3 437.2 82.4 59.3 30.7 68.4 131.6 62.1 355.6 67.8 58.9 118.9 15.5 40.1 57.4 37.5 18.9 111.4 219.4 65.5 362.8 95.0 18.3 64.7 228.9 72.7 117.1 314.6 508.3 46.1 71.0 5.3 43.0 0.2 0.4 768.1 749.7 1.2 94.9 63.9 235.1 283.5 0.1 18.2 9.1 117.4 4.1 134.4 1.1 0.0 20.6 799.9 535.7 0.4 87.1 29.8 0.3 312.7 4442.1 914.9 306.8 1.1 641.5 39.2 223.8 1227.8 13.3 82.5 419.9 1239.9 0.2 18.7 2549.7 0.7 0.1 84.6 2.4 2.3 446.7 0.6 6.0 0.3 0.8 2.3 0.6 16.0 0.0 2.2 4346.8 2609.1 187.9 12.9 3.8 20.1 486.4 508.4 57.3 112.2 3546.9 1.2 2349.8 1105.3 2730.6 474.9 774.6 313.4 73.5 228.5 362.8 583.0 39.0 125.5 268.4 5714.1 962.8 693.6 631.9 392.6 1590.5 48.8 50.5 55.5 99.6 48.2 67.8 82.4 59.3 67.8 65.5 64.7 71.0 1081.4 112.2 198.1 0.7 592.0 175.9 12.5 38.3 8.6 1.1 16.0 28.2 21.2 21.5 57.5 33.1 0.0 10.2 2922.2 2.9 0.0 4.2 4.1 4.6 15.0 566.8 1.8 277.8 0.2 9.8 10.2 87.9 70.3 6.6 2343.1 0.4 636.1 22.1 847.1 0.0 0.5 1.7 0.0 1789.9 6618.2 8.4 7.5 3639.1 556.7 80.6 3188.2 1.4 1292.5 0.0 0.2 1.3 1.2 18.0 1740.9 12.2 0.3 4.7 45.6 5.0 72.3 22.8 97.5 0.9 2.2 8.7 141.8 14.2 2235.9 1.2 5.5 18.1 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133583-196176503 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 376.2;lymphoid tissue: 113.3" "Cell type enhanced" "Detected in many" "B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1" "Region enriched" "Detected in all" 5 "cerebellum: 63.4" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 28.2 8.9 2.1 67.0 2.9 376.2 21.5 3.7 5.3 24.2 3.3 19.1 27.8 5.4 1.8 11.9 5.8 20.4 4.6 4.1 3.3 6.5 8.5 23.6 113.3 3.1 2.0 2.2 12.7 2.1 3.0 16.7 3.2 10.5 17.5 0.4 17.0 5.7 2.4 11.2 40.1 16.8 2.2 56.9 20.1 9.5 4.0 60.9 7.2 3.5 111.1 24.4 5.2 2.9 11.0 7.5 11.2 4.2 47.7 18.1 12.4 25.7 38.4 27.7 28.5 22.8 3.9 122.3 23.1 14.8 7.3 7.4 4.7 11.1 33.4 21.8 12.7 11.6 9.1 2.2 14.2 47.0 118.9 23.1 10.9 34.3 17.7 39.2 11.5 28.5 9.1 111.6 69.4 5.9 61.6 106.0 6.3 19.9 17.2 10.1 67.5 37.4 16.3 25.6 4.2 4.2 6.6 6.4 5.4 17.2 4.3 24.3 14.0 26.8 13.1 19.3 14.7 45.5 78.9 132.1 20.2 15.9 12.1 165.1 74.3 163.1 43.7 81.3 55.4 49.2 77.0 52.8 53.0 58.6 98.6 82.4 236.7 40.8 113.1 37.7 73.8 89.3 2.1 2.9 3.7 5.3 4.1 3.3 3.1 2.0 3.2 2.2 4.0 2.9 23.3 89.8 74.0 48.3 229.3 59.9 27.1 15.1 10.8 0.9 28.9 15.2 2.6 12.8 42.5 11.0 0.0 7.9 267.7 54.0 3.9 6.6 6.8 15.3 14.1 11.3 3.0 68.8 3.4 2.8 24.0 27.2 38.2 26.5 195.1 47.4 5.3 2.4 26.1 0.0 3.1 13.9 18.3 151.1 201.3 3.6 5.6 198.9 58.7 11.2 158.0 0.6 118.4 17.6 0.7 10.9 41.6 4.5 191.8 34.3 80.7 2.5 26.9 0.3 6.6 49.7 19.7 41.1 26.3 16.4 63.4 5.1 342.5 22.6 13.2 53.8 TAGAP "ARHGAP47, FLJ32631, IDDM21" ENSG00000164691 "T cell activation RhoGTPase activating protein" Q8N103 6 159034468-159045152 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 146.6;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" "B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4" "Low region specificity" "Detected in all" "HPA031000, HPA039982" Uncertain Approved Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" Cytosol "HPA031000: AB_10610560, HPA039982: " "unprognostic (9.86e-3)" "unprognostic (7.55e-2)" "unprognostic (2.41e-2)" "unprognostic (1.56e-2)" "unprognostic (6.36e-2)" "unprognostic (3.10e-3)" "unprognostic (1.04e-1)" "unprognostic (5.25e-2)" "unprognostic (3.35e-3)" "unprognostic (8.39e-2)" "unprognostic (6.19e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (5.24e-2)" "unprognostic (7.39e-2)" 5.0 2.8 1.0 28.9 1.1 146.6 3.9 1.3 2.1 3.4 3.0 5.9 4.4 9.5 2.3 4.1 2.0 6.9 1.6 1.2 3.4 1.3 4.1 8.4 39.6 2.7 2.0 2.2 0.9 0.7 0.8 3.4 2.1 2.8 8.2 1.5 3.0 1.8 0.7 1.2 10.2 26.0 2.2 22.8 7.2 1.6 2.2 24.3 1.6 2.3 47.6 10.0 1.2 4.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 30.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 6.2 0.0 0.0 0.0 15.6 42.5 0.3 0.0 0.0 0.0 0.0 0.0 9.0 0.1 43.8 0.0 0.0 4.0 8.2 12.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 0.3 0.2 0.0 0.1 0.1 1.2 0.0 6.9 0.2 0.0 0.0 0.0 0.0 4.7 20.6 39.6 0.0 33.4 0.0 163.6 27.8 88.4 54.8 20.4 62.6 45.9 73.9 64.6 27.9 46.6 56.9 40.8 169.7 45.6 27.6 9.3 57.5 60.9 1.0 1.1 1.3 2.1 1.2 3.4 2.7 2.0 2.1 2.2 2.2 4.2 5.2 3.2 6.6 0.0 249.5 2.8 0.3 0.2 3.4 0.3 4.4 6.0 0.6 0.0 1.4 0.0 0.0 0.7 152.3 0.2 0.0 0.1 0.3 0.5 0.4 5.2 0.0 8.8 1.2 0.0 0.6 4.3 16.8 0.5 19.0 1.8 1.4 0.8 24.9 0.0 1.0 0.0 0.0 21.9 60.2 1.1 1.2 91.1 28.4 20.6 21.5 0.4 86.5 1.5 0.0 0.0 0.0 22.6 272.1 0.3 0.0 0.3 1.2 0.2 0.0 0.8 2.0 0.1 0.1 2.0 2.7 0.8 223.6 4.6 0.4 0.3 TARM1 ENSG00000248385 "T cell-interacting, activating receptor on myeloid cells 1" B6A8C7 19 54069895-54081365 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "bone marrow: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051022, HPA054401" Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "HPA051022: AB_2681315, HPA054401: AB_2682476" "unprognostic (1.56e-1)" 0.0 0.1 0.4 0.0 0.2 6.9 0.0 0.6 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.2 0.4 0.2 0.6 0.5 0.3 0.1 0.3 0.2 0.4 0.1 0.3 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TENT5A "C6orf37, FAM46A, FLJ20037" ENSG00000112773 "Terminal nucleotidyltransferase 5A" Q96IP4 6 81491439-81752774 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 225.9;salivary gland: 104.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 13.5 21.3 4.3 7.9 4.6 225.9 12.2 9.0 5.8 21.3 9.9 17.2 16.4 10.2 19.7 4.4 12.0 32.3 21.7 4.0 14.0 6.4 35.9 9.1 5.2 7.8 7.1 23.6 8.3 9.4 17.4 18.7 6.1 9.9 16.9 8.7 104.4 24.8 2.1 18.7 22.2 11.1 5.0 9.9 37.8 3.7 6.7 2.9 8.8 5.1 4.3 16.6 8.8 5.3 3.5 5.0 3.3 0.2 67.9 29.8 6.2 27.0 19.2 15.7 23.5 51.0 2.6 0.3 1.0 81.9 10.0 2.9 2.4 4.2 11.5 0.0 6.2 0.1 86.1 8.0 21.2 95.6 7.1 13.2 2.4 12.3 2.1 51.2 2.0 0.8 1.4 0.0 10.6 14.7 0.0 67.2 0.9 29.2 3.8 0.0 28.8 0.1 2.1 6.2 3.3 4.4 12.1 5.2 8.3 9.9 1.2 162.0 4.5 17.9 3.8 7.6 7.6 0.4 0.3 0.3 25.3 72.7 7.8 37.3 29.9 46.3 11.5 29.6 6.8 18.2 4.3 5.7 24.2 21.0 8.1 8.0 13.8 16.9 47.3 8.5 5.6 14.0 4.3 4.6 9.0 5.8 4.0 14.0 7.8 7.1 6.1 5.0 6.7 5.3 22.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 40.8 44.2 0.0 0.0 0.0 5.5 0.0 39.9 43.1 0.0 3.9 30.5 0.0 73.1 70.6 2.9 0.0 0.0 0.0 23.4 115.4 32.7 0.0 176.7 0.0 40.9 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 26.7 0.0 0.0 5.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 162.0 9.4 12.6 0.0 0.0 TKT ENSG00000163931 Transketolase P29401 3 53224712-53256052 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 667.0" "Cell type enhanced" "Detected in all" "Kupffer cells: 696.7;monocytes: 624.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6" "Group enriched" "Detected in all" 9 "dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 150000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 152.2 93.2 78.0 66.2 80.0 667.0 71.9 93.2 82.3 59.7 60.5 73.2 84.2 44.7 19.2 168.5 53.7 97.2 27.4 72.3 96.9 68.2 58.1 93.4 69.2 89.2 89.9 87.7 154.0 41.4 45.6 61.2 93.8 48.8 48.8 21.7 54.9 50.9 12.8 47.0 58.1 51.6 77.4 99.8 66.1 20.2 87.9 82.9 116.1 15.2 67.4 130.9 85.5 97.2 313.0 1542.9 216.0 241.5 470.8 570.8 439.5 206.2 353.8 348.8 330.8 430.1 779.3 388.5 96.8 302.9 673.3 438.3 377.9 775.8 102.4 131.0 210.3 259.6 1022.2 655.2 573.9 321.4 168.1 416.0 437.5 418.5 213.7 949.2 444.9 323.8 188.3 164.7 144.5 381.6 338.6 358.1 737.1 603.0 367.9 201.1 98.5 726.2 550.3 520.2 139.6 103.7 383.4 605.3 365.1 656.7 188.8 437.4 335.9 107.2 164.2 320.0 401.9 94.5 190.3 235.7 234.4 321.0 203.8 51.5 447.9 274.4 17.8 199.0 22.8 39.7 25.8 20.6 203.8 21.1 26.6 20.7 375.3 30.8 242.6 34.4 36.7 312.4 78.0 80.0 93.2 82.3 72.3 96.9 89.2 89.9 93.8 77.4 87.9 97.2 79.5 134.6 125.6 46.7 92.1 79.4 384.6 325.3 287.4 41.0 99.3 80.5 14.9 75.8 149.5 62.5 29.2 349.0 69.7 139.1 80.3 197.7 6.5 87.4 79.6 81.8 52.6 150.3 16.9 269.8 249.8 80.2 168.7 95.5 62.7 123.6 75.0 83.4 256.0 37.0 23.9 149.6 142.4 696.7 110.5 8.9 157.2 333.3 76.5 17.8 624.4 88.8 46.4 17.1 39.3 193.6 81.4 106.8 109.4 337.7 141.5 219.1 99.2 46.3 52.6 35.9 102.1 16.8 30.6 409.3 67.1 413.6 78.8 427.2 276.7 413.6 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33097146 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.5" "Cell type enhanced" "Detected in some" "Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 0.6 0.5 0.8 1.4 0.7 5.5 0.6 0.7 1.2 0.6 4.3 1.0 1.2 0.5 0.6 0.6 0.9 0.6 0.4 1.5 0.5 1.0 0.6 1.1 1.1 1.4 1.4 0.6 0.7 1.9 0.3 1.2 1.6 0.5 1.2 2.8 0.7 0.6 0.2 1.1 1.1 0.8 0.2 1.5 1.3 0.3 1.7 0.5 1.0 0.3 1.3 0.8 0.4 0.2 1.4 1.9 1.0 1.7 1.2 1.0 27.2 0.6 1.0 1.6 0.9 2.7 3.8 0.8 1.2 1.7 0.9 1.4 1.7 1.5 2.6 4.2 0.6 3.4 1.9 2.1 0.9 3.0 4.7 1.1 1.2 2.0 1.4 0.8 1.9 1.7 2.6 2.9 1.2 1.3 1.2 1.3 1.0 0.4 1.1 1.5 0.6 1.9 1.5 1.9 0.2 0.6 0.9 2.6 0.6 1.3 1.4 4.2 2.7 2.4 3.0 1.3 2.6 2.3 1.6 0.4 3.0 2.2 1.7 0.0 1.1 0.3 0.1 2.4 0.6 0.3 0.2 0.0 1.0 0.1 0.0 0.0 1.9 0.0 1.1 0.2 0.2 0.4 0.8 0.7 0.7 1.2 1.5 0.5 1.4 1.4 1.6 0.2 1.7 0.2 0.3 0.0 1.3 0.0 0.8 0.8 0.1 0.0 0.0 1.2 0.4 0.4 0.4 0.0 0.2 0.0 0.0 1.1 1.9 1.4 0.0 0.4 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.8 1.7 0.3 0.0 1.1 0.0 0.4 0.4 0.6 0.9 1.7 0.0 0.2 2.0 1.3 1.2 0.0 0.0 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.5 1.4 0.4 1.0 0.2 1.4 0.3 0.4 2.2 0.0 0.2 0.7 0.0 0.0 1.5 0.9 0.4 0.6 0.5 0.6 0.2 TRGJP1 "JP1, TCRGJP1" ENSG00000211692 "T cell receptor gamma joining P1" 7 38276259-38276318 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "bone marrow: 271.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "NK-cell: 1153.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 1153.0" "Group enriched" "Detected in some" 5 "HL-60: 282.5;U-937: 715.8" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" 3.1 0.0 9.8 7.3 11.1 271.5 4.2 9.8 24.0 4.1 7.2 1.1 5.3 0.3 0.0 0.6 2.1 1.3 0.6 9.1 9.4 0.7 1.7 10.2 8.8 12.1 10.8 0.0 0.0 0.0 0.0 3.9 12.3 1.8 4.3 0.0 0.0 0.0 3.9 0.0 2.0 1.2 9.3 27.9 1.1 0.7 11.3 13.6 0.0 0.0 4.5 1.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 282.5 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 715.8 0.0 13.4 0.4 4.4 241.1 0.9 169.1 0.2 16.2 80.9 0.0 0.7 9.3 44.1 4.2 1153.0 0.1 2.8 0.0 58.9 9.8 11.1 9.8 24.0 9.1 9.4 12.1 10.8 12.3 9.3 11.3 10.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430358-125438403 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 365.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 242.7;Distal enterocytes: 281.6;Endometrial stromal cells: 240.1;Plasma cells: 283.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 9.9;neutrophil: 4.7;non-classical monocyte: 3.5;T-reg: 2.8" "Group enriched" "Detected in many" 12 "granulocytes: 9.9;monocytes: 3.5;T-cells: 2.8" "Cell line enhanced" "Detected in many" "HEL: 193.9;U-266/70: 114.2;U-266/84: 123.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA063982: AB_2685165" "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 82.5 25.5 7.5 40.9 9.0 365.5 28.0 12.1 16.2 35.9 7.0 45.1 20.4 25.5 13.6 33.5 15.7 80.2 18.3 8.2 10.1 23.9 139.6 53.7 17.2 9.0 8.4 4.1 43.0 78.9 12.0 28.9 8.7 45.4 51.9 16.3 19.2 7.1 44.0 20.4 32.0 43.2 7.5 22.3 38.0 6.9 11.9 36.0 107.5 19.2 18.0 99.1 5.4 7.6 14.7 16.4 2.2 4.6 4.6 8.8 25.4 9.4 13.2 6.8 2.3 22.1 18.9 26.5 8.5 6.9 40.6 11.0 7.0 9.1 5.8 11.8 34.3 193.9 7.3 43.6 11.6 98.3 17.0 8.5 13.5 27.8 62.8 33.0 20.0 0.3 17.5 81.6 0.9 15.8 9.2 15.3 15.8 35.1 31.6 18.5 3.3 29.2 54.6 55.1 13.7 5.0 22.9 24.6 93.1 14.0 6.4 4.6 10.4 7.3 9.5 7.3 11.7 114.2 123.2 36.6 13.1 0.7 17.7 0.0 0.7 9.9 0.0 1.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 4.7 0.0 3.5 0.3 2.8 0.1 7.5 9.0 12.1 16.2 8.2 10.1 9.0 8.4 8.7 7.5 11.9 7.6 69.6 134.6 168.5 13.7 19.8 100.1 242.7 68.6 77.4 25.5 100.8 71.9 16.6 31.5 67.9 16.5 0.0 12.3 2.8 281.6 11.7 45.3 0.4 96.6 240.1 62.0 112.0 5.3 2.1 24.7 19.1 54.6 58.6 222.5 29.9 0.5 8.2 131.7 35.3 21.9 0.7 129.6 32.6 72.0 59.7 1.7 0.3 85.9 56.9 4.7 27.5 20.1 0.0 4.5 0.2 45.5 130.9 0.4 283.6 139.0 117.4 24.9 39.7 3.8 0.0 36.6 45.1 0.3 2.2 88.2 64.2 30.6 14.8 1.5 106.9 128.7 TRIM58 BIA2 ENSG00000162722 "Tripartite motif containing 58" Q8NG06 1 247857187-247880138 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 32.2;thyroid gland: 15.2" "Cell type enriched" "Detected in many" 23 "Erythroid cells: 456.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 18.3;HEL: 40.7;K-562: 21.8;PC-3: 37.0;U-2 OS: 29.0;WM-115: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023637 Uncertain NA NA "Cluster 37: B-cells - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "HPA023637: AB_1858309" "unprognostic (3.85e-1)" "unprognostic (5.24e-3)" "unprognostic (7.00e-2)" "unprognostic (6.52e-4)" "unprognostic (1.46e-1)" "unprognostic (3.47e-2)" "unprognostic (1.10e-1)" "unprognostic (4.14e-5)" "unprognostic (3.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (3.31e-1)" "unprognostic (1.08e-2)" "unprognostic (3.34e-1)" "unprognostic (1.00e-2)" "unprognostic (2.57e-2)" 0.5 0.6 0.7 0.6 0.5 32.2 0.5 0.1 1.0 0.4 0.0 1.1 0.1 0.2 0.1 0.1 1.3 0.3 0.2 0.6 2.9 0.2 0.2 1.3 0.2 3.2 4.1 0.0 0.2 0.1 0.2 5.8 4.3 1.5 0.9 0.6 0.3 0.2 0.2 0.9 0.3 0.6 1.3 2.4 0.4 2.7 3.1 0.3 15.2 1.6 0.1 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.7 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.4 1.7 18.3 0.0 0.0 0.0 1.3 40.7 0.0 0.0 0.0 5.5 2.4 0.0 0.0 0.2 0.0 0.0 0.0 1.4 21.8 0.1 0.0 0.0 0.2 0.3 2.7 0.0 37.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.2 4.7 0.0 0.0 29.0 0.0 0.0 6.3 0.0 0.0 0.0 13.0 42.1 0.7 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.6 0.7 0.5 0.1 1.0 0.6 2.9 3.2 4.1 4.3 1.3 3.1 0.9 0.6 3.2 3.0 0.3 1.7 1.0 1.4 0.0 0.6 3.4 1.1 0.3 0.5 0.0 5.6 1.8 12.5 3.3 0.4 0.8 0.0 0.1 4.3 2.5 0.7 1.7 1.2 456.4 3.7 0.0 4.6 3.0 0.0 2.1 8.2 0.4 1.8 0.1 2.4 0.0 1.8 0.4 0.0 3.2 1.4 1.2 0.9 19.4 1.8 0.0 1.0 2.7 2.1 0.5 0.3 0.2 0.7 0.7 0.3 4.0 0.0 0.2 3.7 3.7 0.0 0.9 0.7 2.8 9.7 0.1 0.9 4.9 1.7 0.3 0.8 0.8 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042467-41044337 "Predicted membrane proteins, Transporters" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 50.1" "Cell type enriched" "Detected in some" 115 "Erythroid cells: 253.9" "Cancer enhanced" "Detected in some" "liver cancer: 0.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA060691, HPA066996" Enhanced "Plasma membrane" NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 6: Erythroid cells - Oxygen transport" "Plasma membrane" "HPA060691: , HPA066996: AB_2685761" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.0 0.0 0.1 0.1 0.6 50.1 0.0 0.1 0.7 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.4 0.5 0.6 0.2 0.1 0.8 0.4 0.1 0.1 0.0 0.0 1.2 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.7 0.0 0.2 1.3 0.5 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.4 0.0 11.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.7 0.1 0.4 0.8 0.4 0.9 0.2 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.1 0.0 0.0 0.0 253.9 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 VPREB1 "CD179A, VpreB" ENSG00000169575 "V-set pre-B cell surrogate light chain 1" P12018 22 22244780-22245515 "CD markers, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "bone marrow: 29.8" "Cell type enhanced" "Detected in single" "NK-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 5.7;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 4 "B-cells: 5.7" "Group enriched" "Detected in some" 11 "Daudi: 9.4;MOLT-4: 19.8;RPMI-8226: 5.4" "Not detected" "Not detected" HPA055886 Approved "Intracellular and membrane" NA NA 62000 "Cluster 37: B-cells - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 33: Fibroblasts - ECM organization" "HPA055886: AB_2682956" 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 43.2" "Cell type enhanced" "Detected in some" "Early spermatids: 3.4;Late spermatids: 20.3;Macrophages: 4.5;monocytes: 12.4;NK-cells: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 16 "eosinophil: 129.2" "Lineage enriched" "Detected in many" 16 "granulocytes: 129.2" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;hTERT-HME1: 1.0;U-2 OS: 1.0" "Low region specificity" "Detected in all" HPA059365 Approved Vesicles "Secreted to blood" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.2 0.1 0.0 0.2 0.0 43.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.0 1.4 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 129.2 0.0 6.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 8.1 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 3.4 0.2 0.1 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 2.1 0.0 0.4 0.0 0.0 2.5 0.0 20.3 0.0 4.5 0.0 0.0 12.4 0.0 3.1 0.5 0.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 438.1" "Cell type enhanced" "Detected in all" "Late spermatids: 548.0;Plasma cells: 545.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "HPA042809: AB_2678179" "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 65.2 67.0 61.5 44.9 65.6 438.1 55.2 58.0 81.2 61.3 68.2 70.3 40.5 51.4 84.3 55.6 51.3 64.0 56.7 66.0 64.7 87.4 64.4 61.1 62.7 64.0 57.2 60.3 44.8 101.5 45.6 64.6 63.0 68.8 45.5 77.2 63.3 95.5 54.1 51.9 44.4 65.1 61.8 58.9 49.4 71.4 60.8 77.2 61.8 48.7 62.8 78.1 47.0 61.6 35.9 18.1 42.5 20.9 113.3 109.4 35.0 50.7 152.6 28.5 43.3 16.3 36.7 21.4 32.7 100.7 65.0 19.1 9.9 50.5 40.2 94.1 19.1 11.0 8.0 26.0 98.3 3.7 24.9 114.1 100.7 53.0 67.6 122.5 53.8 13.5 15.5 36.8 77.2 18.5 11.3 26.3 23.9 41.2 22.7 7.0 56.8 20.9 96.4 69.6 16.7 51.1 24.6 24.4 65.2 77.1 27.3 20.5 70.6 77.4 29.5 21.2 14.2 86.5 34.9 28.7 55.1 9.9 31.7 229.3 82.4 190.7 53.3 95.4 54.7 89.9 65.8 64.2 78.0 74.0 62.2 55.8 306.9 56.5 149.5 152.9 95.8 146.6 61.5 65.6 58.0 81.2 66.0 64.7 64.0 57.2 63.0 61.8 60.8 61.6 83.8 83.3 90.5 13.4 398.6 134.0 162.9 184.8 122.3 70.7 142.5 105.5 73.2 47.1 119.3 101.2 47.9 172.8 300.4 104.1 138.9 90.9 253.9 178.0 71.0 74.3 208.9 93.7 30.9 78.8 140.4 84.2 126.9 213.7 81.3 46.4 56.0 43.3 103.3 63.9 25.9 94.5 114.0 132.1 168.7 548.0 57.8 214.9 170.7 15.9 321.0 103.4 50.4 19.6 28.3 110.2 108.6 82.8 545.7 143.3 84.8 137.0 101.4 63.5 52.6 87.4 114.9 133.8 78.0 97.4 142.6 408.0 358.5 53.5 46.8 281.2 YRDC "FLJ23476, IRIP, SUA5" ENSG00000196449 "YrdC N6-threonylcarbamoyltransferase domain containing" Q86U90 1 37802945-37808208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 50.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 77.8;Prostatic glandular cells: 87.8;Urothelial cells: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "basophil: 8.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030147 Approved Approved Mitochondria NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Mitochondria "HPA030147: AB_10603327" "unprognostic (2.98e-2)" "unprognostic (6.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.08e-3)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.43e-2)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (3.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-2)" 12.4 11.1 8.2 9.8 8.2 50.1 11.2 9.5 9.8 6.6 7.9 9.8 8.2 7.5 8.0 16.1 8.0 8.6 7.8 8.2 8.8 10.5 14.1 8.9 10.5 8.3 8.3 7.2 14.1 10.8 10.6 13.3 8.8 8.6 11.9 8.1 9.7 6.0 8.6 16.0 8.6 9.4 7.9 9.2 10.6 16.9 8.8 8.3 9.1 5.7 10.9 16.4 9.7 8.0 25.2 17.6 18.7 23.9 12.7 14.6 53.6 20.3 16.5 31.5 19.9 23.7 23.3 60.3 32.6 20.4 36.1 20.0 35.6 32.8 29.2 36.3 35.1 42.1 21.3 24.9 27.9 55.5 41.7 15.2 48.1 35.0 50.3 20.6 22.5 45.7 66.5 26.4 25.4 17.6 32.7 32.4 70.2 36.3 37.1 32.3 30.1 39.3 26.1 25.2 48.5 49.7 22.0 28.0 72.8 33.2 15.3 24.2 20.9 26.8 28.3 29.6 67.8 53.2 81.2 50.3 23.6 35.4 43.8 8.8 0.6 0.5 0.6 0.6 0.6 0.5 0.9 0.5 0.5 0.8 1.0 1.0 0.7 0.5 0.4 0.9 1.0 0.4 8.2 8.2 9.5 9.8 8.2 8.8 8.3 8.3 8.8 7.9 8.8 8.0 31.3 0.0 9.2 3.9 21.0 50.6 77.8 6.3 29.6 10.8 28.3 25.9 3.6 10.0 5.5 5.5 6.2 24.3 23.6 7.6 23.5 7.7 3.5 16.2 15.7 22.5 15.6 17.2 3.5 9.2 48.5 14.4 10.2 25.4 7.0 13.0 10.8 12.5 12.7 21.9 3.8 10.2 4.1 9.4 19.1 1.8 4.1 15.3 5.4 3.7 6.3 10.9 4.1 3.0 5.0 15.9 7.1 4.1 25.6 87.8 6.1 16.8 4.9 8.8 6.6 12.5 22.0 19.4 37.4 28.6 49.3 40.6 20.2 14.2 11.7 92.7 ZBTB21 "KIAA1227, ZNF295" ENSG00000173276 "Zinc finger and BTB domain containing 21" Q9ULJ3 21 41986831-42010387 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.2" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 60.4;U-266/84: 57.0" "Low region specificity" "Detected in all" "HPA024655, HPA031757, HPA031758" Enhanced Enhanced Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032" "unprognostic (1.16e-2)" "unprognostic (3.51e-2)" "unprognostic (8.79e-2)" "unprognostic (1.79e-1)" "unprognostic (5.88e-2)" "unprognostic (4.61e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-2)" "unprognostic (2.67e-1)" "unprognostic (6.21e-3)" "unprognostic (2.67e-2)" "unprognostic (4.59e-2)" "unprognostic (1.35e-3)" "unprognostic (1.81e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-3)" "unprognostic (4.02e-1)" 8.9 35.6 3.2 6.0 3.6 41.2 8.1 4.6 5.6 7.9 2.2 5.7 4.0 13.7 7.1 6.5 6.6 11.9 4.6 3.9 7.2 6.5 11.2 6.9 5.1 5.3 7.2 8.5 9.4 14.0 4.8 6.9 5.0 7.8 4.9 14.2 4.1 4.2 2.5 8.8 4.7 8.5 2.2 6.5 6.5 12.2 5.3 6.4 9.5 3.1 5.4 9.6 5.1 5.4 12.8 10.0 9.6 10.9 13.3 10.2 9.3 11.6 16.6 10.9 16.5 12.0 6.2 22.5 5.1 11.6 19.6 9.5 14.1 8.2 17.6 11.9 13.9 2.6 10.3 7.3 10.2 8.9 5.2 5.9 17.2 15.2 19.9 4.8 6.2 12.2 15.1 38.0 7.8 18.6 24.0 4.3 9.5 9.3 12.3 10.1 10.7 26.4 4.8 10.1 13.6 7.9 16.1 23.8 11.2 4.8 8.5 4.2 7.0 16.0 8.9 11.3 11.5 60.4 57.0 20.9 21.0 14.5 10.6 0.1 2.4 1.2 1.6 2.8 1.9 2.6 1.8 1.3 2.4 1.9 2.6 1.9 2.3 0.5 3.2 2.1 1.3 1.2 3.2 3.6 4.6 5.6 3.9 7.2 5.3 7.2 5.0 2.2 5.3 5.4 19.0 6.4 41.1 8.1 24.7 60.0 32.9 6.2 26.2 14.5 15.6 15.9 4.9 12.8 12.4 7.3 2.1 6.7 20.8 7.1 11.7 5.4 14.0 20.8 34.8 19.6 4.2 2.1 13.8 5.0 5.5 31.9 10.2 27.1 16.5 6.7 9.3 20.4 6.1 32.0 15.5 10.2 10.2 6.3 24.8 5.3 4.1 14.5 35.6 5.6 7.2 10.1 5.2 4.5 8.1 3.9 6.0 10.5 20.3 24.7 5.4 4.8 13.5 13.6 6.6 36.1 21.0 21.5 14.1 19.3 63.2 9.7 20.8 7.3 5.6 20.9 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favorable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 5.3 5.4 4.5 4.7 5.3 60.6 5.9 6.3 6.8 5.0 9.0 4.6 5.2 5.7 4.4 9.5 4.1 5.3 10.6 4.7 4.9 3.9 7.9 8.3 5.6 4.1 5.1 6.1 4.9 9.5 4.6 5.2 4.5 4.4 5.8 9.3 6.0 3.5 32.8 14.4 4.8 5.0 3.5 5.0 7.0 16.2 5.0 5.9 5.3 20.2 6.4 5.1 6.4 6.3 6.3 4.7 8.5 7.8 7.0 9.9 8.7 8.0 8.0 6.3 5.6 11.0 4.3 8.7 3.9 8.4 12.4 18.4 7.5 8.0 7.8 7.6 5.0 6.0 14.6 4.9 9.6 8.6 11.0 12.1 20.2 10.2 25.0 6.0 4.9 7.1 10.6 19.8 9.4 6.8 7.5 5.4 7.8 6.7 8.0 6.3 27.4 7.1 6.8 7.2 7.5 6.9 8.5 8.5 7.8 7.6 7.6 5.4 4.7 7.6 7.1 8.4 7.0 21.0 16.4 3.3 9.4 7.0 6.3 12.0 4.5 3.9 7.0 4.3 6.8 4.2 3.8 4.1 3.7 3.3 4.1 4.8 2.5 6.7 3.5 2.0 6.1 3.3 4.5 5.3 6.3 6.8 4.7 4.9 4.1 5.1 4.5 3.5 5.0 6.3 16.5 35.3 44.7 34.0 23.4 84.9 68.2 37.5 30.7 42.2 36.0 19.9 42.7 27.1 46.1 27.6 108.4 18.2 30.6 80.2 1.9 31.1 91.2 51.7 35.0 25.1 11.4 21.4 44.2 18.5 12.3 27.7 78.5 133.6 31.0 23.7 17.5 25.3 14.7 26.9 40.5 21.6 40.7 21.7 74.1 45.3 17.7 46.4 24.9 12.2 18.3 29.3 21.6 25.6 37.3 43.4 51.5 14.3 27.2 54.9 33.5 7.9 27.7 55.7 13.1 39.4 29.3 49.7 73.1 70.8 117.3 52.0 31.8 22.4 25.6 141.7 ZC3HAV1 "ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043515-139132122 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 85.9" "Cell type enhanced" "Detected in many" "dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" NA NA 24000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: AB_2683903" "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favorable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 13.5 12.7 8.7 19.1 8.9 85.9 11.1 8.1 15.2 8.6 12.2 12.9 9.7 8.6 10.3 12.9 9.7 11.4 6.4 8.1 13.6 11.1 11.0 16.1 24.0 12.3 11.5 10.9 7.3 9.2 6.2 9.3 12.3 9.5 13.7 2.5 14.3 9.1 3.2 13.1 13.9 13.8 12.7 21.0 10.4 6.5 14.9 24.0 10.6 5.6 23.8 11.9 8.7 12.4 25.1 29.5 4.1 24.7 37.4 35.9 17.6 27.5 21.2 46.9 47.7 21.6 31.4 21.9 25.2 43.9 40.6 27.6 33.2 32.6 26.3 37.2 12.2 43.8 29.7 26.9 21.8 51.1 38.6 37.0 20.3 53.3 11.8 17.4 35.3 32.1 37.6 23.5 20.1 23.3 41.9 59.0 16.6 18.6 17.6 48.5 14.6 21.0 32.0 31.0 7.5 15.4 43.1 29.2 37.8 9.3 17.4 30.9 45.3 9.9 14.3 27.6 23.1 17.9 20.2 49.9 22.4 47.0 24.0 78.7 19.6 30.8 43.0 26.0 56.0 32.2 61.9 53.1 15.2 35.3 59.0 58.6 52.5 38.7 30.6 17.7 58.8 30.6 8.7 8.9 8.1 15.2 8.1 13.6 12.3 11.5 12.3 12.7 14.9 12.4 150.3 25.6 41.1 8.1 119.4 28.7 21.7 17.5 62.6 2.8 70.8 44.8 6.2 21.5 21.1 53.3 4.2 12.6 194.8 57.0 9.8 20.2 2.8 185.9 77.7 74.5 53.2 64.4 0.8 21.2 23.1 68.1 60.6 359.9 32.3 41.6 49.2 36.1 35.1 0.0 3.0 42.2 8.2 43.9 150.0 1.9 18.6 84.4 39.2 33.7 57.1 13.9 88.6 27.6 1.0 23.8 33.8 26.7 104.2 41.5 28.0 36.4 29.9 1.3 13.1 79.5 53.6 1.0 1.1 61.7 22.3 2.3 222.3 41.3 35.8 28.0 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99473877-99504857 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 97.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Approved Enhanced Nucleoplasm,Cytosol Yes No "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 13.3 9.6 8.6 10.3 9.5 97.0 12.5 16.4 8.3 11.9 8.8 12.5 10.3 10.4 6.9 12.6 12.5 7.3 12.2 7.7 9.0 10.4 10.1 13.3 13.6 9.8 9.1 13.9 9.7 7.7 9.4 8.1 9.0 13.5 8.6 5.4 10.2 7.7 12.2 15.4 14.3 7.8 8.5 19.2 11.5 10.6 9.4 12.8 10.2 9.6 11.3 11.9 12.2 10.6 10.3 10.2 6.6 14.0 10.4 7.1 13.1 8.5 11.6 9.9 9.7 11.0 11.0 12.4 12.2 9.2 13.5 9.6 9.2 11.2 9.8 9.1 12.0 12.2 12.0 12.1 8.3 17.4 20.0 9.4 9.6 9.6 10.2 7.3 11.6 10.5 17.6 24.0 9.3 19.6 18.3 28.8 15.0 12.9 12.0 10.2 7.3 22.1 11.0 14.7 7.8 16.5 10.2 24.6 16.9 16.5 6.4 21.8 11.9 11.7 12.0 17.4 10.9 19.7 22.1 20.0 8.5 17.4 12.9 56.8 20.6 36.6 31.7 25.5 33.2 24.5 31.8 34.3 22.6 23.6 38.5 30.8 37.8 36.8 26.8 32.8 37.7 24.6 8.6 9.5 16.4 8.3 7.7 9.0 9.8 9.1 9.0 8.5 9.4 10.6 29.3 16.0 19.7 5.2 37.1 35.6 36.1 16.4 16.5 9.7 20.6 14.6 11.4 8.6 16.6 11.0 12.5 15.8 56.7 26.3 17.6 15.7 10.4 17.3 12.9 22.2 20.8 31.5 4.6 14.1 18.2 17.5 25.0 24.4 58.9 17.1 17.5 12.3 18.9 15.2 5.0 16.9 8.2 25.5 29.6 2.9 15.5 29.3 28.4 1.9 19.3 13.6 45.3 7.1 5.6 16.4 20.8 13.5 31.8 29.2 29.7 11.7 19.4 11.7 13.1 22.6 19.7 41.9 30.6 21.5 35.5 29.7 54.3 24.6 18.6 65.6 ZXDC "FLJ13861, MGC11349" ENSG00000070476 "ZXD family zinc finger C" Q2QGD7 3 126437601-126475891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.4" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.4" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;granulocytes: 1.7;monocytes: 4.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049593 Approved Nucleoli Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoli "HPA049593: AB_2680828" "unprognostic (3.06e-1)" "unprognostic (2.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.06e-2)" "unprognostic (5.97e-2)" "unprognostic (4.34e-2)" "unprognostic (3.37e-2)" "unprognostic (2.67e-2)" "unprognostic (1.06e-1)" "unprognostic (8.13e-2)" "unprognostic (2.98e-1)" "unprognostic (4.66e-2)" "unprognostic (1.12e-3)" 6.9 5.2 6.8 6.2 9.4 39.4 6.3 8.7 9.6 8.1 9.2 5.3 5.0 7.8 5.2 7.3 8.8 6.0 5.6 6.6 5.9 6.3 7.6 7.0 7.9 9.6 8.1 10.7 14.9 10.1 3.9 7.5 8.7 7.2 5.4 7.6 8.0 6.6 16.2 9.7 5.9 6.5 6.7 8.8 6.7 6.4 8.3 10.0 8.5 9.8 6.0 6.1 5.6 14.4 15.2 7.6 9.4 8.9 10.1 7.8 16.7 6.7 7.4 9.7 8.6 11.6 6.4 11.2 11.2 6.1 8.9 12.3 12.6 7.9 7.6 6.0 10.8 8.8 9.2 7.7 10.7 13.6 13.7 6.2 15.1 6.0 10.6 9.6 10.0 13.0 9.6 14.6 8.2 8.9 13.1 7.5 13.4 10.0 7.6 14.1 6.4 14.3 6.8 10.9 17.1 9.5 13.0 9.5 18.2 6.2 12.9 11.9 10.2 8.9 11.4 13.4 8.3 12.1 6.1 14.6 9.7 10.5 10.0 1.7 0.4 0.8 0.5 0.2 0.2 0.1 0.3 0.4 0.7 0.4 0.5 0.4 1.2 0.3 4.4 1.1 0.2 0.2 6.8 9.4 8.7 9.6 6.6 5.9 9.6 8.1 8.7 6.7 8.3 14.4 10.1 25.6 15.6 84.5 11.9 6.2 8.3 4.5 10.8 30.1 6.8 6.5 5.5 12.8 7.9 5.5 45.9 7.2 10.0 8.6 7.9 4.8 1.7 8.1 7.9 7.7 3.6 12.0 51.3 6.1 2.6 7.8 9.2 12.2 2.5 16.8 7.9 14.3 5.7 13.5 44.3 6.9 0.0 5.4 4.4 0.8 7.5 9.0 1.8 47.8 7.3 23.0 7.2 67.8 99.2 4.4 5.2 7.5 12.9 6.0 8.4 9.5 7.7 30.4 0.0 13.5 8.9 3.3 9.0 9.0 4.3 6.3 11.1 10.5 6.6 6.3